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receptors to synapses in the accumbens, a process involving CaMKII, is associated with the reinstatement of
cocaine seeking. Additional evidence indicates that the dorsal striatum contributes to aspects of cocaine
addiction. Moreover, relapse to cocaine abuse has been connected to elevated levels of anxiety during
withdrawal and anxiolytic agents decrease the latency for animals to self-administer cocaine. A growing body
of evidence indicates that environmental information can be inherited. We have previously described a
cocaine-resistance phenotype in the offspring of animals that have self-administered cocaine. The
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and accumbens, as well as its indirect consequences for drug-naÃ¯ve offspring. Acute exposure to cocaine in
drug naÃ¯ve rats increased CaMKII-mediated phosphorylation of GluA1-containing AMPA receptors in the
DL striatum, an effect that was not observed during cocaine priming-induced reinstatement of drug seeking.
The increased phosphorylation of CaMKII and GluA1 following acute cocaine may be a compensatory
mechanism in the DL striatum. Accumbens shell CP-AMPAR receptor transmission, mediated through
interactions of GluA1-containing AMPARs with accessory protein SAP97, is necessary for cocaine
reinstatement. Consideration of GluA1 subunit accessory proteins as potential novel targets for
pharmacotherapeutic interventions in cocaine craving and addiction is warranted. Male offspring of cocaine-
experienced sires exhibit baseline anxiety-like behaviors that are unaltered by subsequent cocaine exposure
and dysregulation of hippocampal cellular and molecular correlates of anxiety. This identifies impairments of
male offspring emotional control due to sire cocaine exposure independent of the cocaine-resistance
phenotype. Collectively, these findings advance our knowledge of the direct and intergeneration effects of
cocaine experience on the brain and behaviors.
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ABSTRACT 
 
COCAINE SELF-ADMINISTRATION: 
ADAPTATIONS TO THE GLUTAMATERGIC SYSTEM AND 
CONSEQUENCES FOR OFFSPRING EMOTIONAL CONTROL 
 
Samantha Louise White 
R. Christopher Pierce, Ph.D. 
 
Cocaine abuse and relapse remain a major public health concern in the United States 
and worldwide for which there is currently no approved pharmacotherapeutic 
intervention.  Rodent cocaine self-administration, extinction, and priming-induced 
reinstatement can be used to model human cocaine seeking.  A growing body of 
evidence indicates that the transport and stabilization of calcium-permeable (CP) AMPA 
glutamate receptors to synapses in the accumbens, a process involving CaMKII, is 
associated with the reinstatement of cocaine seeking.  Additional evidence indicates that 
the dorsal striatum contributes to aspects of cocaine addiction.  Moreover, relapse to 
cocaine abuse has been connected to elevated levels of anxiety during withdrawal and 
anxiolytic agents decrease the latency for animals to self-administer cocaine.  A growing 
body of evidence indicates that environmental information can be inherited.  We have 
previously described a cocaine-resistance phenotype in the offspring of animals that 
have self-administered cocaine.  The enhancement of cocaine’s anxiogenic effects may 
contribute to reduced cocaine self-administration among male cocaine-sired rats.  Here, 
a variety of behavioral, cellular, molecular, and electrophysiological techniques are used 
to examine how cocaine experience directly affects the glutamatergic system in the 
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dorsal striatum and accumbens, as well as its indirect consequences for drug-naïve 
offspring.  Acute exposure to cocaine in drug naïve rats increased CaMKII-mediated 
phosphorylation of GluA1-containing AMPA receptors in the DL striatum, an effect that 
was not observed during cocaine priming-induced reinstatement of drug seeking.  The 
increased phosphorylation of CaMKII and GluA1 following acute cocaine may be a 
compensatory mechanism in the DL striatum.  Accumbens shell CP-AMPAR receptor 
transmission, mediated through interactions of GluA1-containing AMPARs with 
accessory protein SAP97, is necessary for cocaine reinstatement.  Consideration of 
GluA1 subunit accessory proteins as potential novel targets for pharmacotherapeutic 
interventions in cocaine craving and addiction is warranted.  Male offspring of cocaine-
experienced sires exhibit baseline anxiety-like behaviors that are unaltered by 
subsequent cocaine exposure and dysregulation of hippocampal cellular and molecular 
correlates of anxiety.  This identifies impairments of male offspring emotional control due 
to sire cocaine exposure independent of the cocaine-resistance phenotype.  Collectively, 
these findings advance our knowledge of the direct and intergeneration effects of 
cocaine experience on the brain and behaviors.   
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PREFACE 
 
COCAINE ADDICTION: A PUBLIC HEALTH CONCERN 
Samantha L. White 
 
Substance abuse is defined as a maladaptive, recurrent pattern of substance use that 
significantly impairs an individual’s daily functioning and/or interpersonal relationships. 
The point when an individual fails to successfully stop drug use, displays symptoms of 
drug tolerance (requiring progressively higher doses to achieve the desired effect), or 
withdrawal (adverse psychological and/or physiological symptoms due to abstinence 
from the drug), is indicative of dependence or addiction (4th ed., text rev.; DSM–IV–TR; 
American Psychiatric Association, 2000). There are three categories of abused 
substances: psychostimulants, depressants, and hallucinogens, which have a variety of 
rewarding effects when used that contribute to their addiction liability.  These effects 
promote continued abuse despite negative consequences to health, career, and 
interpersonal relationships, influencing the lives of more than just the addicted individual 
(4th ed., text rev.; DSM–IV–TR; American Psychiatric Association, 2000). This 
dissertation will focus on the neurobiological, behavioral, and inherited effects of one 
psychostimulant in particular: cocaine.  
The United States spends approximately 181 million dollars annually to combat 
the use of illicit drugs, including cocaine (Karch, 1999; SAMHSA, 2012). In fact, the 
United States is the current leader in global demand for cocaine.  Cocaine use is 
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involved in almost 500,000 emergency room visits annually, and over 600,000 people 
begin using cocaine each year (NIDA, 2009; SAMHSA, 2012; NADCP, 2013). Cocaine 
abuse is positively correlated with the incidence of fatal road accidents, the spread of 
HIV/AIDS and hepatitis, and developmental delays, among myriad other negative effects 
(NIDA, 2010; Elvik, 2012). Unfortunately, cocaine abuse is also associated with a high 
rate of relapse to drug taking following periods of abstinence, making cocaine addiction 
a continuing public health concern that impacts our country’s communities, the 
government, and medical system (O'Brien, 1997). Although efforts have been made by 
society, the government, and the medical field to cope with cocaine addiction and 
relapse, there remains no permanent behavioral or pharmacotherapeutic treatment for 
this disorder. 
Society 
In the relatively recent past, drug addiction, once considered a moral failing by many in 
our society, has been redefined as a medical condition stemming from long-lasting 
changes to brain structure and chemistry (Sowers, 1998; Martinez et al., 2007). Given 
that many recognize that an addict’s first experience with a drug such as cocaine is 
typically voluntary, research showing lasting alterations in brain function has 
encouraged, at best, a reluctant public acceptance of cocaine dependence as a 
biological deficit requiring medical intervention (Childress et al., 1999; Hyman et al., 
2006; Volkow et al., 2009). In fact, self-reported addicts still describe difficulty stopping 
use and/or increased incidence of relapse due to concerns that withdrawal symptoms 
will negatively impact job opportunities and increase the risk for stigmatization by their 
community (Mooney et al., 2012). Because relapse rates inversely correlate with one’s 
level of education and employment, understanding and support by the general public is 
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paramount to the success of those battling addiction in a period rife with school closings 
and spiking unemployment rates (SAMHSA, 2012; Statistics, 2013). Given that 
continued drug abuse and relapse increase the socioeconomic burden for non-drug 
users, and current efforts to treat addiction are only impeded by prejudiced views of 
addiction, it is in the best interest of the public to support policies that advance research 
on treatment of addiction as a medical condition (Dackis et al., 2005; Dackis and 
O'Brien, 2005). 
Government 
Government policies, across executive, legislative, and judicial levels, have recently 
started to address drug addiction in a manner that educates the public and helps 
advance treatment research.  In 2008, President Obama created the Office of National 
Drug Control Policy in an effort to counter the failed “war on drugs” crusade of previous 
administrations; this act established dedicated funds for substance abuse treatment 
programs through 2015 (ONDCP, 2013). The National Drug Control Strategy created by 
this office relies upon scientific research indicating a biological basis for addiction to help 
form public health policy that has successfully reduced drug use and its consequences.  
Countless movements, ranging from novel treatment programs to budgeting for addiction 
rehabilitation and health care, to improvements for prisoners with a history of substance 
abuse, have come before state legislatures in the past decade (NCSL, 2013). One 
benefit of adjustments at the executive and legislative levels can be quantified in the 
judicial system, where for every dollar spent on substance abuse treatment, seven 
dollars are saved in criminal justice system costs (SAMHSA, 2012). Additionally, reform 
of the judicial branch created drug courts: special dockets designed specifically for non-
violent offenders with a history of substance abuse that allow for continued, court-
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managed participation in treatment programs to help reduce the rate of relapse 
associated with jail-time and recent parole (www.nadcp.org; SAMHSA 2010).  These 
actions suggest a growing government awareness and acceptance of drug addiction as 
a disease, which should both decrease lingering stigma in the minds of the general 
public and ensure that the medical system and researchers obtain the support and 
funding necessary to further treatment options. 
Science and Medicine 
Though the scientific and medical communities lead the efforts to define and treat 
substance abuse as a disease, there remain a multitude of roadblocks in translating 
findings to practice.  Despite the inclusion of substance abuse rehabilitation as an 
essential component of health care in the 2010 Affordable Care Act, most addicted 
individuals report paying out-of-pocket for treatment programs and many health 
insurance companies still do not offer coverage for cocaine addiction (Mooney et al., 
2012; SAMHSA, 2012; ONDCP, 2013).  Unlike nicotine, alcohol, or heroin dependence, 
there are no FDA-approved pharmacotherapeutic interventions for cocaine addiction, 
leaving time-consuming behavioral therapies like cognitive behavioral therapy as the 
only alternatives (Penberthy et al., 2010). One attractive proposal that has reached 
stage II clinical trials is the TA-CD cocaine vaccine, which promotes the development of 
antibodies that bind molecules of cocaine before they can bind to receptors in the body, 
blunting the rewarding effects of the drug (Haney et al., 2010). Unfortunately, this 
prospective solution is not without flaws.  Medically, it takes weeks of shots for cocaine-
specific antibodies to build up to therapeutic levels, booster injections are required to 
maintain effectiveness past 2 months, and individuals risk serious injury or death if they 
attempt to overwhelm the antibody response by taking high quantities of cocaine (Haney 
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et al., 2010; Young et al., 2012). Ethical issues arise when contemplating who should 
receive the vaccine, production costs versus ability to afford the injections, prophylactic 
use in at-risk groups, and the potential stigma associated with use of the vaccine (Hall 
and Gartner, 2011; Young et al., 2012). In spite of all that scientific research has done to 
amend policies on drug addiction and to sway public opinion, more work is needed to 
ensure appropriate consideration of this disease in the health care system as well as 
establishing safe, effective interventions that stop the cycle of abuse and relapse. 
Despite the changing perception and management of substance abuse disorders 
by society and the government and evidence that investments in treatment programs 
and biomedical research save money long-term, more must be done to address this 
public health issue.  Over 19 million people still need specialized treatment for addiction 
and increased globalization of cocaine trafficking suggests that use will continue 
regardless of containment policies (Costa Storti and De Grauwe, 2009; Mooney et al., 
2012). Much of the scientific evidence that has provided insight into the nature of 
addiction and has prompted a shift in public opinion of this disease has stemmed from 
preclinical research (Dackis and O'Brien, 2005). The preclinical experiments outlined in 
this dissertation aim to better understand the neurological mechanisms underlying, and 
consequences of, cocaine addiction and relapse with the hope of identifying a novel 
target for future pharmacotherapeutic intervention. 
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CHAPTER 1 
 
GENERAL INTRODUCTION 
 
Samantha L. White 
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Animal Models of Addiction: Cocaine Self Administration and Reinstatement 
To delve into the underlying mechanisms of human cocaine addiction and relapse, 
scientists have relied upon well-established preclinical rodent and non-human primate 
animal models.  In rats, cocaine self-administration, extinction, and reinstatement of 
cocaine-seeking behavior represent the cycle of addiction, recovery, and relapse seen in 
humans (de Wit and Stewart, 1981; Shaham et al., 2003).  The drug-free extinction 
period loosely models the times when human addicts are enrolled in rehabilitation 
centers or are otherwise no longer exposed to cocaine, as true cocaine extinction 
learning does not typically occur in humans (Epstein et al., 2006).  As with human 
relapse, three factors precipitate the reinstatement of drug seeking in rodents: stress 
exposure (a mild foot shock or forced-swim test), environmental stimuli associated with 
the drug (often a light and/or tone paired with drug infusions), or re-exposure to the drug 
itself (non-contingent, experimenter delivered, intra-peritoneal [“i.p.”] injections) (Schmidt 
and Pierce, 2010).   
In the rat model, rodents are implanted with jugular catheters and are trained to 
self-administer cocaine intravenously (i.v.) in an operant chamber (Spealman and 
Goldberg, 1978). Typically, this requires the rodents to learn to press one lever, the 
“active” lever, in an established schedule in order to receive the drug.  The animals must 
also learn that pressing a second, “inactive” lever, has no consequence on drug delivery.  
The schedule of reinforcement can range from a fixed ratio (FR), where the amount of 
work required to obtain a single infusion of the drug remains constant (e.g. one lever 
press results in one infusion, 5 lever presses results in one infusion), to a progressive 
ratio (PR), where animals must respond with an increasing frequency in order to receive 
the same amount of drug (Spealman and Goldberg, 1978).  The extent of self-
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administration also varies in both the amount of cocaine available within a given session 
as well as the total number of self-administration sessions.  Short-access paradigms 
generally use sessions 2 hours or less in length, while long-access or “binge” paradigms 
employ sessions that are 4-6 hours long (Pierce and Wolf, 2013; Purgianto et al., 2013). 
Regardless, following self-administration training, animals either remain in their home 
cage for some period of time, or they participate in extinction sessions where lever 
pressing no longer results in drug administration.   During extinction training, rodents will 
initially seek cocaine by accessing the active lever at a very high rate before gradually 
tapering off the behavior upon learning the drug is no longer available.  This excessive 
drug-seeking behavior when drug is initially absent is known as an “extinction burst,” and 
drug-seeking behavior is considered extinguished once responding is significantly 
reduced (for example, by 15%) from that on the last day of self-administration.   Re-
exposure to the drug, also known as cocaine priming-induced reinstatement, typically 
produces the most robust, lasting drug seeking response in rodents (Shalev et al., 
2002).  While a range of doses can be used during the reinstatement of cocaine seeking, 
the minimum dose to reliably elicit drug-seeking behavior is 10 mg/kg (i.p.) (Anderson et 
al., 2003). 
Cocaine and Neurotransmitter Systems: Dopamine and Glutamate 
Dopaminergic System 
Cocaine prevents the reuptake of all three monoamines (dopamine, serotonin, and 
norepinephrine) in the brain, resulting in disproportionately increased extracellular 
concentrations of these neurotransmitters (NIDA, 2011).  The reinforcing properties of 
cocaine are primarily reinforced by dopaminergic transmission (Pierce and Kumaresan, 
2006).  Increased extracellular dopamine is associated with the reinforcing effects of 
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cocaine and dopamine reuptake inhibitors are sufficient to induce the reinstatement of 
cocaine seeking without re-exposure to the drug itself (Schmidt et al., 2005; Pierce and 
Vanderschuren, 2010).  Dopamine receptors (of which there are 5 subtypes) are G-
protein coupled receptors that are categorized into two groups, which can have opposing 
consequences on intracellular signaling following activation.  D1-like receptors (D1R) 
couple to a Gαs or Gαolf protein to increase cAMP production in the cell, while D2-like 
receptors (D2R) couple to a Gαi or Gαo protein to decrease cAMP production (Neve et 
al., 2004).  That said, neuronal responses due to the activation of D1-like or D2-like 
receptors vary widely, suggesting a modulatory role for dopamine in the brain.   
In the ventral striatum, particularly in the nucleus accumbens (NAc), phasic 
dopamine receptor activity in medium spiny neurons (MSNs) occurs during the 
acquisition of cocaine self-administration (Willuhn et al., 2012).  Further, cocaine 
exposure causes the potentiation of NAc D1R MSNs in parallel with locomotor 
sensitization, and recent work has shown that activation or inhibition of D2Rs in the 
accumbens suppresses cocaine self-administration or increases the motivation to 
acquire drug, respectively (Pascoli et al., 2011; Bock et al., 2013).  Increased dopamine 
transmission through dopamine receptors has been connected to the priming-induced 
reinstatement of cocaine seeking (Schmidt et al., 2005; Shaham et al., 2003).  
Furthermore, D1- and D2-like agonist compounds promote reinstatement in rodents and 
non-human primates (Khroyan et al., 2003; Bachtell et al., 2005; Schmidt and Pierce, 
2006).  Injection of D1R or D2R antagonists into the shell subregion of the accumbens 
attenuates cocaine self-administration without altering food-seeking behavior, 
suggesting a role for both receptors in the reinforcing efficacy of cocaine (Bari and 
Pierce, 2005).  However, the same antagonists injected into the core subregion 
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attenuate both the reinstatement of cocaine- and food-seeking behavior, indicating a 
global influence on reward in this nearby area.   
Glutamatergic System 
Though the excitatory neurotransmitter glutamate is not directly impacted by the 
presence of cocaine, repeated cocaine exposure changes the glutamatergic tone of the 
mesocorticolimbic reward system. Following cocaine exposure, there is increased 
extracellular dopamine in the medial prefrontal cortex (mPFC), which in turn activates 
the glutamatergic pathway from the mPFC to the accumbens subregions, leading to 
altered accumbal glutamate following repeated cocaine exposure and during 
reinstatement (Pierce et al., 1996; Park et al., 2002; McFarland et al., 2003).  In fact, 
cocaine priming-induced reinstatement selectively increases NAc extracellular 
glutamate, and transient inactivation of mPFC efferents using gamma-aminobutyric acid 
(GABA) agonists prevents both the reinstatement of cocaine seeking and the rise in 
glutamate in the NAc (McFarland et al., 2003).   
When released, glutamate, a major excitatory neurotransmitter, binds both 
ionotropic receptors, such as α-Amino-3-hydroxy-5-Methylisoxazole-4-Propionic Acid 
(AMPA) receptors or N-methyl-D-aspartate (NMDA) receptors, and metabotropic 
glutamate receptors (mGluRs) (Pierce and Schmidt, 2010).  While the consequences of 
NMDAR activation during cocaine self-administration and cocaine priming-induced 
reinstatement are complex, there is a much clearer role for glutamatergic transmission 
via AMPARs (Pierce and Schmidt, 2010; Pierce and Wolf, 2013).  The activation of 
D1Rs in the accumbens shell initiates a signaling cascade that stimulates L-type calcium 
channels and produces serial phosphorylation of calcium calmodulin-dependent protein 
kinase kinase α (CaMKII) and the phosphorylation and trafficking of GluA1 subunit of 
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AMPA glutamate receptors to the shell plasma membrane (See Figure 1.1) (Anderson et 
al., 2008).  CaMKII can maintain an activated state via autophosphorylation at threonine 
286, allowing continued phosphorylation of AMPAR subunit GluA1 at serine 831 even 
after D1R signaling has ceased (Miller et al., 1988; Lisman and Zhabotinsky, 2001).  
Disrupting the function, activation, or trafficking of any of these proteins – L-type calcium 
channels, CaMKII, or GluA1 in the shell – attenuates cocaine priming-induced 
reinstatement, which is presumably a result of increased extracellular glutamate acting 
on AMPARs (Anderson et al., 2008). 
Brain Regions Involved during the Reinstatement of Cocaine Seeking 
Cocaine exerts its actions within multiple brain regions that comprise the 
mesocorticolimbic reward system (Ritz et al., 1990; Schmidt and Pierce, 2010).  This 
circuitry encompasses dopaminergic neurons in the ventral tegmental area (VTA), limbic 
structures like the NAc, and cortical areas including the prefrontal cortex (PFC) 
(Feltenstein and See, 2008).  Typically, these regions evolved to identify natural rewards 
like food or sex, but cocaine disproportionately enhances activation of the system 
through changes to neuronal firing patterns, cellular and molecular adaptations, altered 
biochemistry, or some combination of all three (Olsen, 2011; Pierce and Wolf, 2013).   
Ventral Tegmental Area 
The ventral tegmental area (VTA) is located in the midbrain and contains one of the 
largest populations of dopamine-producing neurons in the brain.  These neurons send 
projections to other areas in the mesocorticolimbic reward pathway including the NAc 
and PFC, and connected structures like the amygdala and hippocampus (Figure 1.2) 
(Mameli and Luscher, 2011).  Interestingly, the accumbens and the PFC send inhibitory 
and excitatory projections to the VTA, respectively, creating a feedback loop to modulate 
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reward learning (Sesack and Grace, 2010).  Approximately 60% of VTA neurons are 
dopaminergic and contain excitatory glutamate receptors that increase neuronal 
excitability and neurotransmitter release upon activation (Bayer and Glimcher, 2005).  
The firing pattern of these dopamine neurons switches from tonic to phasic firing upon 
presentation of appetitive stimuli or, if the stimuli have been paired with a visual or 
auditory cue, upon presentation of the cue, providing a neuronal correlate of reward 
prediction (Schultz et al., 1997).  Approximately 35% of all neurons in the VTA GABA-
containing inhibitory interneurons, the activation of which prevents the release of 
dopamine (Nair-Roberts et al., 2008).  As a result of cross-talk between these neuronal 
populations and outside inputs, dopamine neurons in the VTA undergo synaptic 
plasticity upon exposure to drugs of abuse (Sesack and Grace, 2010; Mameli and 
Luscher, 2011).  Acute exposure to cocaine is sufficient to promote an increase in 
calcium-permeable AMPA receptors in VTA neurons that results in transient long-term 
potentiation (LTP), a form of synaptic plasticity often associated with learning and 
memory (Bellone and Luscher, 2006).  In the case of cocaine self-administration, LTP is 
measured in VTA dopaminergic neurons for months following the last infusion of 
cocaine, which may represent a cellular correlate underlying addictive behavior (Chen et 
al., 2008a).  
Prefrontal Cortex 
The prefrontal cortex, and the mPFC in particular, receives dopaminergic projections 
from the VTA and sends excitatory glutamatergic projections back to the VTA as well as 
to other regions of the reward pathway like the NAc (Figure 1.3) (Sun and Rebec, 2005).  
In fact, the connections between the mPFC and the accumbens are required during 
cocaine priming-induced reinstatement (Del Arco and Mora, 2008; Vassoler et al., 2008).  
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Administration of a dopamine receptor agonist directly into the PFC can elicit the 
reinstatement of drug-seeking behavior even when the VTA is inactivated (McFarland 
and Kalivas, 2001).  Tracing studies have identified that the projections between the 
mPFC and the NAc can be separated along the mPFC dorsal (d) to ventral (v) axis, with 
successful attenuation of cocaine priming-induced reinstatement via disruptions to 
dopamine signaling in the dmPFC (McFarland and Kalivas, 2001; Porrino et al., 2004; 
Schmidt et al., 2005).  Further, the interaction of these brain regions provides a key 
connection between the directly influenced dopamine system and the indirect modulation 
of the glutamatergic system.  Activation of dopamine receptors in the PFC via dopamine 
efferents from the VTA increases the surface expression of cortical GluA1 AMPA 
receptor subunits, facilitating excitation and LTP in the PFC (Sun et al., 2005).  The 
probability of glutamate release from the PFC onto accumbens MSNs increases with 
both non-contingent and, to a greater degree, contingent cocaine exposure (Suska et al., 
2013).  Transient, pharmacological inactivation of the dmPFC attenuates priming-
induced reinstatement of cocaine seeking as well as the associated rise in extracellular 
glutamate in the accumbens core (McFarland et al., 2003).  Together, these data 
represent a mechanism through which cocaine exposure promotes synaptic plasticity in 
the PFC to modulate the mesocorticolimbic reward system during drug use.    
Nucleus Accumbens 
Located in the ventral striatum, the nucleus accumbens processes drug and natural 
rewards and can be separated into two subregions, the core and the shell (Schmidt and 
Pierce, 2010).  The neuronal population is relatively homogenous across both 
subregions, comprised mainly of GABAergic medium spiny neurons (MSNs) (Tepper et 
al., 2007).  These MSNs contain dopamine receptor (R) subtypes (D1-like and D2-like) 
	   9	   	  
as well as glutamate receptors (including AMPARs) that activate in response to 
dopaminergic and glutamatergic projections from the VTA and PFC, respectively 
(Figures 1.1 and 1.3) (Sesack and Grace, 2010).  Together, these subregions comprise 
the primary input nuclei of the limbic system and the basal ganglia (Heimer et al., 1991).  
The core receives projections from the dmPFC, while the shell receives projections from 
the vmPFC (Figure 1.3) (Schmidt et al., 2005).  The core is associated with the basal 
ganglia, sending inhibitory projections via the ventral pallidum and substantia nigra to 
motor areas of the cortex, and receives dopaminergic efferents from the VTA after 
processing occurs in the shell (Day and Carelli, 2007; Pierce and Vanderschuren, 2010).  
On the other hand, the accumbens shell is associated with the limbic system, is first to 
receive direct dopaminergic input from the VTA, and projects back to the VTA in addition 
to other subcortical limbic structures (See Figure 1.4) (Haber et al., 2000; Day and 
Carelli, 2007).    
While both regions are important during cocaine self-administration and the 
reinstatement of drug-seeking behavior, their roles are distinct.  Thus, the core is 
involved in the acquisition of drug seeking and cue-induced cocaine seeking, as well as 
broader, non-drug operant learning, while the shell is the primary mediator for the 
reinforcing effects of cocaine (Ito et al., 2004; Bari and Pierce, 2005; Di Ciano et al., 
2008).  Transient inactivation of neurons in either the core or shell subregion of the 
accumbens significantly attenuates cocaine priming-induced reinstatement, while intra-
accumbal microinjection of AMPA alone reinstates cocaine-seeking behavior (Ping et al., 
2008; Vassoler et al., 2008).  Further, injection of D1R or D2R agonists into the 
accumbens elicits the reinstatement of drug seeking, and D1R activation is associated 
with increased AMPAR expression during cocaine-priming induced reinstatement 
(Bachtell et al., 2005; Schmidt et al., 2006; Anderson et al., 2008).  Interestingly, 
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increased surface expression of calcium permeable AMPARs occurs after extended 
abstinence as well as during cocaine priming-induced reinstatement (Pierce and Wolf, 
2013).    
Dorsal Striatum 
While the accumbens in the ventral striatum has clear connections to the rewarding 
efficacy of cocaine, the dorsal lateral (DL) striatum has been implicated in the 
development of habitual drug seeking (Pierce and Vanderschuren, 2010).  Habit-based 
responding is independent of the value of the reinforcer and relies on a stimulus-
response association (Dickinson et al., 2002).  Conversely, goal-directed responding 
encompasses behaviors or actions that are mediated by the value of a given reinforcer 
(Miles et al., 2003).  The ventral striatum is more consistently associated with goal-
directed behaviors, and the dorsal striatum is more involved in habitual responding.  
With limited cocaine self-administration training, negative reinforcers (like foot shock) 
suppress drug-seeking behavior, and blocking dopaminergic transmission in the NAc, 
but not DL striatum, decreases the rewarding efficacy of cocaine (Vanderschuren and 
Everitt, 2004; Bari and Pierce, 2005; Murray et al., 2012).  Interestingly, inactivation of 
the dorsomedial (DM) striatum also prevents the acquisition of operant behaviors, and 
dopamine transmission is required for goal-directed cocaine seeking (Yin et al., 2005; 
Murray et al., 2012).  Following prolonged periods of cocaine self-administration 
experience or cue-controlled self-administration, negative reinforcers no longer influence 
drug seeking, and intra-DL striatum dopamine or AMPAR antagonists attenuate 
responding (Vanderschuren and Everitt, 2004; Vanderschuren et al., 2005).  
A study in primates used antero- and retrograde tracers to establish an 
ascending spiral of connectivity from dopamine neurons in the midbrain across the 
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nucleus accumbens, dorsomedial (DM) striatum, and dorsolateral (DL) striatum (Figure 
1.4) (Haber et al., 2000).  Similar to the accumbens, dorsal striatal brain regions also 
contain GABAergic MSNs that are phasically active, firing in anticipation of movements, 
particularly those associated with reward (Nicola, 2007).  There is increased modulation 
of DM and DL MSN firing, as well as increased MSN excitation and synaptic strength, 
during early and late stages of operant training, respectively (Yin et al., 2009).  During 
the acquisition of cocaine-seeking behavior, dopaminergic processing first occurs in the 
ventral striatum, sending both feed-forward GABAergic inhibitory projections to the DM 
and DL striatum and feedback to the midbrain dopamine neurons (Porrino et al., 2004; 
Pierce and Vanderschuren, 2010).   As rats self-administer cocaine, phasic dopamine 
release increases in the DL striatum over time, but only after initial dopaminergic 
activation in the ventral striatum (Willuhn et al., 2012).  Activation of DL striatum MSNs is 
necessary for the resistance to reinforcer devaluation seen in habit-based operant 
behaviors (Everitt et al., 2008).  Unlike during the acquisition of drug-seeking behavior, 
as cocaine seeking/taking becomes compulsive, extracellular glutamate increases in the 
DL striatum and infusion of a dopamine receptor antagonist will attenuate responding 
(Veeneman et al., 2012).   
Interestingly, a small but growing body of literature also identifies involvement of 
the DL striatum prior to the point at which drug-seeking behavior is considered habitual.  
Reversibly inactivating this region during the acquisition and maintenance of cocaine 
seeking, periods when the reinforcing value of the drug mediates behavior, attenuates 
drug seeking (Pacchioni et al., 2011; Veeneman et al., 2012).  In the DL striatum, 
limited, experimenter-delivered cocaine increases glutamatergic transmission, and 
inactivation of the DL striatum attenuates cocaine-priming and cue-induced 
reinstatement of drug seeking (McKee and Meshul, 2005; Gabriele and See, 2011).  To 
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extend this work, chapter two of this dissertation investigates the biochemical changes 
that occur in the DL striatum during initial cocaine exposure, short-access self-
administration, and priming-induced reinstatement of cocaine seeking. 
AMPA Glutamate Receptors and Cocaine 
The excitatory, ionotropic AMPA glutamate receptors contain four subunits, GluA1-
GluA4, that form a pore to allow the passage of sodium, potassium, and occasionally 
calcium ions after glutamate binding (Bear, 2007).  GluA2-containing AMPA receptors 
are typically calcium impermeable due to GluA2 Q/R editing of the pore-containing 
region of the subunit (Seeburg, 1996).  Consequently, GluA2-lacking AMPA receptors 
allow the influx of calcium upon glutamate binding, leading to an enhanced excitatory 
post-synaptic response (Jonas and Burnashev, 1995).  Inward rectification, a reduction 
in current as membrane voltage increases, provides electrophysiological evidence of 
increased calcium-permeable GluA2-lacking AMPARs.  Approximately 10% of accumbal 
AMPA receptors are calcium-permeable (CP) in drug-naïve rodents, with the vast 
majority being comprised of GluA1/GluA2 subunits (Wolf and Tseng, 2012).  However, 
chronic cocaine exposure followed by 1 month of withdrawal increases accumbal GluA1 
subunit surface expression and produces a 30% increase in rectification index, 
suggesting that these subunits form CP-AMPARs (Conrad et al., 2008).  Confirming that 
withdrawal after chronic cocaine use increases the levels of CP-AMPARs in the 
accumbens, Conrad (2008) illustrates that AMPAR-mediated evoked excitatory post-
synaptic potentials (eEPSCs) of accumbal MSNs are reduced by the CP-AMPAR 
antagonist 1-naphthyl acetyl spermine (Naspm).   
Cocaine priming-induced reinstatement is associated with increased GluA1 
subunit phosphorylation, trafficking, and insertion of GluA1 AMPA receptors into the 
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accumbens shell cell surface (Anderson et al., 2008).  Phosphorylation of GluA1 
subunits occurs at multiple residues during cocaine exposure, but phosphorylation by 
CaMKII at serine 831 increases the single-channel conductance and efficiency of AMPA 
receptor conformational change upon glutamate binding, particularly in the presence of 
transmembrane AMPA receptor accessory proteins (TARPs) (Kristensen et al., 2011; 
Lisman et al., 2012).  It is important to note, however, that CaMKII, phosphorylation of 
GluA1-ser831, and increased GluA1 surface expression during priming-induced 
reinstatement are transient relative to that seen after extended withdrawal from long-
access self-administration (Pierce and Wolf, 2013).  Regardless, none of these receptor 
changes occur following experimenter-delivered, non-contingent drug injections – self-
administration experience, and presumably the maladaptive learning inherent to 
developing cocaine addiction, is necessary (McCutcheon et al., 2011).   
As illustrated in Figure 1.1, stimulation of mGluRs and D1Rs following cocaine 
exposure activates protein kinases C and A, respectively, in addition to CaMKII (Wolf et 
al., 2003; Chen et al., 2007; Schmidt and Pierce, 2010).  In turn, protein kinase C (PKC), 
activated in the intracellular signaling cascade of group 1 mGluRs, also phosphorylates 
GluA1 at serine 831, as well as serines 816 and 818, which enhances GluA1 binding to 
scaffolding protein 4.1N (Lin et al., 2009; Olive, 2009).   Simultaneously with GluA1 
phosphorylation during cocaine priming-induced reinstatement, PKC phosphorylates 
GluA2 subunits at serine 880, altering their interactions with GluA2-specific scaffolding 
proteins to promote internalization of these subunits and potentially contributing to the 
transient shift towards more CP-AMPARs (Famous et al., 2008; Pierce and Wolf, 2013).  
Protein kinase A, PKA, phosphorylates GluA1 at serine 845, leading to insertion of the 
receptor subunit and increased surface expression in conjunction with serine 831 
phosphorylation (Sun et al., 2008).  However, increased serine 845 phosphorylation has 
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only been measured following withdrawal from long-access self-administration, and not 
during cocaine priming-induced reinstatement (Anderson et al., 2008; Ferrario et al., 
2011b).  Together, these findings suggest that cocaine-mediated kinase phosphorylation 
of AMPAR subunits, particularly GluA1, underlies changes in receptor composition at the 
plasma membrane surface.    
GluA1-containing AMPAR Accessory Proteins: 4.1N and SAP97 
Cocaine-mediated changes in surface receptor expression would not be possible without 
accessory proteins to aid in the trafficking and stabilization of GluA1 subunits (Anggono 
and Huganir, 2012; Lisman et al., 2012).  Changes in the trafficking and anchoring of 
GluA1-containing AMPARs to the cell surface mediate the increased glutamatergic 
plasticity in accumbens MSNs following cocaine self-administration and during cocaine 
priming-induced reinstatement.  On its own, GluA1 is unable to associate with a primary 
scaffolding protein at the post-synaptic density (PSD), PSD-95, requiring various other 
accessory proteins to secure GluA1-containing AMPA receptors at and around the 
synapse (Anggono and Huganir, 2012).  While CaMKII directly phosphorylates GluA1 at 
serine 831 as part of this process, it also regulates AMPAR trafficking indirectly by 
phosphorylating proteins like synapse-associated protein 97 (SAP97) that help to anchor 
GluA1 at the PSD (Nikandrova et al., 2010; Opazo et al., 2010).  In addition to PSD95, 
GluA1 subunits are stabilized in synapses against the actin-spectrin cytoskeleton by 
another accessory protein, 4.1N (See Figure 1.1) (Shen et al., 2000).     
SAP97 
Despite the fact that GluA1 does not directly bind PSD-95, the C-terminal domain of 
GluA1 contains a PDZ (PSD95-Discs large-ZO-1) binding motif that associates with the 
second PDZ domain of SAP97 (Cai et al., 2002).  Like GluA1, SAP97 complexes with 
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CaMKII and is phosphorylated at serines 39 and 232, and over-expression of this protein 
can rescue GluA1 subunit trafficking in a double knockout of PSD95/93, offering an 
alternative mode of stabilization at the plasma membrane (Nikandrova et al., 2010).  
Deletion of the last 4 amino acids of GluA1 prevents interaction with SAP97 and reduces 
GluA1 surface expression, and a point mutation in GluA1 changing threonine 887 to an 
alanine also blocks SAP97 binding and slows GluA1 subunit insertion at the cell surface 
(Passafaro et al., 2001).  Over-expression of SAP97 in cultured neurons increases the 
level of synaptic AMPARs, as well as their associated miniature evoked post-synaptic 
currents, an effect that is dependent on the ability of SAP97 to bind 4.1N (Rumbaugh et 
al., 2003).  That said, there is also evidence that while SAP97 is involved in GluA1 
trafficking and retention at the membrane, it is not required (Howard et al., 2010).  Over-
expression of SAP97 in HEK293 cells that also express GluA1 has no effect on subunit 
movement (Cai et al., 2002).  Further, while SAP97 over-expression enhances the 
formation of dendritic spines and theoretically, synaptic connections, knockout of SAP97 
does not reliably prevent GluA1 surface expression (Kim et al., 2005; Zhou et al., 2008).  
Together, these findings indicate that SAP97 localization at the PSD and its interactions 
with proteins like GluA1-containing AMPARs and 4.1N, particularly in the context of 
cocaine priming-induced reinstatement, requires further investigation.  
4.1N 
4.1N is an accessory protein that contains an actin/spectrin binding domain and binds 
with the membrane proximal region of GluA1 subunits (Shen et al., 2000; Coleman et al., 
2003; Anggono and Huganir, 2012).  Phosphorylation of GluA1 at serines 816 and 818 
by PKC regulates GluA1 association with 4.1N (Lin et al., 2009).  Lin and colleagues 
(2009) have shown that interaction between GluA1 subunits and the actin/spectrin 
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binding protein 4.1N improves their extrasynaptic insertion.  Accordingly, cocaine-
mediated activation of PKC and subsequent GluA1 phosphorylation could contribute to 
the increased expression of GluA1 at the accumbens surface via 4.1N (Xue et al., 2012; 
Pierce and Wolf, 2013).  Knock down of 4.1N or inhibition of PKC reduces insertion of 
native GluA1 into the plasma membrane, and mutant forms of GluA1 lacking the 
membrane proximal region show significantly reduced insertion (Lin et al., 2009).  
Further, 4.1N contains a FERM (Four.1-Ezrin-Radixin-Moesin) domain that promotes 
binding to the I3 insert of the membrane-associated guanylate kinase, SAP97, to aid in 
SAP97 targeting to the membrane (Lue et al., 1994; McLaughlin et al., 2002; Hanada et 
al., 2003).  These results suggest that 4.1N could be a novel target mediating the 
trafficking and stabilization of GluA1-containing AMPARs during cocaine reinstatement. 
Viral Vector Methodologies 
Given a growing body of evidence supporting the role of AMPA receptors and GluA1 
subunit localization during cocaine priming-induced reinstatement, delineating the 
necessity of GluA1 and its associated proteins in a selective, time-specific manner is of 
utmost importance.  Behavioral pharmacology offers manipulation of some receptors 
and related proteins at a particular point in time, such as during a reinstatement session, 
but specific drug interventions for all of the proteins mentioned thus far do not yet exist.  
With even the most specific compounds, the risk for off-target interactions and effects 
remains, particularly at concentrations required for functional consequences (Wang et 
al., 2012).  Genetic manipulations in mice have become increasingly sophisticated; 
addiction researchers are able to directly target single amino acids in a particular protein 
(such as CaMKII), in a particular brain region (the striatum) and even in a particular 
timeframe (using inducible promoters) (Kourrich et al., 2012).  Unfortunately, modeling 
cocaine self-administration and reinstatement in mice requires additional training time, 
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has a much higher attrition rate, and has greatly reduced behavioral output measures 
relative to paradigms using rats (Thomsen and Caine, 2007).  While the same genetic 
manipulations in rats are in still their infancy, viral vector manipulations may provide a 
methodology that can tease apart the details of glutamatergic plasticity during cocaine 
priming-induced reinstatement (Simonato et al., 2000; Zheng et al., 2012).  Further, the 
differing expression profiles of viruses, including latency, duration, and spread across 
neurons, allow researchers the opportunity to make temporally and spatially distinct 
manipulations of the reward system at various points throughout complex behaviors like 
those in the reinstatement paradigm.   
Vector Options 
Herpes simplex virus (HSV) has amplicon vectors with small plasmid size of 5-10kb but 
can hold a large cDNA insert of up to 150kb and can readily over-express the transgene 
of interest in high titers (over 108 infectious units/mL) (Jerusalinsky et al., 2012).  
Because HSV are replication-deficient, a ‘helper virus’ allows naturally neurotropic HSV 
to rapidly express the cDNA insert in neurons and glia, peaking 48-72 hours post-
infection, without the risk of integrating into host chromosomes (Neve et al., 2005).  This 
allows for time and location specific over-expression or knock down of a given protein 
with minimal toxicity to the animal and reduced probability of insertional mutagenesis.  
Further, the virus becomes dormant 7-10 days after the initial infection, allowing the host 
system involved to return to an endogenous state.  Unfortunately, though HSV no longer 
contains infectious aspects of the herpes virus from which it is derived, there remains the 
risk of immune response and potential infection in those working with the vector (Braun, 
2006).   
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HSV vectors are not the only option for expressing recombinant DNA in vivo.  
One alternative viral vector approach, adeno-associated virus (AAV), has a reduced 
biosafety risk but is much smaller with a limited construct size of 4.7kb (Coura and Nardi, 
2007).  While AAV has long lasting gene expression (on a scale of months), it is slow to 
initiate transgene expression due to the conversion of single-stranded AAV DNA to 
double stranded DNA in the host (Coura and Nardi, 2007).  Further, the AAV viral 
genome inserts into chromosome 19, increasing the risk of unanticipated mutation due 
to potential disruption of a coding region of the genome (Kotin et al., 1990; Jerusalinsky 
et al., 2012).  Another viral vector option is lentivirus, which can infect a variety of 
dividing and non-dividing CNS cells in addition to neurons and carries recombinant 
constructs almost twice the size of AAV (Davidson and Breakefield, 2003; Li et al., 
2012).  Similar to AAV, lentivirus produces long-lasting gene expression due to its ability 
to incorporate into the host genome, typically in non-coding regions of chromosomes 
(Sakuma et al., 2012).  Unlike AAV, however, lentiviral vectors are derived from HIV, 
which dramatically increases the biosafety risk of using these vectors as recombination 
events could potentially produce replication-competent HIV (Sakuma et al., 2012).   
In the case of modulating neuronal signaling during cocaine-priming induced 
reinstatement, HSV provides far more flexibility than AAV or lentivirus in terms of the 
type of constructs created, timing of expression, and duration of expression.  
Subsequently, experimenters can manipulate proteins at discrete periods during the 
paradigm (during reinstatement), without interfering with neurochemistry during other 
aspects of training (self-administration), and later confirm baseline behavioral and 
biochemical activity within the same animals (due to viral dormancy).  In chapter three of 
this dissertation, HSV vectors are used to manipulate the molecular milieu of nucleus 
accumbens MSNs, specifically during cocaine priming-induced reinstatement.  Vectors 
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that express wild-type or a dominant-negative mutant of GluA1 will be used to directly 
manipulate GluA1-containing AMPARs in an attempt to identify the necessity of CP-
AMPARs during reinstatement.  Additional vectors expressing a dominant-negative 
mutant of 4.1N or a micro RNA sequence that knocks down endogenous SAP97 
expression will be employed to elucidate the trafficking, stabilization, and function of 
GluA1-containing AMPARs during cocaine priming-induced reinstatement.  
 The above outlines some of the profound cellular and molecular effects cocaine 
exposure has on the brain that mediate addiction and relapse.  However, a growing body 
of evidence links cocaine exposure to modifications of inherited genetic material as well 
(Nestler, 2013).  Indeed, cocaine use has spread into younger generations as evidence 
by the fact that 2% of American high school students, a demographic vulnerable to 
developing cocaine addiction, abuse the drug annually (Johnston et al., 2012; Wong et 
al., 2013).  Investigating the mechanisms through which parental cocaine use influences 
the behaviors of subsequent generations are paramount to establish the appropriate 
interventions for cocaine addiction and relapse.  
Epigenetic Inheritance and Drug Addiction  
Certain evolutionary adaptations may occur via ancestral perturbations that disrupt the 
physiology and/or behavior of offspring (Feil and Fraga, 2012; Champagne, 2013).  
Exposure to famine in one generation correlates with an inability to appropriately 
process insulin two generations later (Pembrey et al., 2006).  Prenatal exposure to 
bisphenol A, a chemical found in plastics that mimics sex hormones, has sex-specific 
influences on emotional regulation in children (Braun et al., 2011).  Similarly, drug 
addiction in humans can often be tracked through family lines, with addictive behaviors 
passed down from parent to child, sometimes across multiple generations (Johnson and 
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Leff, 1999; Ivanov et al., 2012).  Yet, the natural selection of “traditional” Darwinian 
evolution occurs over hundreds of years, begging the question: how could isolated 
challenges to one generation influence the DNA of subsequent generations?  
Epigenetics offers a mechanism through which gene transcription is regulated – not 
through direct changes to DNA base pairs, but via chemical modifications to DNA and its 
associated histones (Crews, 2008; Handel and Ramagopalan, 2010; Roth and Sweatt, 
2011). 
Epigenetic Modifications to DNA 
In the cell nucleus, DNA is packaged as chromatin, which is made up of 147 base pair 
strands wrapped around proteins called histones (Nakao, 2001).  In its most condensed 
state, chromatin is inactive and no gene transcription occurs, whereas transcriptional 
machinery readily accesses DNA when chromatin is in an open state (Nestler, 2013).  
Reversible modifications that alter the state of chromatin to increase or decrease 
transcription often include post-translational modifications of histone N-terminal tails, 
such as methylation, acetylation, and phosphorylation, or even methylation of DNA itself 
(Champagne, 2013).  Transcriptionally inactive chromatin generally has methylated 
histones and unmethylated DNA, while transcriptionally active chromatin generally has 
acetylated histones and methylated DNA (Roth and Sweatt, 2011).  The epigenome 
describes the genome-wide patterns of epigenetic modifications that increase or 
decrease gene transcription (Curley et al., 2011).  It is likely that environmental 
challenges alter gene expression, potentially across generations, through epigenetic 
mechanisms like these.    
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Epigenetic Inheritance 
Epigenetic modifications and correlated gene expression changes can be passed across 
generations in a context-dependent or germline-dependent manner (Crews, 2008).  
Instances where an environmental perturbation directly changes the methylation or 
acetylation of histones and DNA of the subject are considered context-dependent 
(Crews, 2008).  Occasions where epigenetic modifications to DNA remain, independent 
of the initial cause and without need for repeated exposure, are considered germline-
dependent (Crews, 2008; Curley et al., 2011).  Transgenerational, epigenetic inheritance 
requires the transmittance of information about the epigenome through the germline 
(See Figure 1.5).   
In utero or prenatal exposure to some insult, whether toxin or otherwise, offers 
one common example of context-dependent modifications (Crews, 2008; Champagne, 
2013).  Acute stress to pregnant mothers due to war or famine is correlated with 
increased incidence of schizophrenia in their children, presumably because these 
children were exposed to stress hormones in utero (St Clair et al., 2005; Malaspina et 
al., 2008).  Similarly, gestational exposure to drugs of abuse, like nicotine or cocaine, is 
well established to have a negative impact on fetal and child development due to direct 
effects of the drugs on the fetal epigenome (Dow-Edwards, 2011; Abbott and Winzer-
Serhan, 2012).  Many preclinical studies identify impairments of executive function and 
memory, disrupted cortical and hippocampal development, and reduced motivation to 
respond for cocaine in offspring that were exposed to cocaine in utero (Hecht et al., 
1998; Lidow, 2003; He et al., 2006b).  As modeled in Figure 1.5, in such cases the fetus, 
including its developing germ cells, was directly exposed to the same environmental 
conditions as the mother, making any epigenetic modifications context-dependent.  
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Thus, the first point at which germline-dependent epigenetic inheritance can be identified 
is the third generation, as all prior progeny had some exposure to the original context 
(Curley et al., 2011; Champagne, 2013).       
In studies of paternal transmission, information about experiences is limited to 
what is retained in the spermatozoa (Curley et al., 2011).  There is evidence of children 
who display characteristics of fetal alcohol system with alcoholic fathers, but non-
drinking mothers (Lemoine et al., 2003).  The offspring of male rodents exposed to 
alcohol before mating with naïve females exhibit altered development of reflexes and 
disruption of metabolic functioning (Emanuele et al., 2001; Jamerson et al., 2004).  The 
second generation (F2) male offspring of prenatally stressed male mice exhibit brain 
dysmasculinization and a stress-sensitive behavioral phenotype (Morgan and Bale, 
2011).  In these scenarios, the third example of paternal transmission meets the 
requirements for germline-dependent epigenetic inheritance.  The first two cases involve 
exposing sire sperm to alcohol, which means that half the genetic and epigenetic 
material of the first generation has also been exposed.  In the third example, the F2 
generation has not experienced the stressful context of the first and originating 
generations, meaning any epigenetic changes are mediated via the germline, as 
modeled in Figure 1.5. 
Epigenetic Transmission of a Cocaine Resistance Phenotype     
Recently, our group established a paradigm using paternal (sire) cocaine self-
administration to identify intergenerational consequences of cocaine abuse without 
directly exposing the fetus to cocaine (Vassoler et al., 2013).  We identified behavioral 
and epigenetic evidence of a cocaine-resistance phenotype in first generation male 
offspring due to sire cocaine exposure.   Male, but not female, cocaine-sired offspring 
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exhibited delayed acquisition and reduced maintenance of cocaine self-administration.  
Further, male offspring of cocaine-experienced sires displayed increased levels of brain 
derived neurotrophic factor (BDNF) in the mPFC, which has been previously reported to 
reduce the reinforcing efficacy of cocaine (Sadri-Vakili et al., 2010; Vassoler et al., 
2013).  Interestingly, spermatozoa contain binding sites for cocaine and decreased DNA 
methyltransferase 1, a key enzyme DNA methylation, is observed in sires that self-
administered cocaine (Yazigi et al., 1991; Reik et al., 2001; He et al., 2006a).  This 
model allowed for strict control of additional environmental influences on offspring, 
focusing on the effects of paternal exposure to cocaine on inherited genetic material.  
This may account for the discrepancy in our data with that of human literature identifying 
heritability of cocaine abuse (Kendler et al., 2007).  That said, the presence of a cocaine 
resistance phenotype remains intriguing and has prompted additional exploration.        
Anxiogenic Effects of Cocaine 
Behavioral Consequences 
Cocaine is well known for its euphoric effects, with addicts reporting feeling energetic 
and alert and having less need for food or sleep (Karch, 1999).  However, those who 
abuse the drug indicate negative feelings of irritability and anxiety as early as 45 minutes 
after use, which can extend for days after the last exposure (Ward et al., 1997; 
Gunnarsdottir et al., 2000).  Interestingly, individuals with anxious-impulsive traits are 
significantly more likely to develop cocaine dependence (Ersche et al., 2012).   
These reports of cocaine-induced anxiety have been recapitulated in rodents.  A 
15 mg/kg cocaine injection (i.p.) produces anxiolytic effects 10 minutes after the injection 
yet anxiogenic effects 30 minutes following the injection (Muller et al., 2008).  The 
competing positive and negative effects of cocaine, or opponent-processes, enroll 
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multiple brain systems and create ambivalence towards the drug despite chronic use 
(Ettenberg, 2004).  In fact, the runway model of rodent self-administration, where rats 
are trained to run from a start box, down a runway, and into an infusion chamber, 
consistently captures an “approach-avoidance” behavior.  Cocaine-addicted animals 
hesitate to enter, or even retreat from, the infusion box multiple times before finally 
entering to receive an infusion (Ettenberg, 2009).  In this paradigm, the dorsal raphe, 
which produces the neurotransmitter serotonin and is involved in the expression of 
anxiety, can be reversible inactivated to reduce rodent avoidance behavior, preventing 
the anxiogenic effects of cocaine (Ettenberg et al., 2011).    
In other studies, anxiogenic effects of cocaine include decreased self-
administration (via lever press) and decreased levels of dopamine in the nucleus 
accumbens in continuously subordinate, but not episodically defeated, rats (Miczek et 
al., 2011).  Rodents repeatedly injected with cocaine (20 mg/kg, i.p.) during adolescence 
display heightened anxiety-like responses to novelty in adulthood (Stansfield and 
Kirstein, 2007).  Pharmacological agents used to reduce anxiety, like diazepam, 
enhance cocaine self-administration and reduce response latency without altering 
extracellular dopamine, suggesting correction of anxiety-like behavior without 
enhancement of reward (Maier et al., 2008).  Rodents selectively bred for a depressive-
like phenotype exhibit blunted mesocorticolimbic dopamine signaling in addition to 
reduced motivation to seek cocaine and attenuated cocaine priming-induced 
reinstatement (Lin et al., 2012).   
Given these data, it is conceivable that the cocaine-resistance phenotype in male 
cocaine-sired offspring could be connected to an increased sensitivity to the anxiogenic 
effects of cocaine.  Chapter four of this dissertation investigates the presence of an 
	   25	   	  
anxiety phenotype in these offspring, particularly in conjunction with cocaine exposure, 
which could shed light onto additional mechanisms underlying the resistance to cocaine-
seeking behavior.  Of course, even the most robust behaviors must have cellular, 
molecular, and even genetic correlates.  In addition to the aforementioned behavioral 
studies, there is a growing literature describing the neurological correlates between 
cocaine abuse and anxiety that may aid interpretations of these findings. 
Neurological Correlates 
Along with dopamine, cocaine prevents the reuptake of serotonin (5-HT), the binding of 
which to various 5-HT receptors located in the dorsal raphe contributes to anxiety and 
avoidance behaviors (Filip et al., 2005; Ettenberg et al., 2011; Donaldson et al., 2013).  
The mesocorticolimbic reward system processes the rewarding effects of cocaine but 
also shows involvement in cocaine-induced anxiety.  During cocaine withdrawal, 
serotonin levels are decreased in the accumbens, the local reversal of which has been 
shown to alleviate withdrawal symptoms such as anxiety (Filip et al., 2005).  Rats that 
display a characteristic anxiety-like behavior of excessive grooming take more cocaine 
and have reduced serotonin release relative to low grooming rats, though this difference 
is abolished with the administration of serotonergic anxiolytic agents (Homberg et al., 
2004).   
However, anxiety-like behaviors following cocaine exposure are not solely 
mediated via serotonergic transmission.  The neuropeptide corticotropin releasing factor 
(CRF) and its two G-protein coupled receptors (CRF R1 and R2) have been illustrated to 
co-localize with dopamine terminals on neurons in the accumbens (Lemos et al., 2012).  
Activation of the CRF receptors has been illustrated to modulate HPA axis activation and 
anxiety-like behavior (Bale and Vale, 2004).  Lemos and colleagues (2012) illustrated 
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acute activation of accumbal CRF receptors promotes dopamine release and CPP 
whereas chronic activation, traditionally correlated with anxiety phenotypes, does not.  In 
rats, BDNF exhibits a time-dependent increase in the accumbens during the incubation 
of cocaine craving which correlates to a period where human addicts describe strong 
feelings of agitation and anxiousness (Grimm et al., 2003).  One study found repeated 
experimenter-administered cocaine increases signaling of accumbens BDNF and rodent 
susceptibility to social defeat via epigenetic modifications of chromatin like histone 
methylation and downregulation of methyltransferases (Covington et al., 2011). 
Another limbic region involved in the expression of anxiety and influenced by 
cocaine exposure is the hippocampus (Deschaux et al., 2012; Kheirbek et al., 2013).  
The hippocampus contains receptors for the corticosterone and CRF released following 
HPA axis activation, and sends negative feedback projections to deactivate the stress 
system (Herman et al., 2005).  Additionally, serotonergic transmission in the 
hippocampus is reduced by exposure to psychostimulants, potentially via down-
regulation of a major corticosteroid stress receptor (Barr and Forster, 2011).  Prenatal 
stress increases anxiety-like behaviors in offspring as well as levels of hippocampal 
proBDNF, the BDNF precursor that activates cell death pathways and increases long 
term depression in hippocampal synapses (Martinowich et al., 2007; Yeh et al., 2012).  
Altered BDNF levels in the hippocampus are associated with decreased anxiety-like 
behavior in the novelty induced hypophagia task, and serontonergic transmission has 
been shown to underlie changes in BDNF mRNA expression in stressed animals 
(Vaidya et al., 1999; Schmidt and Duman, 2010).  Additionally, withdrawal from repeated 
experimenter-delivered cocaine enhances hippocampal LTD, an effect that is blocked by 
application of a CRF R2 antagonist.  Finally, prenatal cocaine exposure modulates 
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hippocampal DNA methylation in newborn and adolescent rodents, altering the 
expression of a variety of genes (Novikova et al., 2008; Guan et al., 2009).   
Together, these experiments indicate that limbic system modulators of the stress 
and anxiety pathway, such as serotonergic, BDNF, and CRF signaling, are likely to 
mediate anxiety-like behaviors following cocaine exposure.  In addition to behavioral 
characterization, chapter four of this dissertation examines the consequences on stress 
and anxiety systems due to paternal cocaine experience by delineating the 
neurochemical phenotypes of cocaine-sired offspring.  Experiments in this chapter will 
examine cellular and molecular correlates of anxiety, such as corticosterone, serotonin, 
BDNF, and CRF expression, in drug naïve cocaine- and saline-sired male offspring to 
identify changes due solely to paternal cocaine exposure.   
Exposure to cocaine has myriad consequences, extending from immediate 
biochemical adaptations in the brain to neurological and behavioral changes in 
subsequent generations.  Focusing on cocaine-induced changes to the glutamatergic 
system, chapters two and three use a rodent model of cocaine self-administration and 
reinstatement to examine select brain regions and receptors involved during initial use 
(chapter two) and during priming-induced reinstatement (chapter three).  Subsequently, 
chapter four expands the scope of this dissertation beyond the effects of cocaine on the 
user, to include the influence of paternal cocaine experience on first generation behavior 
and neurochemistry.  As a whole, the work encompassed in this dissertation advances 
our understanding of both the biochemical mechanisms underlying and the heritable 
consequences of cocaine use and relapse. 
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FIGURE 1.1 
	  
	  
Glutamate receptor–mediated signaling. Glutamate released into the synaptic cleft 
binds to and activates ionotropic glutamate receptors (NMDA, AMPA, and kainate 
[KA] receptors) on postsynaptic membranes. Due to enzymatic editing of GluA2 
AMPAR subunits, GluA2-containing AMPARs are calcium impermeable, while GluA2-
lacking AMPARs are calcium permeable.  Extracellular glutamate also binds to and 
activates perisynaptic metabotropic glutamate receptors located on postsynaptic 
(mGluR1/5s heteroreceptors) membranes. Influx of Na+, Ca2+, and K+ ions through 
activated AMPA/KA receptors depolarizes the neuron and subsequently relieves the 
Mg2+ block from voltage-sensitive NMDA receptors and activates L-type voltage-
gated Ca2+ channels. In addition to propagating action potentials, influx of cations 
through ionotropic glutamate receptors activates several intracellular signaling 
pathways including, but not limited to, PKC, CaMKII, and protein kinase A (PKA).  
These kinases phosphorylate various residues in the ionotropic glutamate receptors to 
modulate their channel properties. Group I (mGluR1/5) metabotropic glutamate 
receptors are coupled via Gq to intracellular enzymes. Stimulation of mGluR1/5s 
activates phospholipase C (PLC), which catalyzes the production of inositol-1,4,5-
triphosphate (IP3) and diacylglycerol (DAG) from phosphatidylinositol-4,5 
bisphosphate (PIPs). The resulting increase in cytoplasmic IP3 triggers release of 
Ca2+ from intracellular stores (not shown). Also present are metabotropic D1-like (D1, 
D5) dopamine receptors that initiate intracellular signaling cascades via Gs and Golf. 
Stimulation of D1-like receptors promotes adenylyl cyclase (AC) activity, thus 
increasing intracellular levels of cAMP and PKA. The cytoplasmic proteins PSD-95, 
glutamate receptor-interacting protein (GRIP), synapse associated protein 97 
(SAP97), protein 4.1N, and actin anchor GluA2- and GluA1-containing glutamate 
receptors to the PSD complex.  Cocaine exposure induces phosphorylation events by 
CaMKII, PKC, and/or PKA that modulate interactions between receptor subunits and 
these proteins to alter the population of AMPARs at the synapse, changing the 
excitability of the post-synaptic cell. (Figure adapted from: Schmidt and Pierce, 2010). 
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FIGURE 1.2 
 
Dopaminergic projections through the mesocorticolimbic reward system.  
Schematic of dopaminergic projections from the ventral tegmental area (VTA) and 
substantia nigra pars compacta (SNpc) enlisted during the processing of rewards.  
Cocaine priming-induced reinstatement of drug seeking modulates the release of 
dopamine across the striatum in the subregions of the nucleus accumbens (NAc) and 
the dorsomedial (DM) and dorsolateral (DL) striatum.  Dopaminergic signaling of 
cocaine reward also occurs in limbic structures such as the hippocampus (Hipp) and 
amygdala (Amyg), and areas of executive function like the medial prefrontal cortex 
(mPFC).  
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FIGURE 1.3 
 
Glutamatergic projections modulate processing in the mesocorticolimbic 
reward system.  Schematic of the dopaminergic and glutamatergic projections in the 
mesocorticolimbic reward circuitry.  Cocaine exposure directly influences 
dopaminergic projections initiating from midbrain dopamine neurons in the ventral 
tegmental area (VTA) and substantia nigra pars compacta (SNpc) that terminate in 
the nucleus accumbens (NAc), dorsomedial (DM) and dorsolateral (DL) striatum, and 
medial prefrontal cortex (mPFC).  Cocaine exposure indirectly influences 
glutamatergic projections initiating in the mPFC that provide excitatory feedback to the 
VTA in addition to modulating the excitation of neurons across the striatum. 
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FIGURE 1.4 
 
Progressive recruitment of striatal subregions as cocaine use becomes 
habitual. Schematic of the dopaminergic and GABAergic projections in midbrain and 
striatal reward circuitry.  Initial exposure to cocaine activates dopaminergic projections 
from the medial ventral tegmental area (mVTA) to the nucleus accumbens (NAc) 
shell, which then provides GABAergic inhibitory feedback across the VTA, modulating 
subsequent dopaminergic projections to the NAc core.  With continued cocaine 
experience, the core sends GABAergic projections to the substantia nigra pars 
compacta (SNpc), which modulates dopaminergic projections from the SNpc to the 
dorsomedial (DM), followed by the dorsolateral (DL) striatum.  The shell and core also 
send GABAergic projections to the ventral and dorsal ventral pallidum (vVP, dVP) that 
modulates limbic and motor processing, respectively.   
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FIGURE 1.5 
 
Parental environmental perturbations can produce context- and germline-
dependent epigenetic modifications to genetic material transmitted across 
generations. Schematic of how epigenetic modifications due to an environmental 
challenge (lightening bolt) such as cocaine exposure in one generation transmits to 
subsequent generations.  In a maternal lineage, epigenetic modifications are context-
dependent through the first two generations (F1 and F2) as the gametes of the 
developing fetus are exposed to the same environmental perturbations as the mother. 
By the third generation (F3), remaining epigenetic modifications have entered the 
germline. In a paternal lineage, epigenetic modifications switch from context- to 
germline-dependent by the second generation as only the gametes of the father are 
exposed to the environmental challenge.  
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CHAPTER TWO 
 
ACUTE COCAINE INCREASES PHOSPHORYLATION OF CAMKII AND GLUA1 IN 
THE DORSOLATERAL STRIATUM OF DRUG NAÏVE RATS, BUT NOT COCAINE-
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Abstract 
Transport of GluA1-containing AMPA glutamate receptors to synapses in the nucleus 
accumbens, a process that involves phosphorylation of key serine residues by CaMKII, 
is associated with the reinstatement of cocaine-seeking behavior.  A growing body of 
evidence indicates that the dorsal striatum contributes to aspects of cocaine addiction.  
However, the potential role of CaMKII-mediated phosphorylation of GluA1 subunits in 
the dorsolateral (DL) striatum during cocaine reinstatement has not been examined.  In 
this study, rats were trained to self-administer cocaine and were partnered with saline-
yoked rats that received injections of saline.  Following extinction, each pair of rats 
received either a systemic priming injection of cocaine (10 mg/kg, i.p.) or saline.  As 
expected, cocaine-experienced rats displayed robust reinstatement of cocaine seeking 
in response to a challenge injection, whereas yoked saline controls did not.  The DL 
striatum was dissected immediately following the reinstatement test session. Results 
from Western blotting experiments showed increased pGluA1-ser831 and pCaMKII-
thr286 in the DL striatum of saline-yoked rats given an acute injection of cocaine.  This 
effect was absent in cocaine-experienced rats that received a saline injection, and no 
changes were observed following a priming injection of cocaine in cocaine-experienced 
rats.  These results indicate that acute exposure to cocaine in drug naïve rats increased 
CaMKII-mediated phosphorylation of GluA1-containing AMPA receptors in the DL 
striatum, an effect that was not observed during cocaine priming-induced reinstatement 
of drug seeking.  It is possible, therefore, that increased phosphorylation of CaMKII and 
GluA1 following acute cocaine is a compensatory mechanism in the DL striatum. 
 
 
 
	   35	   	  
Introduction 
It is well documented that changes in glutamatergic transmission in subregions of the 
striatum play a role in the reinstatement of cocaine seeking, an animal model of relapse 
(Pierce and Vanderschuren, 2010).  Although the majority of this work has focused on 
the nucleus accumbens (Anderson et al., 2008; Famous et al., 2008; Schmidt and 
Pierce, 2010), recent evidence indicates that pharmacological inhibition of the 
dorsolateral (DL) striatum attenuates cocaine seeking in rats following short-access (1- 
or 2-hour daily) self-administration (See et al., 2007; Pacchioni et al., 2011).  In terms of 
glutamatergic transmission, infusion of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic 
(AMPA) glutamate receptor antagonists into the DL striatum blocked cue-controlled 
reinstatement and attenuated cocaine self-administration when injected into the 
dorsomedial (DM) striatum (Vanderschuren and Everitt, 2004; Famous et al., 2008; 
Murray et al., 2012; Schneck and Vezina, 2012).  Though there is an established role for 
the DL striatum in cue-induced reinstatement, there is little to no data on DL striatum 
involvement in cocaine priming-induced reinstatement of drug seeking. 
AMPA glutamate receptors are ionotropic, excitatory ion channels comprised of 
four subunits (GluA1-GluA4) that are involved in several forms of neuronal plasticity 
(Bredt and Nicoll, 2003).  The GluA1 subunit in particular has been associated with 
synaptic plasticity in animals exposed to cocaine (Boudreau and Wolf, 2005; Bachtell et 
al., 2008).  Activity-mediated autophosphorylation of calcium/calmodulin-dependent 
protein kinase II (CaMKII) at threonine 286 promotes phosphorylation of GluA1 at serine 
831, resulting in enhanced GluA1 subunit trafficking to the plasma membrane and 
associated increases in synaptic strength (Lisman et al., 2002; Bredt and Nicoll, 2003).  
Indeed, there is evidence that reinstatement of cocaine seeking in rats involves CaMKII 
phosphorylation of the GluA1 subunit in the nucleus accumbens, and pharmacological 
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inhibition of CaMKII in the accumbens prevents cocaine seeking (Mammen et al., 1997; 
Anderson et al., 2008).   
A single cocaine injection promotes glutamate release in the DL striatum of 
cocaine-naïve rats (Barrot et al., 2001; McKee and Meshul, 2005).  Acute or repeated 
experimenter-delivered cocaine increases levels of phosphorylated GluA1 AMPA 
receptor subunits and GluA1 surface expression in the DL striatum (Kim et al., 2009b; 
Ferrario et al., 2010).  Here, we extend this work by examining expression of phospho-
CaMKII and –GluA1 in the DL striatum during cocaine priming-induced reinstatement of 
drug seeking.  
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Materials and Methods 
Animals and Housing 
Male Sprague-Dawley rats (Rattus novergicus) weighing 250-300 g were obtained from 
Taconic Laboratories (Germantown, NY, USA).  Animals were individually housed with 
food and water available ad libitum.  A 12h light/dark cycle was used and all experiments 
were performed during the light cycle.  All experiments used Med-Associates (East 
Fairfield, VT, USA) operant chambers equipped with response levers, house light, and 
pumps for injecting drugs intravenously. Operant chambers were enclosed within 
ventilated, sound attenuating chambers. All experimental procedures were consistent 
with the ethical guidelines of the U.S. National Institutes of Health and were approved by 
the University of Pennsylvania School of Medicine Institutional Animal Care and Use 
Committee.   
Drugs 
Cocaine hydrochloride was obtained from the National Institute on Drug Abuse 
(Rockville, MD, USA) and dissolved in bacteriostatic 0.9% saline.   
Surgery 
Prior to surgery, the rats were anesthetized with 80 mg/kg ketamine (i.p.; Sigma-Aldrich, 
St. Louis, MO, USA) and 12 mg/kg xylazine (i.p.; Sigma-Aldrich, St. Louis, MO, USA).  
An indwelling silastic catheter (CamCaths, UK) was placed into the right jugular vein and 
sutured in place.  The catheter was routed to a mesh backmount platform and implanted 
subcutaneously dorsal to the shoulder blades.  Catheters were flushed daily with 0.3 ml 
of an antibiotic (Timentin, 0.93 mg/ml, Henry Schein, Melville, NY, USA) dissolved in 
heparinized saline.  The catheters were sealed with plastic obturators when not in use.   
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Cocaine Self-Administration and Extinction 
Following a 7-day recovery period from surgery, 50% of the rats were randomly selected 
to self-administer cocaine.  The remaining 50% were paired to a cocaine self-
administering animal as yoked-saline controls that only receive infusions of saline.  
Cocaine self-administering rats were placed in operant chambers and allowed to lever 
press for intravenous cocaine infusions (0.25 mg/59 µl saline over 5 s) over a 2-hour 
time period daily for 16 days.  Yoked-saline controls received the same number and 
temporal pattern of infusions as the paired cocaine self-administering rat.  Rats were 
initially trained using a fixed ratio (FR) 1 schedule of reinforcement, with each daily self-
administration session initiated by a priming injection of cocaine (0.25 mg, i.v.) to fill the 
catheter (limited to 30 injections per 120 min).  Once animals achieved stable 
responding, as defined by at least 20 infusions over the 2 h session for 2 consecutive 
days, they were transitioned to an FR5 schedule of reinforcement (limited to 30 
injections per 120 min).  For both schedules of reinforcement, a 20s time-out period 
followed each cocaine infusion, during which time active, drug-paired lever responses 
were tabulated but had no scheduled consequence.  Each operant chamber was also 
equipped with an inactive lever.  Responses made on the inactive lever, which had no 
scheduled consequence, were also recorded during all training sessions.   
Following cocaine self-administration, drug-taking behavior in cocaine self-
administering rats was extinguished by replacing cocaine with 0.9% bacteriostatic saline.  
Extinction continued until responding on the drug-paired lever was <15% of the 
response rate on the last day of cocaine self-administration using the FR5 schedule of 
reinforcement.  Typically, it took rats 5 days to meet this criterion. 
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Cocaine Priming-Induced Reinstatement of Drug Seeking 
Following extinction, animals entered the reinstatement phase of the experiment.  During 
reinstatement, satisfaction of the response requirements for FR5 resulted in saline rather 
than cocaine infusions.  The FR5 schedule was used for the reinstatement test session.  
Pairs of cocaine self-administering/yoked-saline rats were randomly assigned to receive 
saline or cocaine (10 mg/kg, i.p.) injections immediately prior to the start of the 
reinstatement test session.  Rats were placed into the operant chambers immediately 
following injection of saline or cocaine. Responding was recorded for 30 minutes, after 
which the pairs of rats were removed from the operant chambers and immediately 
decapitated.  Whole brains were extracted and flash-frozen in isopentane on dry ice, 
then stored at -80° C. Brains were sliced on a cryostat (300 µm sections) and striatal 
subregions (+1.7 mm to –0.08 mm A/P; –3.8 mm to –6.0mm D/V; DM: ±1.2 mm – 2.8 
mm M/L and DL: ±2.8 mm – 4.4 mm M/L) dissected by tissue punch (2.0 mm Harris Uni-
core stainless steel punchers, Ted Pella, Inc.).  Tissue samples were stored at -80° C 
until processing for Western blot as described below. 
Western Blot 
Whole-cell tissue was processed for Western blot as described previously (Anderson et 
al., 2008).  For all samples, protein concentration was quantified using a Pierce BCA 
Protein Assay Kit (Thermo Scientific).  Equal amounts of protein (10 µg for whole-cell) 
were loaded and separated in 10% Tris-Glycine gels (Invitrogen) and transferred to 
nitrocellulose membranes using the i-Blot dry transfer system (Invitrogen).  Membranes 
were blocked with either 5% non-fat dry milk in TBST or 5% BSA in TBST, according to 
antibody instructions.  Membranes were incubated overnight at 4° C with selective 
antibodies to: GluA1 (1:1000, Abcam), phosphorylated (p) GluA1-S831 (1:500, 
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Millipore), CaMKII (1:1000, Millipore), pCaMKII-T286 (1:1000, Cell Signaling), and 
GAPDH (1:2000, Cell Signaling).  Membranes were then incubated with fluorescent 
secondary antibodies (1:5000, IR-dye 680 or IR-dye 800), before being imaged on an 
Odyssey fluorescent scanner (Licor Biosciences).  To ensure equal loading, GAPDH 
expression was used as a loading control.  
Behavioral Experiment Data Analyses 
Drug-paired and inactive lever responding was analyzed using a two-way ANOVA.  The 
between subjects factors were pretreatment (cocaine self-administration or yoked-saline) 
and drug challenge injection (10 mg/kg cocaine or saline).  Bonferroni post-tests were 
used to establish significant difference (p<0.05). 
Western Blot Data Analyses 
Quantification was performed by normalizing the intensity of all bands with protein-
specific antibodies to the GAPDH intensity, followed by normalizing that value to saline-
control (yoked-saline, i.p. saline) values.  The immunoblot analyses were performed 
using a two-way ANOVA.  The between-subjects factors were pretreatment (cocaine 
self-administration or yoked-saline) and drug challenge injection (10 mg/kg cocaine i.p. 
or saline).  Bonferroni post-tests were used to establish significant difference (p<0.05). 
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Results 
A priming injection of cocaine, but not saline, elicits robust reinstatement of drug-seeking 
behavior in animals with cocaine self-administration experience.  
Total drug-paired lever responding (mean +/- SEM) for the reinstatement test session 
are plotted in Fig 2.1.  Responding was analyzed using a two-way ANOVA.  Analyses 
revealed a significant main effect of pretreatment (F1,24=119.39, p<0.0001), a significant 
main effect of challenge injection (F1,24=92.14, p<0.0001), as well as a significant 
pretreatment × challenge interaction (F1,24=78.93, p<0.0001).  Post-hoc tests revealed a 
significant difference of drug-paired lever responding due to cocaine challenge injection 
(Bonferroni p<0.001).  There was no significant effect of pretreatment (F1,24=0.03, 
p=0.8543) or challenge (F1,24=3.68, p=0.0671) on inactive lever responding (data not 
shown). 
Exposure to acute cocaine in drug naïve animals increases expression of pGluA1-
ser831 and pCaMKII-thr286 in the DL Striatum. 
The average fluorescent intensity for pGluA1-ser831 in the DL striatum was expressed 
as percent change from control and is plotted in Fig 2.2A.  Percentages were analyzed 
by two-way ANOVA, which revealed a significant main effect of pretreatment (cocaine 
self-administration vs. yoked-saline, F1,12=14.03, p<0.005), a significant main effect of 
challenge (10 mg/kg cocaine or saline, F1,12=30.68, p<0.0001), as well as a significant 
pretreatment × challenge interaction (F1,12=20.75, p<0.0007).  Post hoc tests revealed a 
significant difference in pGluA1-ser831 expression between yoked-saline and cocaine 
self-administering animals after cocaine challenge injection (Bonferroni p<0.001).  There 
was no significant effect of pretreatment or challenge on the native GluA1 protein (Fig 
2.2B).  
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The average fluorescent intensity for pCaMKII-thr286 in the DL striatum was 
expressed as percent change from control and plotted in Fig 2.2C.  Percentages were 
analyzed by two-way ANOVA, which revealed a significant main effect of pretreatment 
(F1,11=15.73, p<0.0022), a significant main effect of challenge (F1,11=48.62, p<0.0001), 
as well as a significant pretreatment × challenge interaction (F1,11=9.78, p<0.0096).  Post 
hoc tests revealed a significant difference in pCaMKII-thr286 expression between yoked-
saline and cocaine self-administering animals after cocaine challenge injection 
(Bonferroni p<0.01).  There was no significant effect of pretreatment or challenge on 
native CaMKII protein (Fig 2.2D).  
Acute cocaine decreases expression of pGluA1-ser831, but not pCaMKII-thr286, in the 
DM striatum regardless of cocaine exposure.  
The average fluorescent intensity for pGluA1-ser831 in the DM striatum was expressed 
as percent change from control and plotted in Fig 2.3A.  Percentages were analyzed 
with a two-way ANOVA, which revealed no significant effect of pretreatment (p=0.3542) 
and no pretreatment × challenge interaction (p=0.9403), but a significant main effect of 
challenge (F1,24=4.33, p<0.05).  There was no significant effect of pretreatment or 
challenge on the average fluorescent intensity of native GluA1 protein in the DM striatum 
(Fig 2.3B).   
The average fluorescent intensity for pCaMKII-thr286 in the DM striatum was 
expressed as percent change from control and is plotted in Fig 2.3C.  Percentages were 
analyzed with a two-way ANOVA, which revealed no significant effect of pretreatment 
(p=0.1615) or challenge (p=0.2906).  There was no significant effect of pretreatment or 
challenge on the average fluorescent intensity of native CaMKII protein in the DM 
striatum (Fig 2.3D). 
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Discussion 
The present findings indicate that an acute injection of cocaine increased expression of 
pCaMKII-thr286 and pGluA1-ser831 in the DL, but not the DM, striatum of drug-naïve 
rats.  Since the phosphorylation of CaMKII at threonine 286 is associated with increased 
phosphorylation of GluA1 at serine 831 and subsequent trafficking of these subunits 
(Boehm and Malinow, 2005), these results suggest that an acute cocaine injection may 
increase the surface expression of AMPA receptors in the DL striatum.  However, 
following cocaine self-administration and extinction, a cocaine challenge injection had no 
effect on DL striatal pCaMKII-thr286 or pGluA1-ser831 expression.  Taken together, 
these results indicated that tolerance to cocaine-induced increases in the 
phosphorylation of DL striatal CaMKII and GluA1 develops following cocaine self-
administration. 
Our findings are consistent with previous work that showed increased pCaMKII-
thr286 and pGluA1-ser831 in the DL striatum following acute cocaine (Edwards et al., 
2007; Kim et al., 2009a).  A single exposure to cocaine also increases immediate early 
gene expression in the dorsal striatum (Graybiel et al., 1990; Larson et al., 2010; Philibin 
et al., 2011).  Additionally, a single microinjection of cocaine into the dorsal striatum 
enhances locomotor activity (Delfs et al., 1990).  Taken together, these results indicate 
that cocaine-induced hyperlocomotion is associated with increased neuronal activation 
in the DL striatum and increased phosphorylation of CaMKII and GluA1.  Future studies 
are required to determine the functional significance of increased phosphorylation of 
CaMKII and GluA1 following acute cocaine exposure. 
There also is evidence of altered glutamatergic transmission in the DL striatum 
following prolonged cocaine administration (Porrino et al., 2007).  Animals identified as 
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vulnerable to cocaine relapse following cocaine self-administration showed down-
regulation of genes for GluA1 and activity-regulated cytoskeletal protein, both of which 
are involved in synaptic plasticity and AMPA receptor trafficking (Brown et al., 2011).  
While we did not investigate alternate phosphorylation sites of GluA1 subunits in this 
study, there is also evidence of decreased expression of phospho-GluA1 ser845, a 
known target of protein kinase A, in the dorsal striatum in animals with chronic cocaine 
self-administration experience (Mattson et al., 2005; Edwards et al., 2007).  Functionally, 
pharmacological inactivation of the DL striatum attenuates cocaine seeking in rats with a 
history of short- or long-access to cocaine self-administration (Pacchioni et al., 2011).  
Moreover, an intra-striatal infusion of an AMPA/kainate receptor antagonist attenuates 
cue-controlled cocaine seeking (Vanderschuren et al., 2005; Pacchioni et al., 2011).  
Furthermore, overexpression of a dominant negative peptide that prevents trafficking of 
GluA1 to the membrane surface in the DL striatum attenuated cocaine-induced 
behavioral sensitization in juvenile mice (Kim et al., 2009a).  It is important to note, 
however, that unlike adult mice, the juveniles exhibited increased GluA1 surface 
expression following repeated cocaine, suggesting that age at time of cocaine exposure 
influences DL striatal glutamatergic plasticity.  Transgenic mice that express 
constitutively active CaMKII, where threonine 286 is replaced with aspartic acid, in the 
dorsal striatum exhibit impairments in goal-directed behaviors, with impairments in both 
cue- and reward-primed reinstatement (Wiltgen et al., 2007).  As a whole, these results 
indicate that the changes in AMPA receptor transmission in adult rodents that contribute 
to cocaine sensitization and reinstatement are not likely due to increases in CaMKII or 
GluA1 phosphorylation in the DL striatum.  Our data showed changes the 
phosphorylation state of CaMKII and GluA1 in DL striatum of drug naïve rats following 
acute cocaine only, offering novel biochemical support for such conclusions.  
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The present findings suggest differential involvement of the glutamatergic system 
in the DL striatum relative to the ventral striatum, particularly after cocaine self-
administration and the reinstatement of cocaine seeking.  It is well known that CaMKII 
plays a key role in phosphorylating GluA1 subunits at serine 831 and promotes AMPA 
receptor trafficking to the membrane surface (Boehm and Malinow, 2005).  In fact, 
plasticity of the glutamatergic system in the ventral striatum, including increased 
phosphorylation of CaMKII and GluA1 as well as increased GluA1 surface expression 
occurs in a variety of paradigms involving chronic cocaine exposure (Boudreau and 
Wolf, 2005; Conrad et al., 2008; Ferrario et al., 2011).  More specifically, during cocaine 
priming-induced reinstatement, there is increased phosphorylation of CaMKII and GluA1 
AMPA receptor subunits, as well as increased trafficking of GluA1 to the plasma 
membrane in the accumbens shell (Anderson et al., 2008).  Inhibiting CaMKII or 
preventing the trafficking of GluA1 subunits in the shell is sufficient to block 
reinstatement of cocaine seeking (Anderson et al., 2008).  These findings coupled with 
the data presented here suggest that phosphorylation of CaMKII and GluA1 in the 
ventral, but not DL, striatum is required for reinstatement of cocaine seeking.  Thus, 
changes in phospho-CaMKII and –GluA1 in the DL striatum likely reflect a compensatory 
mechanism in response to acute cocaine.  
Our results indicate that acute cocaine increases expression of pCaMKII-thr286 
and pGluA1-ser831 in the DL, but not DM, striatum and that these effects are not 
associated with the reinstatement of cocaine seeking.  Therefore, changes in phospho-
CaMKII and –GluA1 most likely reflect a compensatory adaptation in the DL striatum 
during early stages of drug use.  It is possible that acute cocaine promotes transient 
biochemical modifications in the DL striatum that reverse with additional input from areas 
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like the ventral striatum and/or prefrontal cortex as cocaine experience is extended 
(Edwards et al., 2007). 
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FIGURE 2.1 
 
An acute, priming injection of cocaine elicits robust reinstatement of drug-
seeking behavior in rats with cocaine self-administration experience. Total 
drug-paired lever responding for the 30-minute reinstatement test session is plotted 
for animals that received saline or cocaine challenge injection. There was a 
significant increase of drug-paired lever responding for cocaine-experienced rats 
that received cocaine compared to animals that received a saline injection. N = 
7/group, “SA” = self-administration (The asterisk represents a significant difference 
from yoked-saline controls. 2-way ANOVA: Bonferroni p<0.001) 
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FIGURE 2.2 
 
Acute cocaine exposure increases expression of pGluA1-ser831 and pCaMKII-
thr286 in the DL striatum and these effects are reversed after cocaine self-
administration. Following an acute cocaine injection, yoked-saline controls show a 
significant increase in pGluA1-ser831 (A) and pCaMKII-thr286 (B) protein expression 
in the DL striatum. No significant changes in pGluA1-ser831 (A) and pCaMKII-thr286 
(B) protein expression were observed in cocaine-experienced animals when 
compared to yoked-saline controls that received saline injections. There was no 
significant effect of training or challenge injection on native GluA1 (C) or native 
CaMKII (D) protein expression for any treatment. N = 4-7/group, “SA” = self-
adminstration (Asterisks represent significant differences from yoked-saline controls 
that received a saline challenge injection. 2-way ANOVA: pGluA1 Bonferroni p<0.001; 
pCaMKII Bonferroni p<0.01) 
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FIGURE 2.3 
 
An acute, priming cocaine injection decreases pGluA1-ser831 in the DM 
striatum regardless of cocaine experience. (A) pGluA1-ser831 protein expression 
was decreased in both cocaine-experienced rats and yoked-saline controls in the DM 
striatum after a cocaine challenge injection. There is no change in native GluA1 (B), 
pCaMKII-286 (C), or native CaMKII (D) protein expression in the DM striatum, 
regardless of cocaine experience. N = 4-7/group, “SA” = self-administration (The # 
represents a significant effect of challenge injection, p<0.05. There was no significant 
effect of pretreatment and no significant interaction.) 
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Abstract 
A growing body of evidence indicates that the transport of calcium-permeable AMPA 
receptors (CP-AMPARs) to synapses in subregions of the nucleus accumbens promotes 
the reinstatement of cocaine seeking.  Consistent with these findings, the present results 
show that administration of the CP-AMPAR blocker, Naspm, into the accumbens core or 
shell attenuated cocaine priming-induced reinstatement of cocaine seeking.  Moreover, 
viral-mediated over-expression of “pore-dead” GluA1-containing AMPA receptors (via 
HSV GluA1-Q582E) into the core or shell attenuated the reinstatement of cocaine 
seeking, whereas over-expression of wild-type GluA1 subunits (via HSV GluA1-WT) in 
the shell, but not the core, enhanced the reinstatement of cocaine seeking.  These 
results indicate that activation of GluA1-containing CP-AMPARs in accumbens 
subregions reinstates cocaine seeking.  We next examined potential roles of SAP97 and 
4.1N, proteins involved in GluA1 trafficking and stabilization at synapses, in this process.  
Viral-mediated expression of a microRNA that reduces SAP97 protein expression (HSV 
miSAP97) in the accumbens shell attenuated cocaine seeking.  Viral expression and 
function were characterized by immunofluorescence and whole-cell patch clamp.  In all 
cases, virus expression had no influence on the reinstatement of food seeking.  
Moreover, SAP97-mediated trafficking of GluA1-containing AMPA receptors to synapses 
in the accumbens shell is necessary for cocaine reinstatement.  These results support 
investigation into GluA1 subunit accessory proteins as potential novel targets for 
pharmacotherapeutic intervention in cocaine craving and addiction. 
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Introduction 
Although cocaine does not directly influence glutamate systems, repeated exposure to 
cocaine results in adaptations in glutamate transmission in limbic regions such as the 
nucleus accumbens.  For example, during the reinstatement of cocaine seeking, an 
animal model of relapse, extracellular glutamate levels increase in the nucleus 
accumbens (Baker et al., 2003; McFarland et al., 2003).  Moreover, administration of 
AMPA glutamate receptor antagonists into the nucleus accumbens attenuates cocaine 
priming-induced reinstatement, whereas activation of accumbens AMPA receptors 
promotes the reinstatement of cocaine seeking (Cornish et al., 1999; Cornish and 
Kalivas, 2000; Suto et al., 2004; Kruzich and Xi, 2006; Ping et al., 2008).  The nucleus 
accumbens is divided into two major subregions, the core and shell.  Increased AMPA 
receptors (AMPAR) transmission in both accumbal subregions of the nucleus 
accumbens contribute to the reinstatement of drug seeking precipitated by a cocaine 
priming injection (Schmidt and Pierce, 2010).  Thus, microinjection of the AMPA receptor 
antagonist, CNQX, into either the core or shell attenuated cocaine priming-induced 
reinstatement (Famous et al., 2008) and administration of AMPA itself into either 
accumbens subregion elicited cocaine seeking (Ping et al., 2008). 
There are four AMPA receptor subunits, GluA1-4, all of which become permeable 
to sodium and potassium upon activation (Pierce and Wolf, 2013).  However, absence of 
GluA2 subunits from the AMPAR tetramer results in calcium permeability.  GluA2-lacking 
calcium-permeable AMPARs (CP-AMPARs) have larger single channel conductance 
and faster kinetics relative to calcium-impermeable (CI) AMPARs that include GluA2 
subunits (Tanaka et al., 2000; Cull-Candy et al., 2006; Lee, 2012).  A growing body of 
evidence indicates that the balance of AMPARs in the nucleus accumbens is shifted to 
CP-AMPARs following repeated exposure to cocaine.  Increased cell surface GluA1, but 
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not GluA2, expression was observed in the nucleus accumbens following cocaine self-
administration (Anderson et al., 2008; Conrad et al., 2008).  Electrophysiological studies 
demonstrated inward rectification of evoked AMPA receptor EPSCs, a hallmark of CP-
AMPARs, in cocaine-experienced rats (Conrad et al., 2008; McCutcheon et al., 2011).  
These biochemical and electrophysiological results indicated an increase in CP-
AMPARs (GluA1 homomers or GluA1/A3 receptors) in accumbens synapses after 
prolonged withdrawal.  Supporting the functional significance of these findings, 
suppression of GluA1 transcription in either the accumbens core or shell impaired the 
reinstatement of drug seeking induced by a cocaine priming injection (Ping et al., 2008) 
and microinjection of the CP-AMPAR antagonist Naspm into the accumbens core 
blocked the expression of incubated cue-induced cocaine seeking (Conrad et al., 2008).  
Cocaine reinstatement also was attenuated by viral-mediated impairment of the 
transport of GluA1-containing AMPA receptors to synapses in the accumbens shell 
(Anderson et al., 2008).  Together, these data indicate that increased glutamate 
transmission through accumbens shell CP-AMPARs promotes the reinstatement of 
cocaine seeking.  Collectively, these findings suggest that synaptic incorporation of CP-
AMPARs in the nucleus accumbens translates into enhanced drug seeking. 
 In order to expand upon these findings, we assessed the influence of Naspm 
administered into the core or shell on the reinstatement of cocaine seeking.  We also 
used herpes simplex viral vectors to enhance or diminish the GluA1-mediated 
transmission in the core and shell prior to cocaine reinstatement.  The mechanisms 
underlying the enhanced role of GluA1-containing AMPARs following cocaine exposure 
remain unclear.  Multiple scaffolding proteins are involved in the trafficking and 
stabilization of GluA1 AMPAR subunits at the cell surface.  For example, SAP97 is a 
PDZ domain-containing protein that assists in the trafficking of GluA1 subunits from 
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intracellular pools and the endoplasmic reticulum as well as the stabilization of GluA1-
containing AMPARs the plasma membrane (Cai et al., 2002; Passafaro et al., 2001; 
Nikandrova et al., 2010) and 4.1N is an actin/spectrin binding protein that contributes to 
the trafficking and stabilization of GluA1-containing AMPARS at the cell surface (Lin et 
al., 2009).  Interestingly, 4.1N also interacts with SAP97 to aid its targeting to the plasma 
membrane (Hanada et al., 2003).  Using viral vectors strategies, we assessed the roles 
of accumbens SAP97 and 4.1N in the reinstatement of cocaine seeking.  	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Materials and Methods 
Animals and Housing 
Male Sprague-Dawley rats (Rattus novergicus) weighing 250-300 g were obtained from 
Taconic Laboratories (Germantown, NY, USA). Animals were individually housed with 
food and water available ad libitum.  A 12h light/dark cycle was used and all experiments 
were performed during the light cycle. All experiments used Med-Associates (East 
Fairfield, VT, USA) operant chambers equipped with response levers, house light, and 
pumps for injecting drugs intravenously.  Operant chambers were enclosed within 
ventilated, sound attenuating chambers.  All experimental procedures were consistent 
with the ethical guidelines of the U.S. National Institutes of Health and were approved by 
the University of Pennsylvania School of Medicine Institutional Animal Care and Use 
Committee.   
Drugs and Viruses 
Cocaine hydrochloride was obtained from the National Institute on Drug Abuse 
(Rockville, MD, USA) and dissolved in bacteriostatic 0.9% saline.  We obtained 1-
Naphthyl acetyl spermine trihydrochloride (Naspm) from Sigma-Aldrich (St. Louis, MO) 
and dissolved it in phosphate buffered saline (PBS). Dr. Rachael Neve at the MIT Viral 
Core packaged the viruses, GluA1-Q582E (Bachtel et al, 2008), GluA1-WT (Carlezon et 
al 1997), and 4.1N-CTD (Lin et al, 2009) into a Herpes Simplex Virus (HSV) p1005 
plasmid, driven by an IE 4/5 promoter.  The laboratory of Dr. Robert Kalb created the 
construct for miSAP97 (CAGTGACTGCCTTAAAGAATA) and scramble, and Dr. Rachel 
Neve at the MIT Viral Core also packaged these constructs into HSV.  All viruses co-
express green fluorescent protein (eGFP) driven under a separate CMV promoter.  
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Surgery  
Rats were handled daily and allowed 1 week to acclimate to their home cages upon 
arrival.  Prior to all surgeries, rats were anesthetized with 80 mg/kg ketamine (i.p.; 
Sigma-Aldrich, St. Louis, MO, USA) and 12 mg/kg xylazine (i.p.; Sigma-Aldrich, St. 
Louis, MO, USA).  For cocaine self-administering animals, an indwelling silastic catheter 
(CamCaths, UK) was placed into the right jugular vein and sutured in place.  The 
catheter was routed to a mesh backmount platform and implanted subcutaneously 
dorsal to the shoulder blades.  Catheters were flushed daily with 0.3 ml of an antibiotic 
(Timentin, 0.93 mg/ml, Henry Schein, Melville, NY, USA) dissolved in heparinized saline. 
The catheters were sealed with plastic obturators when not in use.  Following catheter 
insertion, we mounted animals in a stereotaxic apparatus and bilaterally implanted 
stainless steel guide cannulae (14 mm, 24 gauge) 2 mm dorsal to the medial nucleus 
accumbens shell, core or dorsal striatum.  Dental acrylic affixed to stainless steel screws 
secured in the skull cemented the cannulae in place.  The coordinates for the ventral 
ends of the guide cannulae, relative to bregma according to the atlas of Paxinos and 
Watson (1997) were as follows: shell = +1.0 mm A/P, ±1.0 mm M/L, –5.0 mm D/V; core 
= +1.0 mm A/P, ±2.5 mm M/L, –5.0 mm D/V; dorsal striatum = +1.0 mm A/P, ± 4.0 mm 
M/L, -5.0 mm D/V.  In order to prevent occlusion, we inserted an obturator (14 mm, 33 
gauge wire) into each guide cannula following surgery.  
Animals used for food self-administration experiments had guide cannulae implanted 
into the nucleus accumbens core and shell, as described above.  They did not receive a 
catheter.  
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Virus Injections 
We mounted drug-naïve animals in a stereotaxic apparatus and 22 gauge Hamilton 
syringes holding 2.0 µl virus (according to experiment) were affixed to the stereotax and 
lowered bilaterally 0.5 mm dorsal to the medial nucleus accumbens shell and core.  The 
coordinates for the ventral ends of the Hamilton syringes, relative to bregma according 
to the atlas of Paxinos and Watson (Paxinos and Watson, 1997) were as follows: shell = 
+1.0 mm A/P, ±1.0 mm M/L, –6.5 mm D/V; core = +1.0 mm A/P, ±2.5 mm M/L, –6.5 mm 
D/V.  Virus was injected manually over the course of 10 minutes (0.2µl /minute) and the 
syringes were left in place for an additional 2 minutes to allow the virus to disperse. 
Upon recovering from anesthesia, animals were returned to their home cages until 
sacrificed for viral expression, biotinylation, or electrophysiological experiments.  
Self-Administration and Extinction 
Cocaine  
Following a 7-day recovery period from surgery, rats were placed in operant chambers 
and allowed to lever press for intravenous cocaine infusions (0.25 mg/59 µl saline over 5 
s) over a 2-hour time period daily for 21 days.  Each self-administration session began 
with the i.v. administration of 59 µl cocaine (0.25 mg) to fill the catheter (little or none of 
this non-contingent injection reached the systemic circulation).  Rats were initially trained 
using a fixed ratio (FR) 1 schedule of reinforcement (limited to 30 injections per 120 
min).  Once animals achieved stable responding, as defined by at least 20 infusions over 
the 2 h session for 2 consecutive days, they were transitioned to an FR5 schedule of 
reinforcement (limited to 30 injections per 120 min).  For both schedules of 
reinforcement, a 20s time-out period followed each cocaine infusion, during which time 
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active, drug-paired lever responses were tabulated but had no scheduled consequence. 
Each operant chamber was also equipped with an inactive lever.  Responses made on 
the inactive lever, which had no scheduled consequence, were also recorded during all 
training sessions.   
Following cocaine self-administration, drug-taking behavior was extinguished by 
replacing cocaine with 0.9% bacteriostatic saline.  Extinction continued until responding 
on the drug-paired lever was <15% of the response rate on the last day of cocaine self-
administration using the FR5 schedule of reinforcement. 
Sucrose 
After a 7-day recovery period, we food deprived (4 pellets/day, 80% body weight) the 
rats and trained them to administer sucrose pellets on a fixed ratio (FR) 1 schedule, 
where they received one food pellet each time they pressed the active lever (Bio-Serv, 
Frenchtown, NJ).  After receiving over 20 pellets per session over two consecutive self-
administration sessions, the rats then advanced onto a FR 5 schedule where they 
received one sucrose pellet after pressing the active lever five times.  Rats self-
administered sucrose pellets for a total of 14 days with a maximum of 30 pellets per 
session.  
Following sucrose self-administration, sucrose-seeking behavior was extinguished 
where active lever pressing resulted in no sucrose pellets.  Extinction of sucrose-seeking 
behavior continued on an FR5 schedule until responding on the active lever was 15% or 
less of that on the last self-administration day.   
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Microinjections for Reinstatement Experiments 
Naspm  
We removed the obturators from the guide cannulae and inserted 33 gauge stainless 
steel microinjectors (Small Parts Inc) into the guide cannula.  We cut microinjectors to a 
length that extended 2 mm below the ventral end of the guide cannulae, and lowered the 
microinjectors into the medial nucleus accumbens shell, accumbens core, or dorsal 
striatum.  Bilateral infusions occurred over a 120 s time period for a total volume of 0.5 µl 
of Naspm (40µg) or saline per hemisphere.  This dose has been previously confirmed in 
the literature to produce behavioral effects (Conrad et al., 2008).  Following 
microinfusion of either Naspm or saline, the microinjectors remained in place for 60 s in 
order to allow the solution to diffuse away from the tips of the microinjectors before 
removal. 10 min following microinjections we administered a systemic priming injection 
of cocaine (10 mg/kg, i.p.) or experimenter-delivered sucrose pellets and began the 
reinstatement session (see below).  
The goal of the experimental design was to have each animal serve as its own control 
and receive up to two microinjections per brain region (i.e. one dose of Naspm plus 
saline for a maximum of two microinjections per brain region).  However, we were 
frequently forced to deviate from this experimental design when technical difficulties (i.e. 
blocked microinjection cannula or loss of catheter patency) made it impossible of Naspm 
plus vehicle in each brain region.  Therefore, we used a mixed-factors design in these 
behavioral experiments.  In every case, however, an animal received at a minimum, 
treatment of one drug dose and its vehicle.  In order to control for potential order effects 
of drug and vehicle administrations, all drug and vehicle treatments were 
counterbalanced across reinstatement sessions.  
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Using this experimental design, subjects underwent a series of alternating extinction and 
reinstatement sessions that lasted for approximately 16 days.  During this period, 
extinction of the ability of priming injections of cocaine to induce reinstatement is a 
concern.  However, we have previously shown that reinstatement of cocaine seeking 
persists for at least 20 days after the initial extinction of cocaine self-administration 
behavior (Anderson et al., 2008; Famous et al., 2008).  
Viral Vector 
Only one viral vector was microinjected bilaterally per animal in a between-subjects 
design.  We removed the obturators from the guide cannulae and inserted 33 gauge 
stainless steel microinjectors (Small Parts Inc).  We cut microinjectors to a length that 
extended 2 mm below the ventral end of the guide cannulae and lowered them into the 
medial nucleus accumbens shell or core. Bilateral infusions of HSV GluA1-Q582E, 
GluA1-WT, 4.1N-CTD, eGFP, miSAP97, or scramble occurred simultaneously over a 10 
min time period for a total volume of 2.0 µl per side.  Following the injections, we left 
microinjectors in place for 120 s to allow the solution to diffuse away from the tips of the 
cannula before they were removed.  Animals underwent daily extinction sessions until 
reaching the first reinstatement test session 3 days (GluA1-Q582E, GluA1-WT, 4.1N-
CTD, eGFP) or 4 days (miSAP97, scramble) post-infusion (see below).  Animals in viral 
vector experiments were then maintained on extinction sessions until the second 
reinstatement test at 1-week post-injection. 
Cocaine Priming-induced Reinstatement  
Upon reaching extinction criteria, animals received microinjections of Naspm or viral 
vectors as previously described (see Table 3A for cohort details).  Immediately prior to 
the reinstatement test session, animals received a systemic priming injection of 10 
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mg/kg cocaine or 5 mg/kg cocaine (i.p.).  Following the priming injection of cocaine, we 
placed animals in the operant chamber for a 2 h reinstatement session under extinction 
conditions (i.e. active lever presses resulted in an infusion of saline instead of cocaine). 
We recorded active and inactive lever responding.  Extinction sessions followed each 
reinstatement session until responding was again less than 15% of the response rate 
maintained by cocaine self-administration.  
Sucrose Reinstatement 
Upon reaching extinction criteria, animals received microinjections of Naspm or viral 
vectors as previously described (see Table 3B for cohort details).  To assess sucrose 
reinstatement in all groups, we placed the animals in the operant chambers and the 
session began with a prime of two non-contingent sucrose pellets.  Over the first 10 min 
of the reinstatement session, the experimenter remotely administered two non-
contingent sucrose pellets every 2 minutes.  Active lever responding was recorded for 
the entire 60-minute session.  Extinction sessions followed each reinstatement session 
until responding was again less than 15% of the response rate maintained by sucrose 
self-administration. 
Verification of Cannulae Placements 
After the completion of all behavioral experiments, the animals were given an overdose 
of pentobarbital (100 mg/kg) and then the brain was removed and stored in formalin for 
at least three days.  Subsequently, coronal sections (100 µm) were taken at the level of 
the nucleus accumbens with a Vibratome (Technical Products International; St. Louis, 
MO).  The sections were mounted on gelatin-coated slides.  An individual unaware of the 
animals' behavioral response determined cannula placements as well as potential drug- 
or cannula-induced neuronal damage.  Cellular death and associated gliosis also were 
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assessed.  Animals with cannulae placements outside of the areas of interest, or with 
excessive mechanical damage, were excluded from subsequent data analysis.  
Viral Expression 
To ascertain viral expression via green fluorescent protein, we injected (2µl/side) HSV 
GluA1-Q582E, HSV 4.1N-CTD, HSV GluA1-WT, or HSV miSAP97 into the nucleus 
accumbens of separate, drug-naïve rats (N=10).  At 3 days, 4 days, or one week after 
injection, animals received 100 mg/kg pentobarbital (i.p.) before perfusion with 120mL 
ice-cold PBS followed by 60 mL 4% PFA dissolved in ice-cold PBS. Brains were 
removed and placed in 4% PFA for 24 hours before storage in 30% sucrose dissolved in 
PBS with 1% sodium azide.  Experimenters sliced 10-30µm coronal sections on a 
cryostat (Cryotome FE, Thermo) and mounted them directly onto polarized glass slides. 
Dry slides were washed in 1X PBS, and then blocked for one hour in 0.1% triton and 3% 
normal donkey serum in 1X PBS.  We then added primary antibody (Anti-eGFP, Ms/Rb 
Millipore, diluted 1:1000 in 0.1% triton + 3% donkey serum in PBS) to the slides and 
incubated overnight at 4°C.  The next day, experimenters washed the slides in 1X PBS 
before incubating in secondary fluorescent antibody at room temperature for 2 hours. 
Secondary fluorescent antibodies included: Anti-Rabbit and Anti-Mouse Alexa Fluor 488 
(1:500, Jackson Immuno Research).  After 2 hours, slides were washed in 1X PBS 
before being cover-slipped using Vectashield mounting medium (Vector Laboratories) 
and imaged for eGFP expression using fluorescent microscopy.  
Electrophysiology 
Separate, drug-naïve rats received bilateral injections of HSV GluA1-Q582E, HSV 
GluA1-WT, or HSV miSAP97 (2µl) into the accumbens shell.  After 3- or 4-days, animals 
were anesthetized with isofluorane in preparation for electrophysiological experiments as 
described previously (Ortinski et al., 2012).  Briefly, the brain was removed and coronal 
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slices (300 mm) containing the nucleus accumbens were cut with a Vibratome 
(VT1000S, Leica Microsystems) in ice-cold artificial cerebrospinal fluid solution (ACSF), 
in which NaCl was replaced by an equiosmolar concentration of sucrose.  ACSF 
consisted of 130mM NaCl, 3mM KCl, 1.25mM NaH2PO4, 26mM NaHCO3, 10mM 
glucose, 1mM MgCl2, and 2mM CaCl2 (pH 7.2–7.4 when saturated with 95% O2/5% 
CO2).  Slices were incubated in ACSF at 32–34 1C for 45 min and kept at 22–25 1C 
thereafter, until transfer to the recording chamber.  Slices were viewed using infrared 
differential interference contrast optics under an upright microscope (Eclipse FN1, Nikon 
Instruments) with a 40X water immersion objective. 
For evoked EPSCs (eEPSCs), a minimal stimulation intensity required to evoke a 
consistent post-synaptic response was determined.  Peak eEPSC amplitudes were then 
measured at double and triple the minimal stimulation intensity (at 0.05-0.1 Hz) to 
construct the input/output diagrams.  Average responses were then calculated based on 
5-10 eEPSCs at each stimulation intensity.  The rectification index of AMPA receptor-
mediated eEPSCs was measured as the ratio of the peak current amplitude at +40 mV 
to the peak current amplitude at -70 mV.  For rectification index, the measurements were 
based on 5-10 eEPSCs evoked at 0.1 Hz. 
Western Blot 
For HSV 4.1N-CTD protein expression, drug-naïve animals received unilateral injections 
of HSV 4.1N-CTD or HSV eGFP (2µl) into each hemisphere of the accumbens shell 
(N=10/virus) and were returned to recover in their home cage for 3 days, respectively.  
To measure knock down of SAP97 protein expression due to HSV miSAP97, drug-naïve 
animals received bilateral injections of HSV miSAP97 or HSV Scramble into the core 
and shell of the nucleus accumbens (N=6/virus) and were returned to recover in their 
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home cage for 4 days.  Following rapid, live decapitation, brains were extracted and 
flash-frozen in isopentane (-80 C).  Experimenters used a cryostat to dissect out the 
nucleus accumbens before processing whole-cell tissue for Western blot as described 
previously (Anderson et al., 2008).  
For all samples, protein concentration was quantified using a Pierce BCA Protein 
Assay Kit (Thermo Scientific).  Equal amounts of protein (10-20 µg) were loaded and 
separated in 10% Tris-Glycine gels (Invitrogen) under reducing conditions, then 
transferred to nitrocellulose membranes using the i-Blot dry transfer system (Invitrogen). 
Membranes were blocked with Odyssey Blocking Buffer (Invitrogen), according to 
manufacturer instructions.  Membranes were incubated overnight at 4° C with selective 
antibodies to: SAP97 (Rb 1:1000, AbCam), 4.1N (Rb 1:1000, Millipore), and GAPDH 
(1:2000, Cell Signaling) diluted in Odyssey Blocking Buffer.  After washing with TBST, 
membranes were then incubated with infrared secondary antibodies at room 
temperature for 1 hr (1:5000, IR-dye 680 or IR-dye 800), before being imaged on an 
Odyssey fluorescent scanner (Licor Biosciences).  To ensure equal loading, GAPDH 
expression was used as a loading control and all proteins were normalized to GAPDH 
integrated intensity values. 
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Results 
Blocking CP-AMPARs in the accumbens core or shell, but not dorsolateral striatum, 
selectively attenuates cocaine priming-induced reinstatement of drug seeking 
In order to assess the role of CP-AMPARs in the reinstatement of cocaine seeking, a 
CP-AMPAR antagonist (Naspm) was microinjected into regions of the striatal complex 
that contribute to various aspects of cocaine-seeking behavior.  Total active and inactive 
lever responding (mean ± SEM) during the reinstatement of cocaine seeking following 
microinjection of saline or 40 µg Naspm into the accumbens core, accumbens shell or 
DL striatum are shown Figures 3.1A, 3.1C and 3.1E.  Reinstatement data were analyzed 
with three separate analyses of variance (ANOVAs) with both drug treatment and lever 
as the between subjects factors in all cases.  Analysis of the core data revealed 
significant main effects of treatment (F1,11=11.98, p<0.0053) and lever (F1,11=57.02, 
p<0.0001) as well as a significant treatment × lever interaction (F1,11=11.72, p<0.0057).  
Post hoc tests revealed a significant difference in active lever responding between 
treatments (Bonferroni, p<0.05, Figure 3.1A).  Analysis of the shell data showed 
significant main effects of treatment (F1,7=16.51, p<0.0048) and lever (F1,7=47.76, 
p<0.0002) as well as a significant drug × lever interaction (F1,7=22.37, p<0.0021).  
Pairwise comparisons demonstrated a significant difference in active lever responding 
between treatments (Bonferroni, p<0.05, Figure 3.1C).  Analysis of the DL striatum data, 
which is shown in Figure 3.1E, showed a significant main effect of lever (F1,3=22.0, 
p<0.0186) but no significant main effect of treatment (F1,3=0.004, p<0.9538) and no 
significant treatment × lever interaction (F1,3=0.0063, p<0.9417). 
Decreases in responding, such as following intra-core or shell Naspm, could be 
due to generalized behavioral disruption.  Although Naspm produced no effect on 
	   66	   	  
inactive lever responding, the low average number of inactive responses per session 
decreases the utility of this measure as a means to judge drug-induced behavioral 
suppression.  Therefore, we also assessed the reinstatement of sucrose seeking.  Total 
responses on the active lever (mean ± SEM) during the sucrose reinstatement sessions 
are summarized in Table 3.1.  Microinjection of Naspm into the shell had no influence on 
the reinstatement of sucrose seeking (p<0.8221).  However, intra-core Naspm 
significantly attenuated sucrose seeking (p<0.0104), which indicates that CP-AMPARs in 
the core may have a more generalized influence on behaviors motivated by cocaine as 
well as natural reinforcers. 
Over-expression of “pore dead” GluA1 subunits in the core and shell reversibly 
attenuates cocaine seeking 
We initially characterized HSV GluA1-Q582E (pore dead GluA1) electrophysiologically in 
naïve rats (i.e. not exposed to cocaine) three days after microinjection of the virus into 
the nucleus accumbens.  Representative examples of eEPSCs recorded at minimum 
stimulation intensity (1X) as well as double (2X) and triple (3X) minimum stimulation 
intensity are shown in Figure 3.2A (left).  Quantification of this experiment is depicted in 
Figure 3.2B.  These data were analyzed with a two-way ANOVA, which revealed 
significant main effects of treatment (F1,9=11.69, p<0.0076) and stimulation intensity 
(F2,18=15.33, p<0.0001) as well as a significant interaction between these factors 
(F2,18=10.96, p<0.0008).  Subsequent pairwise tests showed a significant difference 
between amplitudes measured from eGFP negative and eGFP positive cells at the 3X 
stimulation intensity (Bonferroni, p<0.05, Figure 3.2B).  The Rectification Index (RI) was 
measured as the ratio of the peak current amplitude at +40 mV to the peak current 
amplitude at -70 mV in accumbens eGFP negative and eGFP positive neurons, as 
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illustrated in Figure 3.2A (right).  Quantification of this experiment is depicted in Figure 
3.2C.  These data were analyzed with a t-test (unpaired, two-tailed), which revealed a 
significant effect of GluA1-Q582E expression on RI (t6=3.068, p<0.022). 
Next, we examined the effect of HSV GluA1-Q582E administered into the core or 
the shell on the reinstatement of cocaine seeking.  As summarized in the experimental 
design outlined in Figure 3.3A the first reinstatement session occurred three days after 
the virus microinjection (HSV eGFP or HSV GluA1-Q582E), which is when HSV 
expression peaks (see Figure 3.3B).  Total active and inactive lever responding during 
the first reinstatement session for animals administered viruses into the core or shell are 
depicted in Figures 3.3C and 3.3D, respectively (the DL striatum was not examined due 
to the negative Naspm results summarized previously).  Reinstatement was prompted by 
administration of 10 mg/kg cocaine (i.p.).  These data were analyzed with separate 
mixed factors ANOVAs with virus as the between subjects factor and lever and the 
within subjects factor.  Analysis of the core data showed significant main effects of virus 
(F1,15=9.629, p<0.0073) and lever (F1,15=42.11, p<0.0001) as well as a significant 
treatment × lever interaction (F1,15=10.72, p=0.0051).  Analysis of the shell data revealed 
significant main effects of virus (F1,19=30.02, p<0.0019) and lever (F1,19=30.51, 
p<0.0001) as well as a significant treatment × lever interaction (F1,19=10.75, p<0.0039).  
Subsequent pairwise analyses revealed significant differences between active lever 
virus effects for both the core and the shell (Bonferroni, p<0.05).  Sucrose reinstatement 
also was assessed 3 days after virus administration in a separate cohort of animals.  
The data, which are summarized in Table 3.1, indicated no significant differences 
between HSV eGFP and HSV GluA1-Q582E when administered into either the core 
(p<0.6299) or shell (p<0.8180). 
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As shown in Figure 3.3E, HSV is dormant 7 days after administration.  A second 
reinstatement session was performed at this time point and the results were analyzed 
the same as described above for reinstatement session 1.  Analyses indicated only 
significant main effects of lever for both the core (F1,9=143.5, p<0.0001, Figure 3.3F) and 
shell (F1,11=28.23, p<0.0002, Figure 3.3G).  Taken together, these results show that the 
peak expression of pore-dead GluA1 subunits in either the core or the shell attenuated 
cocaine seeking.  Equivalent levels of cocaine reinstatement were observed during the 
second reinstatement session, at which point the virus was dormant. 
Over-expression of GluA1 subunits in shell, but not the core, promotes cocaine seeking 
In these experiments HSV eGFP or HSV GluA1-WT were microinjected into the core or 
shell using the same paradigm as depicted in Figure 3.3 with the exception that a 
subthreshold dose of cocaine (5 mg/kg, i.p.) was used in the reinstatement sessions.  
The statistical analyses were the same as used in Figure 3.3.  The analysis of the core 
data indicated no significant main effects or interactions at either reinstatement session 
(see Figures 3.4A and 3.4C).  For the shell, analysis of the first reinstatement session 
indicated a significant main effect of treatment (F1,15=13.97 p<0.002), a significant main 
effect of lever (F1,15=46.25 p<0.0001) and a significant treatment × lever interaction 
(F1,15=8.452 p<0.0108).  Post hoc tests revealed a significant active lever difference 
between treatments (Bonferroni, p<0.05, Figure 3.4B).  For the second reinstatement 
test, there was a significant main effect of lever (F1,14=8.446 p<0.0115) but no other 
significant main effect or interaction (see Figure 3.4D).  These data indicate that a 
normally subthreshold dose of cocaine induced cocaine seeking when GluA1 subunits 
were over-expressed in the accumbens shell, but not the core. 
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Inhibiting the interaction between 4.1N and GluA1 in the shell has no effect on cocaine 
seeking 
The next experiments examined potential mechanisms underlying the influence of prior 
cocaine exposure on GluA1-containing AMPAR-mediated transmission.  Since the most 
consistent results of the previously described experiments were obtained with shell 
manipulations, we focused our attention of this accumbal subregion.  We first tested the 
virus in naïve rats and confirmed that eGFP expression in the nucleus accumbens 
peaked 3 days following administration (see Figure 3.5A) and was absent seven days 
after microinjection (data not shown).  4.1N protein expression was significantly 
increased 3 days after HSV 4.1N-CTD (t18=2.694, p<0.0148, Figure 3.5B). 
Cocaine priming-induced reinstatement was assessed at two time points, as 
described previously.  Analysis of the reinstatement data revealed only a significant main 
effects of lever responding for the first (F1,19=47.30 p<0.0001, Figure 3.5C) and second 
(F1,10=20.37 p=0.0011, Figure 3.5D) reinstatement sessions.  Thus, over-expression of 
4.1N-CTD in the accumbens shell had no influence on the reinstatement of cocaine 
seeking. 
Reduced expression of SAP97 in the accumbens shell attenuates cocaine priming-
induced reinstatement 
HSV miSAP97 was initially tested in naïve rats.  Knockdown of SAP97 protein by over-
expression of miSAP97 in vivo (Figure 3.6A) was assessed using western blot.  SAP97 
protein expression levels were analyzed using a t-test (unpaired, two-way).  Analysis of 
in vivo injection of miSAP97 in the accumbens shell and core revealed a trend towards a 
30% decrease of SAP97 protein expression compared to HSV Scramble injection 
(t(9)=1.719 p=0.1197, Figure 3.6A).  We have initiated electrophysiological 
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characterization of HSV miSAP97.  Preliminary electrophysiological analysis of peak 
eEPSC amplitude (mean ± SEM) recorded at minimum stimulation intensity (1X) as well 
as double (2X) and triple (3X) minimum stimulation intensity is shown in Figures 3.6B. 
eEPSC amplitudes were analyzed using a two-way ANOVA.  In miSAP97 expressing 
cells, preliminary analysis of eEPSC amplitude across 3 stimulation intensities revealed 
no effect of treatment (p=0.2574), a significant main effect of stimulation intensity 
(F2,22=14.46, p<0.0001), and no treatment × intensity interaction (F2,22=1.71, p=0.2039, 
Figure 3.6B).   
As summarized in the experimental design, the first reinstatement session 
occurred four days after the virus microinjection (HSV eGFP or HSV miSAP97), to allow 
sufficient time for SAP97 knock down by miSAP97 (see Figure 3.7A). With this virus, the 
peak effect was observed 4 days after administration of HSV miSAP97 into the nucleus 
accumbens shell (Figure 3.7B).  The virus was dormant 7 days after microinjection (see 
Figure 3.7C).  The 4 and 8-day time points were used for the two reinstatement 
sessions.  Analysis of the reinstatement data collected during the first session revealed 
significant main effects of treatment (F1,16=8.225, p<0.0112) and lever (F1,16=57.19, 
p<0.0001) and a significant treatment × lever interaction (F1,16=7.107, p<0.01).  Post hoc 
tests revealed a significant active lever difference between treatments (Bonferroni, 
p<0.05, Figure 3.7D).  Analysis of the second reinstatement session showed only a 
significant main effect of lever (F1,11=90.56, p<0.0001) with no other significant main 
effect or interaction (see Figure 3.7E).  The reinstatement of sucrose seeking also was 
assessed.  HSV miSAP97 had no effect on sucrose seeking (p<0.4717, see Table 3.1). 
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Discussion 
The present results revealed that administration of the CP-AMPAR blocker, Naspm, into 
the shell of the nucleus accumbens attenuated the reinstatement of cocaine seeking.  In 
the nucleus accumbens, CP-AMPARs are predominantly GluA1 homomers or 
GluA1/GluA3 heteromers (Pierce and Wolf, 2013).  The current findings showed that 
viral-mediated impairment of GluA1 function in the accumbens shell attenuated cocaine 
reinstatement, whereas viral-mediated over-expression of GluA1 subunits in the shell 
enhanced cocaine seeking.  In order to examine mechanisms underlying the enhanced 
influence of CP-AMPARs during the reinstatement of cocaine seeking, a viral vector was 
used to impair the interaction between AMPARs and SAP97, a protein involved in the 
trafficking of GluA1-containing AMPARs to the cell surface.  Reduced shell expression of 
SAP97 attenuated the reinstatement of drug-seeking behavior.  Collectively, these 
results indicate that SAP97 plays a critical role in functioning of CP-AMPARs in the 
accumbens shell during the reinstatement of cocaine seeking. 
CP-AMPARs and Cocaine Reinstatement 
It was previously shown that administration of Naspm into the accumbens core blocked 
enhanced (“incubated”) cue-induced reinstatement following extended access cocaine 
self-administration and protracted forced abstinence (Conrad et al., 2008).  Consistent 
with this finding, we showed that Naspm administered into either the accumbens core or 
the shell (but not the DL striatum) attenuated the reinstatement of cocaine seeking 
induced by a cocaine priming injection.  Administration of Naspm into the core also 
impaired sucrose seeking, suggesting that CP-AMPARs in the core may serve a broader 
role in the modulation of reinforced behaviors.  The shell effect was reinforcer-specific in 
that intra-shell Naspm had no influence on sucrose reinstatement.  Taken together, 
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these results indicate that CP-AMPARs in the shell play a specific role in cocaine 
priming-induced reinstatement of drug seeking following limited access (2-hour/day) 
cocaine self-administration. 
GluA1-containing AMPARs and Cocaine Reinstatement 
In order to examine the influence of GluA1-containing AMPARs specifically, pore dead 
GluA1-Q582E was over-expressed in the core or shell.  Impairing GluA1 AMPAR 
function in both the core and shell attenuated cocaine priming-induced reinstatement, 
without altering sucrose seeking behaviors.  Correspondingly, the present results 
showed that viral-mediated over-expression of wild type GluA1 in the shell promoted 
drug seeking when combined with a subthreshold dose of cocaine.  HSV-GluA1-Q582E 
administered into the accumbens core was previously shown to enhance the 
reinstatement of cocaine seeking induced by a cocaine priming injection or intra-core 
AMPA, while core over-expression of WT GluA1 produced the opposite effect (Bachtell 
et al., 2008).  These researchers used a paradigm that incorporated abstinence periods 
between the self-administration and extinction phases (Bachtell et al., 2008), which is 
not typical in priming-induced reinstatement experiments.  Moreover, rats were food 
trained prior to cocaine self-administration, which makes it difficult to determine if the 
reinstatement was drug seeking alone or combined with food seeking.  It is not clear if 
methodological differences such as this explain these results.  Regardless, these 
findings oppose the consensus view that activation of accumbens GluA1-containing 
AMPA receptors promotes the reinstatement of cocaine seeking, which is consistent with 
the current results.  Numerous studies have shown that AMPAR antagonists 
microinjected into the core or shell impairs cocaine seeking (Famous et al., 2008; Ping et 
al., 2008; Cornish et al., 2000; Park et al., 2002).  Moreover, decreased GluA1-
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containing AMPAR transmission in the core or shell disrupts the reinstatement of 
cocaine seeking (Anderson et al., 2008; Ping et al., 2008; Conrad et al., 2008).  
GluA1 Accessory Proteins and AMPA Receptor Function 
Synapse-associated protein 97 (SAP97) and protein 4.1N are two of many accessory 
proteins involved in the trafficking, stabilization, and function of GluA1-containing AMPA 
receptors at the cell surface (Lisman et al., 2012).  The interaction between the C-
terminal domain (CTD) of 4.1N and the membrane proximal region of GluA1 subunits 
aids their insertion into the cell membrane in vitro (Shen et al., 2000; Lin et al., 2009).  
Additionally, binding of the N-terminal Four.1-Ezrin-Radixin-Moesin (FERM) domain in 
4.1N with the I3 insert of SAP97 aids the targeting of SAP97 to the cell surface (Lue et 
al., 1994; Hanada et al., 2003).  A multitude of in vitro experiments identify a role for 
SAP97 interactions with GluA1 subunits, seen in the rate of subunit insertion into the cell 
surface, GluA1 spine clustering and dendritic growth, and AMPAR-mediated mini EPSCs 
(Passafaro et al., 2001; Mauceri et al., 2004; Zhou et al., 2008; Waites et al., 2009).  
These consequences of SAP97-GluA1 subunit interactions are mediated by post-
translational modifications mediated by the serine/threonine kinase, CaMKII (Schluter et 
al., 2006).  Interestingly, cocaine priming-induced reinstatement activates CaMKII 
(Anderson et al., 2008), which phosphorylates both SAP97 and GluA1 subunits to 
regulate their targeting and function (Mauceri et al., 2004).   
Our results indicated that disrupting the interaction between 4.1N and GluA1-
containing AMPARs had no influence on cocaine priming-induced reinstatement.  When 
we virally over-expressed only the CTD of 4.1N in the accumbens shell, animals 
displayed robust reinstatement of drug-seeking behavior in response to systemic 
cocaine.  Our original hypothesis predicted that the virus would reduce GluA1-containing 
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AMPAR surface expression because GluA1 subunits would be bound by the 
recombinant 4.1N-CTD that lacked the domains necessary to interface with the plasma 
membrane or actin/spectrin cytoskelton.  Given our previous results, such a 
manipulation should attenuate the reinstatement of cocaine-seeking behaviors.  
However, expression of 4.1N-CTD had no effect on endogenous 4.1N or SAP97, leaving 
endogenous 4.1N available to interact with SAP97 that can freely bind GluA1, potentially 
protecting the trafficking and function of GluA1 subunits indirectly (Rumbaugh et al., 
2003). 
We found that transient knock down of SAP97 in the accumbens shell reduced 
AMPAR function in MSNs in a manner similar to pore dead GluA1-Q582E.  While there 
is some evidence that SAP97 binding to the PDZ motif in the extreme C-terminus of 
GluA1 alters receptor trafficking, others find no change in GluA1 trafficking due to 
mutations of the C-tail or over-expression of SAP97 (Passafaro et al., 2001; Mauceri et 
al., 2004; Zhou et al., 2008).  In agreement with literature indicating that SAP97 is 
necessary for GluA1 subunit trafficking, we measured a trend towards decreased 
AMPAR-mediated EPSCs and decreased GluA2-lacking AMPAR currents in infected 
cells.  Our results demonstrated novel, drug-specific effects on reinstatement behaviors 
after expression of a microRNA against SAP97 in the accumbens shell.  Knockdown of 
SAP97 in the accumbens shell, presumably due to disrupted functioning of CP-
AMPARs, attenuated cocaine priming-induced reinstatement.  Reduced SAP97 
expression in the shell did not influence the reinstatement of food-seeking behavior, 
suggesting that the knockdown did not have a generalized effect on behavior or natural 
rewards.  These findings are in agreement with our Naspm and GluA1-Q582E data in 
that all three experiments disrupted shell CP-AMPAR function, which impaired cocaine 
priming-induced reinstatement of drug seeking without affecting food seeking.  Taken 
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together, these results indicate that SAP97 plays a necessary role in the up-regulation of 
CP-AMPARs in the accumbens shell following cocaine self-administration. 
Conclusions 
These experiments have shown that excitatory transmission through CP-AMPARs in the 
nucleus accumbens shell mediates the reinstatement of cocaine-seeking behavior.  
Knockdown of the GluA1 accessory protein SAP97 is sufficient to reduce AMPAR 
currents, particularly those via GluA2-lacking AMPARs, in accumbens MSNs.  
Additionally, knockdown of SAP97 in the accumbens shell attenuated cocaine priming-
induced reinstatement of drug seeking.  Taken together, these findings indicate that 
SAP97 interactions with GluA1 subunits in the shell are necessary to maintain 
functionally up-regulated CP-AMPARs that are required for the reinstatement of cocaine 
seeking.  Further, these data identify SAP97 as a potential novel target for 
pharmacotherapeutic intervention in cocaine craving and addiction.     
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TABLE 3A 
Treatment Region N Cocaine (i.p.) Time post-injection 
Shell 8 10 mg/kg 10 min 
Core 13 10 mg/kg 10 min 
Naspm/Saline 
Dorsal 
Striatum 
5 10 mg/kg 10 min 
Shell 6-8 10 mg/kg 3 days, 1 week GluA1-Q582E 
Core 6-8 10 mg/kg 3 days, 1 week 
Shell 9 5 mg/kg 3 days, 1 week GluA1-WT 
Core 8-9 5 mg/kg 3 days, 1 week 
4.1N Shell 5-8 10 mg/kg 3 days, 1 week 
Shell 7-13 5 or 10 mg/kg 3 days, 1 week eGFP 
Core 7-9 5 or 10 mg/kg 3 days, 1 week 
miSAP97 Shell 6-9 10 mg/kg 4 days, 1 week 
Scramble Shell 7-9 10 mg/kg 4 days, 1 week 
 
Cocaine priming-induced reinstatement experimental cohorts.  The 
microinjection treatment, brain region, animals used, cocaine dose (i.p.), and time of 
reinstatement test following microinjection are as indicated. 
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TABLE 3B 
Treatment Region N Time post-injection 
Shell 8 10 min Naspm/Saline 
Core 5 10 min 
Shell 6 3 days, 1 week GluA1-Q582E 
Core 6 3 days, 1 week 
Shell 6 3 days, 1 week eGFP 
Core 6 3 days, 1 week 
miSAP97 Shell 6 4 days, 1 week 
Scramble Shell 6 4 days, 1 week 
 
Non-contingent sucrose reinstatement experimental cohorts.  The microinjection 
treatment, brain region, animals used, and time of reinstatement test following 
microinjection are as indicated. 
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The effects of intra-core or –shell pharmacological and viral vector-mediated 
manipulation of CP-AMPAR transmission on the reinstatement of sucrose 
seeking.  Summary of findings across sucrose reinstatement experiments indicating 
microinjection, region, and total active lever responding (mean ± SEM). All data were 
analyzed using a two-tailed t Test. Intra-core microinjection of Naspm significantly 
attenuated sucrose-seeking behavior compared to saline controls. * indicates p<0.05 
 
TABLE 3.1 
Treatment Region Injected Reinstatement 1 
(Active Lever) 
Statistics 
Saline Core 85.80±14.10 t8=3.327, p<0.0104* 
Naspm Core 28.60±9.826  
Saline Shell 77.5±13.19 t14=0.2291, p<0.8221 
Naspm Shell 81.25±9.689  
 
Control Core 77.67±16.64 t10=0.4970, p<0.6299 
Pore Dead GluA1 Core 89.83±17.96  
Control Shell 117.0±24.46 t9=0.2370, p<0.8180 
Pore Dead GluA1 Shell 125.2±23.93  
 
Control Shell 117.0±36.88 t10=0.7485, p<0.4714 
miSAP97 Shell 158.0±40.5  
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FIGURE 3.1 
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Figure 3.1: Microinfusion of CP-AMPAR antagonist Naspm into the accumbens 
core or shell, but not the DL striatum, attenuates cocaine priming-induced 
reinstatement. The data are expressed as the mean (± SEM) lever responding on the 
active and inactive levers during the 2-hour reinstatement test sessions. A) Total lever 
responding following intra-core microinfusions of saline or Naspm (40µg/side, 
n=12/group) 10 minutes prior to a systemic injection of cocaine (10 mg/kg, i.p.). 
Bonferroni post hoc p<0.05 for active lever responding between saline and Naspm 
treatments. B) Cannula placements in the core of the nucleus accumbens.  The numbers 
indicate mm anterior to bregma according to Paxinos and Watson (1997). C) Total lever 
responding following intra-shell microinfusions of saline or Naspm (40µg/side, 
n=8/group) 10 minutes prior to a systemic injection of cocaine (10 mg/kg, i.p.). 
Bonferroni post hoc p<0.05 for active lever responding between saline and Naspm 
treatments. D) Cannula placements in the shell of the nucleus accumbens. E) Total lever 
responding following intra-DL striatum microinfusions of saline or Naspm (40µg/side, 
n=5/group) 10 minutes prior to a systemic injection of cocaine (10 mg/kg, i.p.). F) 
Cannula placements in the DL striatum of the nucleus accumbens.  
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FIGURE 3.2 
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Figure 3.2: Over-expression of GluA1-Q582E in medium spiny neurons attenuates 
synaptic strength and decreases inward rectification of AMPAR eEPSCs. Infected 
cells (eGFP+ Pore dead GluA1) were identified by eGFP expression and compared to 
uninfected cells (eGFP-) in slices from the same animal. Peak AMPAR eEPSC 
amplitudes (pA) across increasing stimulus intensities are plotted (mean ± SEM). 
Rectification index is plotted as the ratio of eEPSC -70mV /eEPSC +40mV (mean ± 
SEM) obtained from 5-10 eEPSCs evoked at 0.1 Hz. A) Representative eEPSC traces 
across stimulation intensities and representative eEPSC traces at +40mV and -70mV for 
eGFP+ and eGFP- neurons.  B) The input-output relationship of AMPAR eEPSCS 
illustrates decreased synaptic strength in MSNs expressing GluA1-Q582E (n=6 cells). 
Bonferroni post hoc p <0.001 for peak eEPSC amplitude compared to non-GFP controls 
(n=5 cells) at 3X stimulation. C) Decreased rectification index in MSNs expressing 
GluA1-Q582E (n=3 cells) indicates reduced CP-AMPAR contribution. p <0.025 for 
rectification index compared to non-GFP controls (n=5).  
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FIGURE 3.3 
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Figure 3.3: Over-expression of pore-dead GluA1-Q582E in the nucleus accumbens 
core or shell reversibly attenuates cocaine priming-induced reinstatement. The 
data are expressed as the mean (± SEM) lever responding on the active and inactive 
levers during the 2-hour reinstatement test sessions. A) Schematic of experimental 
paradigm. B) Representative image of peak eGFP fluorescence in accumbens 3 days 
following GluA1-Q582E infusion. C) Total lever responding following intra-core 
microinfusion of HSV eGFP (n=9) or HSV GluA1-Q582E (n=8) 72 hours prior to a 
systemic injection of cocaine (10 mg/kg, i.p.). Bonferroni post hoc p<0.05 for active lever 
responding between eGFP- and GluA1-Q582E-treated animals. D) Total lever 
responding following intra-shell microinfusion of HSV eGFP (n=13) or HSV GluA1-
Q582E (n=8) 72 hours prior to a systemic injection of cocaine (10 mg/kg, i.p.). Bonferroni 
post hoc p<0.05 for active lever responding between eGFP- and GluA1-Q582E-treated 
animals. E) Representative image of absent eGFP fluorescence 7 days following GluA1-
Q582E infusion due to viral dormancy. F) Total lever responding following intra-core 
microinfusion of HSV eGFP (n=5) or HSV GluA1-Q582E (n=6) 1 week prior to a 
systemic injection of cocaine (10 mg/kg, i.p.) with cannula placements for core 
microinfusions.  The numbers indicate mm anterior to bregma according to Paxinos and 
Watson (1997). G) Total lever responding following intra-shell microinfusion of HSV 
eGFP (n=7) or HSV GluA1-Q582E (n=6) 1 week prior to a systemic injection of cocaine 
(10 mg/kg, i.p.) with cannula placements for shell microinfusions.  
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FIGURE 3.4 
 
Over-expression of GluA1-WT in the nucleus accumbens shell, but not the core, 
promotes cocaine priming-induced reinstatement. The data are expressed as the 
mean (± SEM) lever responding on the active and inactive levers during the 2-hour 
reinstatement test sessions. A) Total lever responding following intra-core 
microinfusion of HSV eGFP (n=7) or HSV GluA1-WT (n=8) 72 hours prior to a 
systemic injection of cocaine (5 mg/kg, i.p.). B) Total lever responding following intra-
shell microinfusion of HSV eGFP (n=8) or HSV GluA1-WT (n=9) 72 hours prior to a 
systemic injection of cocaine (5 mg/kg, i.p.). Bonferroni post hoc p<0.05 for active 
lever responding between eGFP- and GluA1-WT-treated animals. B) Total lever 
responding following intra-core microinfusion of HSV eGFP (n=7) or HSV GluA1-WT 
(n=8) 1 week prior to a systemic injection of cocaine (5 mg/kg, i.p.) with cannula 
placements for intra-core microinfusions. The numbers indicate mm anterior to 
bregma according to Paxinos and Watson (1997). D) Total lever responding following 
intra-shell microinfusion of HSV eGFP (n=7) or HSV GluA1-WT (n=9) 1 week prior to 
a systemic injection of cocaine (5 mg/kg, i.p.) with cannula placements for intra-shell 
microinfusions.  
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FIGURE 3.5 
 
Over-expression of 4.1N-CTD in the nucleus accumbens shell has no effect on 
cocaine priming-induced reinstatement. The data are expressed as the mean (± 
SEM) lever responding on the active and inactive levers during the 2-hour 
reinstatement test sessions. A) Representative image of peak eGFP fluorescence in 
accumbens 3 days following 4.1N-CTD infusion. B) Western blot quantification (mean 
± SEM) of 4.1N protein expression 3 days following eGFP infusion (n=10) or 4.1N-
CTD infusion (n=10) into the accumbens shell and representative bands. 4.1N-CTD 
significantly increased 4.1N protein expression compared to eGFP control 
(p<0.0148). C) Total lever responding following intra-shell microinfusion of HSV eGFP 
(n=13) or HSV 4.1N-CTD (n=8) 72 hours prior to a systemic injection of cocaine (10 
mg/kg, i.p.). D) Total lever responding following intra-core microinfusion of HSV eGFP 
(n=7) or HSV 4.1N-CTD (n=5) 1 week prior to a systemic injection of cocaine (10 
mg/kg, i.p.) with cannula placements for intra-shell microinfusions. The numbers 
indicate mm anterior to bregma according to Paxinos and Watson (1997).  
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FIGURE 3.6 
 
Preliminary characterization of HSV miSAP97 indicates knock down of SAP97 
protein with no effect on accumbens MSN synaptic strength. For in vivo 
knockdown experiments, protein expression levels of SAP97 in total homogenate 4 
days following viral microinfusion (2 µl/side) into the accumbens core and shell were 
measured using quantitative western blot (mean ± SEM). A) Microinfusion of 
miSAP97 (n=6) reduces SAP97 protein expression compared to Scramble control 
(n=6) injections (p<0.1198). B) Infected cells (eGFP+ miSAP97) were identified by 
eGFP expression and compared to uninfected cells (eGFP-) in slices from the same 
animal. Peak AMPAR eEPSC amplitudes (pA) across increasing stimulus intensities 
are plotted (mean ± SEM) in B. Preliminary analysis of the input-output relationship of 
AMPAR eEPSCS illustrates unchanged synaptic strength in MSNs expressing 
miSAP97 (n=3 cells).  
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Figure 3.7 
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Figure 3.7: HSV miSAP97-mediated redution of SAP97 protein expression in the 
accumbens shell attenuates cocaine priming-induced reinstatement. The data are 
expressed as the mean (± SEM) lever responding on the active and inactive levers 
during the 2-hour reinstatement test sessions. A) Schematic of experimental paradigm. 
B) Representative image of peak eGFP fluorescence in accumbens 3 days following 
miSAP97 infusion. C) Representative image of absent eGFP fluorescence 7 days 
following miSAP97 infusion due to viral dormancy. D) Total lever responding following 
intra-shell microinfusion of HSV Scramble (n=9) or HSV miSAP97 (n=9) 4 days prior to a 
systemic injection of cocaine (10 mg/kg, i.p.). p<0.05 for active lever responding 
between Scramble- and miSAP97-treated animals. E) Total lever responding following 
intra-shell microinfusion of HSV Scramble (n=7) or HSV miSAP97 (n=6) 1 week prior to 
a systemic injection of cocaine (10 mg/kg, i.p.) with cannula placements for intra-shell 
microinfusions. The numbers indicate mm anterior to bregma according to Paxinos and 
Watson (1997).    
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Abstract 
We previously demonstrated that paternal cocaine exposure resulted in delayed 
acquisition and reduced maintenance of cocaine self-administration in male, but not 
female, offspring (Vassoler et al., 2013).  This cocaine resistance phenotype was shown 
to be due to reduced cocaine reinforcing efficacy in the male offspring.  It is possible, 
however, that enhancement of cocaine’s anxiogenic effects may also contribute to 
reduced cocaine self-administration among male cocaine-sired rats.  Here, adult male 
rats were allowed to self-administer cocaine (controls received saline passively) for 60 
days and then were bred to naïve females.  Measures of anxiety and cocaine-induced 
anxiogenic effects were assessed in the adult offspring.  Sire cocaine experience had no 
effect on anxiety-like behaviors of female offspring, as measured by novelty induced 
hypophagia tasks.  In contrast, cocaine-sired male offspring exhibited increased anxiety-
like behaviors relative to saline-sired males.  When challenged with an anxiogenic dose 
of cocaine (5 mg/kg, i.p.) measures of anxiety were enhanced in all subjects to an equal 
degree regardless of sire drug experience.  Since anxiety and depression of often 
comorbid, we also assessed measures of depression.  Sire cocaine experience had no 
effect on depression-like behaviors, as measured by the forced swim test, among male 
or female offspring.  In a separate group of naïve littermates, select hippocampal cellular 
and molecular correlates of anxiety were measured.  Increased mRNA and/or protein 
expression of tissue plasminogen activator, pro-brain derived neurotrophic factor, and 
CRF receptor 2 were measure in the hippocampus of cocaine-sired male offspring.  
Together, these data identify the presence of a baseline anxiety phenotype in the male 
offspring of cocaine-experienced sires that is unaltered by subsequent cocaine 
exposure. 
 
	   92	   	  
Introduction 
Environmental challenges to one generation can result in various behavioral and 
physiological adaptations in subsequent generations, which are often linked to 
epigenetic mechanisms (Feil and Fraga, 2012).  Paternal transmittance of a cocaine-
resistance phenotype to the male offspring was recently described (Vassoler et al., 
2013).  Adult male rats were trained to self-administer cocaine for 60 days and then bred 
with naïve females.  Male, but not female, offspring of cocaine-exposed sires exhibited 
delayed acquisition and reduced maintenance of cocaine self-administration.  This effect 
was due at least in part to increased brain-derived neurotrophic factor (BDNF) in the 
medial prefrontal cortex (mPFC) (Vassoler et al., 2013), which was previously shown to 
decrease both the reinforcing efficacy of cocaine and the reinstatement of cocaine 
seeking (Berglind et al., 2007; Sadri-Vakili et al., 2010).  Interestingly, an epigenetic 
modification (acetylation) of BDNF promoters was observed in the sperm of the sires 
that self-administered cocaine, suggesting that cocaine-induced reprogramming of the 
germline was responsible for the cocaine resistance phenotype observed in the male 
offspring. 
The delayed acquisition and decreased maintenance of cocaine self-
administration among the male offspring of cocaine-experienced sires appeared to be 
primarily due to a decrease in the reinforcing effects of cocaine (Vassoler et al., 2013).  
However, it is possible that an enhancement of cocaine’s aversive effects could also 
reduce cocaine intake in male cocaine-sired rats.  It is well documented that cocaine 
produces both appetitive and aversive effects.   This is demonstrated by the fact that 
rodents trained to voluntarily travel down a runway into a chamber to receive cocaine 
infusions exhibit avoidance and retreating behaviors at the entrance to the chamber 
(Ettenberg and Geist, 1991).  These effects are reduced following administration of an 
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anxiolytic agent, which suggests that previous anxiety-like associations with the chamber 
in which cocaine was administered promote avoidance (Ettenberg, 2009).  The 
appetitive-aversive effects of cocaine are time-dependent.  That is, the immediate effects 
of cocaine are appetitive but delayed effects including agitation and anxiety are aversive 
(Ettenberg and Bernardi, 2007).  The conditioned place preferences for cocaine are 
observed only when rats are exposed to a specific context immediately following cocaine 
administration.  In contrast, when exposed to a distinct context 15 minutes following 
cocaine administration, rats subsequently avoid that environment (Ettenberg et al., 
1999).  The aversive effects of cocaine in this model were attenuated by administration 
of an anxiolytic drug (Ettenberg and Bernardi, 2007).  Together, these results indicate 
that cocaine is initially reinforcing but quickly transitions to producing anxiety, which may 
explain instances of resilience to cocaine abuse in humans and rodents (Majewska, 
2002; Kreek et al., 2009; Simmons et al., 2012). 
The current experiments were designed to assess the extent to which the 
cocaine-resistance phenotype in male cocaine-sired rats is due to enhanced anxiogenic 
effects of cocaine.  We assessed measures of anxiety as well as the anxiogenic effects 
of cocaine in the male and female offspring of cocaine-experienced sires using open 
field and novelty induced hypophagia (NIH) paradigms.  Since anxiety and depression 
are often comorbid, we also used an animal model of depressive behavior (forced swim).  
Western blot and RT-PCR to were used to examine cellular and molecular correlates of 
these behaviors in select brain regions. 
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Materials and Methods 
Animals and housing.   
For the F0 generation, we obtained adult male and female Sprague-Dawley rats (Rattus 
norvegicus) weighing 250–300 g from Taconic Laboratories (Germantown, NY).  
Animals remained individually housed except for 1 week of pair housing during the 
mating period.  Food and water were available ad libitum. A 12/12 hr light/dark cycle with 
the lights on at 7:00 a.m. was used; all experimental procedures occurred during the 
light cycle. 
Materials.   
All self-administration experiments used Med-Associates (East Fairfield, VT) 
instrumentation enclosed within ventilated, sound attenuating chambers. All apparatus 
contained response levers, stimulus lights, food pellet dispensers and injection pumps.  
Cocaine hydrochloride was obtained from the National Institute on Drug Abuse 
(Rockville, MD, USA) and dissolved in bacteriostatic 0.9% saline. 
Surgery.   
Researchers employed 80 mg/kg ketamine and 12 mg/kg xylazine to anesthetize the 
rats.  After threading the catheter subcutaneously over the shoulder blade and routed to 
a mesh backmount platform (CamCaths, Cambridge, UK) and sutured below the skin 
between the shoulder blades, we positioned an indwelling silastic catheter into the right 
jugular vein and sutured it in place.  Investigators flushed catheters daily with an 
antibiotic (Timentin, 0.93 mg/ml) dissolved in heparinized saline and sealed with plastic 
obturators when not in use. 
 
	   95	   	  
F0 Cocaine Self-Administration.  
Following a 7-day recovery from surgery, we placed the F0 males in operant chambers 
and randomly assigned half to lever press for cocaine infusions (0.25 mg cocaine/56 ml 
saline/infusion over 5 sec; the cocaine dose was not adjusted for animal weight) while 
the other half received non-contingent saline infusions of the same number and 
frequency.  Rat operant training used an FR1 schedule of reinforcement.  A 20-sec 
timeout period followed each cocaine infusion. We limited the rats to 75 infusions per 
daily 2-hour session.  Self-administration continued for a total of 60 days. 
Breeding.  
Twenty-four hours after the last day of self-administration, we placed F0 male rats into a 
cage with naïve females.  The animals remained co-housed for 7 days.  Three out of 18 
F0 males continued receiving daily self-administration sessions during the breeding 
period.  There were no differences in the behavior of the offspring so the groups were 
combined. 
F1 offspring of cocaine self-administering males (CocSired) or saline control males 
(SalSired) were littermates of animals generated in Vassoler et al., 2013 that were not 
exposed to cocaine.  Some animals underwent food self-administration prior to 
behavioral testing, but were allowed at least 2 weeks with ad libitum food between tests. 
Behavioral Tasks 
For all behavioral tasks, offspring were weaned and group housed at P26, before being 
singly housed at P60.  Testing occurred between P60-P100. 
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Novelty Induced Hypophagia (NIH) 
NIH protocol was adapted from the procedures of Carr and Lucki (2010).  Animals from 
multiple saline-sired and cocaine-sired litters were selected (n=6-10 males, n=9-10 
females).  90 min prior to training and testing, food and water were removed from the 
animals’ home cage and rats were habituated to the testing room.  For 8 days of training, 
5 peanut butter chips (Reese’s Peanut Butter Chips, 2.257 g) were placed in a small 
Pyrex bowl and the bowl was placed in the rats’ home cage.  Rats received 15 minutes 
to access the peanut butter chips, after which uneaten peanut butter chips were 
discarded.  On day 9 and day 11, the subjects were tested in their home cage. The 
testing sessions were identical to the training sessions.  On day 10, testing was done in 
a novel environment.  The novel cage contained a wire mesh floor and the walls were 
coated with 409 cleaning solution.  A 60 W, 120 V light bulb was placed above each 
cage (8 inches), and white boards were set up on each side of the cage to reflect the 
light (1380 lux). For all testing sessions, animals received 15 minutes to access the 
peanut butter chips.  Across training and testing, the latency to take the first chip from 
the bowl (s), number of chips eaten, and total time to finish all chips (s) was recorded.  
To determine the anxiogenic effects of cocaine, separate animals (naïve, saline-sired, or 
cocaine-sired) were randomly assigned to receive acute injections of saline, 2.5 mg/kg, 
or 5 mg/kg cocaine (i.p.) 30 min prior to the three test sessions.  Animals were 
habituated to the injection on the last 3 days of training using a sham i.p. injection. 
Forced Swim Test 
This protocol was adapted from the procedures of Detke et al. (1995).  Animals were 
habituated to the testing room for 90 min prior to a single, 15 min forced swim session.  
A clear, cylindrical, plastic chamber (12 inches in diameter, 15 inches deep) was filled to 
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a depth of 10 inches with water (23 C ± 1).  To assess the effects of sire cocaine 
experience on behavior, animals from multiple saline-sired or cocaine-sired litters were 
selected (n=4/each).  Animals were placed in the swim chamber and behavior was 
videotaped for 15 min.  At the end of the session, rats were dried with paper towels and 
returned to their home cage on a heating pad to counteract hypothermic effects of the 
swim.  Behaviors were scored by an individual blind to rat’s background (i.e. saline-sired 
or cocaine-sired) in 5 s time bins for the first 5 min of the task.  Behavioral measures 
included: climbing (upward directed movement of the forepaws along the side of the 
chamber), swimming (horizontal movement throughout the chamber), or immobility (no 
additional activity aside from that required to stay afloat).   
Biochemical Experiments 
Acute Corticosterone Response 
Serum corticosterone levels were measured using an enzyme immunoassay kit 
according to manufacturer instructions (ADI-900-097, Enzo Life Sciences) to assess 
animal response to an acute stressor (single 5 min forced swim task).  A clear, 
cylindrical, plastic chamber (12 inches in diameter, 15 inches deep) was filled to a depth 
of 10 inches with water (23 ± 10 C). Animals were placed in the swim chamber for 5 
minutes, and then returned to their homecage for a 15 minute recovery period after 
which they were immediately decapitated.  Trunk blood was collected in heparinized 
blood collection tubes and inverted multiple times to prevent coagulation.  Blood was 
transferred to 1.5 mL Eppendorf tubes, centrifuged for 20 min (1.0 x g, 40 C), and serum 
was collected and stored at -80C until the immunoassay.  For the assay, serum was 
diluted 1:100 and optical density was read at 405nm in a microplate reader (Bioteck, 
Synergy HT).   
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Western Blot 
At P60, offspring not selected for behavioral tasks were sacrificed.  Brains were rapidly 
extracted and bilateral hippocampi dissected and flash-frozen.  Whole-cell hippocampal 
tissue was processed for Western blot as described previously (Anderson et al., 2008).  
For all samples, protein concentration was quantified using a Pierce BCA Protein Assay 
Kit (Thermo Scientific).  Equal amounts of protein (20 µg) were loaded and separated in 
10% Tris-Glycine gels (Invitrogen) and transferred to nitrocellulose membranes using the 
i-Blot dry transfer system (Invitrogen).  Membranes were blocked with Odyssey Blocking 
Buffer (928-40000), according to manufacturer instructions.  Membranes were incubated 
overnight at 4° C with selective antibodies to: proBDNF (1:1000, Millipore), mBDNF 
(1:1000, Santa Cruz), CRF R2 (1:1000, Santa Cruz), tPA (1:1000, AbCam), TrkB 
(1:1000, Cell Signaling), or GAPDH (1:2000, Millipore). Membranes were then incubated 
with fluorescent secondary antibodies (1:5000, IR-dye 680 or IR-dye 800), before being 
imaged on an Odyssey fluorescent scanner (Licor Biosciences).  GAPDH was used as a 
loading control and all proteins were normalized to GAPDH integrated intensity values.  
RT-PCR 
For quantitative real-time PCR with reverse transcription (RT–PCR) experiments, naïve 
SalSired and CocSired rats were handled daily for a week. Hippocampal dissections 
were performed and alternated between SalSired and CocSired animals. Hippocampi 
were flash-frozen on dry ice and stored at -80  °C. Thawed hippocampi were 
homogenized using a TissueRuptor (Qiagen) and RNA was purified using the RNeasy 
system (Qiagen) according to the manufacturer’s protocol. RNA concentration and purity 
was quantified by NanoDrop spectrophotometry (Thermo Fisher Scientific).  Generation 
of cDNA was carried out using Superscript II (Invitrogen).  
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Reactions were prepared in 96-well optical reaction plates (ABI) with optical 
adhesive covers (ABI) using SYBR Green PCR Master Mix (ABI).  Three technical 
replicates were used for each animal.  Reactions were carried out in the Step One Plus 
with an initial incubation at 95  °C for 10  min, and 40 subsequent cycles of 95  °C for 15  s, 
60° C for 30  s.  Primer sequences can be found in Table 1.  Data were normalized to 
Hprt, Tuba4a and Gapdh before calculation of differences.  Fold change was calculated 
from the ΔCt values with corrections for housekeeping gene expression levels for each 
sample.  For each sample, the ΔCt was calculated against the mean for that gene’s 
sample set.  Next, these ΔCt values were normalized to the ΔCt from housekeeping 
genes for each sample to account for variability in cDNA input.  Because Ct values are 
on a logarithmic scale, fold change is equal to two raised to the difference between 
experimental and control ΔCt values.  The data presented is the calculated mean for the 
biological replicates with n being equal to the number of biological replicates (that is, the 
number of rats examined). 
Statistical Analyses 
Novelty Induced Hypophagia Analyses 
To analyze the effects of sire cocaine experience on offspring latency to feed in a novel 
environment, analyses were performed using a two-way ANOVA.  The between-subjects 
factors were sire (saline-sired or cocaine-sired) and environment (home cage or novel).  
Bonferroni post-tests were used to establish significant difference (p<0.05). 
To analyze the effects of sub-threshold cocaine on latency to feed in a novel 
environment, analyses were performed using a two-way ANOVA.  The between-subjects 
factors were environment (home cage or novel) and challenge injection (saline, 2.5 
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mg/kg, or 5 mg/kg cocaine i.p.).  Bonferroni post-tests were used to establish significant 
difference (p<0.05).   
To analyze the effects of sub-threshold cocaine on saline- or cocaine-sired 
offspring latency to feed in a novel environment, analyses were performed using a two-
way ANOVA.  The between-subjects factors were drug challenge injection (saline or 2.5 
mg/kg cocaine, i.p.) and environment (home cage or novel).  Bonferroni post-tests were 
used to establish significant difference (p<0.05). 
Forced Swim Test Analyses 
Differences between saline-sired and cocaine-sired males during immobility, swimming, 
and climbing behaviors in the forced swim test were analyzed using Student’s t-test 
(unpaired, two-tailed).   
Serum Corticosterone Analyses 
Quantification of serum corticosterone was performed using an enzyme immunoassay 
kit as described above and the MyAssays data analysis software (www.myassays.com).  
Corticosterone concentration (pg/mL) was calculated from optical density measurements 
using a 4-paramter standard curve.  Analyses of serum corticosterone levels were 
performed using a two-way ANOVA.  The between-subjects factors were sire (saline-
sired or cocaine-sired) and sex (male or female).  Bonferroni post-tests were used to 
establish significant difference (p<0.05) 
Western Blot Data Analyses 
Quantification was performed by normalizing the intensity of all bands with protein-
specific antibodies to the GAPDH intensity, followed by normalizing that value to the 
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saline control (saline-sired male) values.  Immunoblot analyses for baseline samples 
were performed using a t-test (unpaired, one-way, p<0.05).  Immunoblot analyses for 
drug challenge samples were performed using Student’s t-test (unpaired, one-tailed). 
RT-PCR Data Analyses 
For quantitative real-time RT–PCR experiments, t-tests were used to compare fold 
change values for each gene between cocaine- and saline-sired rats.  Two-tailed P   
values are reported in Table 1. 
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Results 
Enhanced novelty-induced hypophagia in male, but not female, cocaine-sired rats  
In order to assess a measure of anxiety in cocaine-sired and saline-sired rats, latency to 
feed in familiar (home cage) and novel environments was assessed.  Latencies (s) were 
analyzed using two-way mixed factors ANOVAs.  Environment was the within subjects 
factor; sire was the between subjects factor.  Analysis of the male offspring (Figure 4.1A) 
revealed a significant main effect of sire (F1,17=8.44, p<0.0099), a significant main effect 
of environment (F2,34=18.18, p<0.0001), and a significant sire × environment interaction 
(F2,34=8.33, p<0.0011).  Post hoc analyses indicated a significant increase in latency to 
feed in the novel environment in cocaine-sired relative to saline-sired males (Bonferroni, 
p<0.001) (Figure 4.1A).  Analysis of the NIH data from female offspring (see Figure 
4.1B) demonstrated a significant main effect of environment (F2,34=34.02, p<0.0001), but 
no significant effect of sire (p<0.424) and no significant sire × environment interaction 
(p<0.496) (Figure 4.1B).  Thus, novelty-induced hypophagia was observed in all groups.  
However, whereas siring condition had no influence on NIH in females, cocaine-sired 
males displayed a significantly enhanced latency to feed in a novel environment relative 
to saline-sired males. 
Cocaine increased novelty-induced hypophagia equally in all siring conditions 
We next wanted to examine whether cocaine would enhance anxiety in the NIH task.  
However, cocaine-induced appetite suppression was a potential confound for this 
experiment.  Therefore, we assessed the influence of lower doses of cocaine on latency 
to feed in the NIH paradigm in naïve male rats (i.e. with typical siring history).  
Consistent with previous reports, 2.5 and 5.0 mg/kg cocaine (i.p.) had no influence on 
feeding in the homecage (Cooper, 1993) but dose-dependently increased latency to feed 
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in a novel environment (Figure 4.2).  The latency to feed data were analyzed with a two-
way mixed factors ANOVA.  Environment was the within subjects factor; dose was the 
between subjects factor.  Analysis of the effect of cocaine on latency to feed in naïve 
rats (see Figure 4.2) revealed a significant main effect of drug (F2,9=9.64, p<0.0058), a 
significant main effect of environment (F2,9=72.75, p<0.0001), and a significant drug × 
environment interaction (F4,18=10.30, p<0.0002).  Post hoc tests revealed a significant 
increase in latency to feed in the novel environment at 2.5 mg/kg and 5 mg/kg cocaine 
(i.p.) relative to saline (i.p.) (Bonferroni, p>0.01 at 2.5 mg/kg, p<0.001 at 5 mg/kg).  
The effect of 2.5 mg/kg cocaine (i.p.) on NIH was assessed in saline-sired 
(Figure 4.3A) and cocaine-sired (Figure 4.3B) rats.  Note that enhanced NIH among the 
male offspring of cocaine-experienced sires was replicated in that the latency to feed in 
the novel environment was significantly greater in cocaine-sired relative to saline sired 
rats [t17=2.918, p<0.0096].  The data from saline-sired and cocaine-sired rats were 
analyzed with separate mixed-factors ANOVAs (environment=within subjects, saline-
cocaine=between subjects).  Analysis of the saline-sired data showed a significant main 
effect of drug treatment (F1,13=4.782, p<0.0476), a significant main effect of environment 
(F2,26=14.63, p<0.0001), and a significant treatment × environment interaction 
(F2,26=5.097, p<0.0136).  Post hoc tests revealed a significant difference between groups 
on Day 2 (Bonferroni, p<0.01) indicating that cocaine increased NIH in saline-sired rats 
(Figure 4.3A).  Analysis of the cocaine-sired data pre-exposure to 2.5 mg/kg cocaine 
(i.p.) on cocaine-sired offspring latency to feed in a novel environment revealed a 
significant effect of environment (F2,28=16.20, p<0.0001), but no significant effect of drug 
treatment (p<0.9737) and no significant treatment × environment interaction (p<0.9878).  
These results indicate that cocaine did not further enhance NIH in cocaine-sired rats 
(see Figure 4.3B). 
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Sire cocaine experience has no effect on immobility, swimming, or climbing behaviors in 
the forced swim test.    
Because anxiety and depression are often comorbid, we also assessed behavior in a 
model of depression (forced swim test).  Forced swim behaviors (immobility, swimming, 
or climbing) were analyzed using a two-way ANOVA with siring condition as the between 
subjects factor and behaviors as the within subjects factor (see Figure 4.4).   Analysis 
revealed no significant effect of sire (p<1.00), a significant main effect of behavior 
(F2,18=32.54, p<0.0001), and a significant sire × behavior interaction (F2,18=3.62, 
p=0.0477).  However, post hoc tests revealed no significant effect of sire on any 
behavior (immobility, swimming, or climbing). 
Sire cocaine experience has no effect on serum corticosterone response 15 minutes 
after a 5 minute forced swim session. 
To assess differences in HPA axis activation that might underlie the expression this 
behavioral phenotype, serum corticosterone was measured after acute swim stress.  
Serum corticosterone concentration (pg/mL, mean±SEM) for saline-sired and cocaine-
sired offspring is plotted in Figure 4.5.  Corticosterone concentrations were analyzed 
using a two-way ANOVA, which revealed a significant main effect of sex (F1,20=66.49, 
p=0.0001), but no significant effect of sire (p=0.9683) and no significant sex × sire 
interaction (p=0.5900).  
Increased mRNA and/or protein expression of various cellular and molecular correlates 
of anxiety in the hippocampus of male cocaine-sired rats.  
The hippocampus modulates the expression of stress and anxiety via a variety of cellular 
and molecular correlates (McEwen et al., 2012).  We use quantitative PCR to assess 
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hippocampal mRNA expression levels in male saline- and cocaine-sired rats (Table 4.1).  
The fold change for select transcripts is plotted in Figure 4.6A.  Fold change was 
analyzed using a t-test (unpaired, two-tailed).  There was a significant increase in Crhr2 
mRNA in cocaine-sired rats relative to saline-sired controls (t(11)=2.553, p<0.05).  
Additionally, there was a trend towards an increase in Plat mRNA in cocaine-sired rats 
(t(11)=1.885, p=0.0862).  There were no significant differences in expression of Bdnf 
(p=0.6413), Crhr1 (p=0.8434), or Ntrk2 (p=0.5704) mRNA transcripts (Figure 4.6A).   
We next measured hippocampal protein expression levels of saline- and cocaine-
sired offspring using Western blot.  The average fluorescent intensity for select proteins 
in the hippocampus, expressed as percent change from control, is plotted in Figure 4.6B.  
Percentages were analyzed using a t-test (unpaired, two-tailed).  Analyses of sire 
cocaine exposure revealed an increase in expression of CRF receptor 2 (t(12)=3.285, 
p<0.0065), and proBDNF (t(12)=1.964, p<0.05) in cocaine-sired males.  There was a 
trend towards increased protein expression of tPA (t(8)=2.184, p<0.0605) and TrkB 
receptor (t(12)=2.079, p=0.0597) in cocaine-sired males.  There was no significant 
difference in mature BDNF (p=0.7325) protein expression (Figure 4.6B). 
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Discussion 
We previously showed that sire cocaine experience reduces the acquisition and 
maintenance of cocaine self-administration in male, but not female, F1 offspring 
(Vassoler et al., 2013).  The current experiments extended this work to investigate 
measures of anxiety and depression in the male and female offspring of sires that self-
administered cocaine.  There were no differences among groups in a model of 
depression. However, the present findings of increased latency to feed in a novel 
environment indicated an anxiety-like behavioral phenotype among male, but not female, 
offspring of cocaine-experienced sires.  Using the NIH paradigm we also assessed the 
anxiogenic effects of cocaine, which increased the latency to feed to a similar extent in 
all groups.  This result indicates that enhancement of the aversive effects of cocaine 
does not appear to contribute to the reduced self-administration of cocaine in male 
cocaine-sired rats as previously described, but could have implications for aspects of 
emotional regulation (Vassoler et al., 2013).  
Parental Drug Use and Offspring Emotional Regulation 
A growing body of evidence suggests that parental drug exposure enhances anxiety-like 
or depressive-like behaviors in offspring.  In mice, offspring of alcohol-consuming sires 
demonstrate increased immobility during the forced swim test that is rescued by a single 
dose of imipramine or propranolol, suggesting an increased anxiety-like phenotype 
behind the altered swim behavior (Abel and Bilitzke, 1990).  Offspring from dams 
exposed to nicotine throughout pregnancy exhibit increased anxiety- and depressive-like 
behaviors that are correlated with impairments in hippocampal glutamatergic 
transmission (Parameshwaran et al., 2012).  Perinatal exposure to the cannabinoid 
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receptor ligand in cannabis increases pup ultrasonic vocalizations and adult anxiety-like 
behaviors of offspring (Trezza et al., 2008).   
The consequence of parental cocaine use on offspring emotionality has been 
minimally investigated.  Mouse sires that experienced experimenter-delivered cocaine 
produced offspring with increased immobility in the tail suspension test, a model of 
depression, but no evidence of increased anxiety-like behavior in the elevated plus maze 
(Killinger et al., 2012).  Conversely, prenatal cocaine exposure in rats increases anxiety-
like behaviors in the elevated plus maze and open field in male offspring to a greater 
degree than female offspring (Salas-Ramirez et al., 2010).  In the open field task, both 
male and female offspring with prenatal exposure to cocaine exhibit increased latency to 
enter the center of the arena, an indicator of enhanced anxiety (Sithisarn et al., 2011).  
Our study expands upon this literature by illustrating that paternal cocaine self-
administration selectively increased the expression of anxiety-like behaviors in drug-
naïve male offspring in the novelty induced hypophagia tasks, without also enhancing 
depressive-like behaviors.  Additionally, acute cocaine exposure (i.p.) further increased 
latency to feed in saline-sired males only, suggesting impaired processing of anxiogenic 
stimuli in cocaine-sired males. 
Cocaine Exposure and Neurochemical Correlates of Anxiety 
Cocaine exposure also modulates stress hormones and associated receptors in the 
hippocampus and the hypothalamic-pituitary-adrenal (HPA) axis.  Typically, the 
hippocampus inhibits the HPA axis, and activation of the HPA axis by cocaine promotes 
the release of corticotropin releasing factor (CRF) and corticosterone, both of which act 
on receptors in the hippocampus (Herman et al., 2005; Armario, 2010).  In mice, a single 
episode of restraint stress activates the HPA axis and increases the expression of CRF 
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receptor 2 (CRF R2) mRNA in the hippocampus (Greetfeld et al., 2009).  Prenatal 
cocaine exposure increases baseline corticosterone and enhances activation of the HPA 
axis in response to a CRF challenge injection in male offspring (Sithisarn et al., 2011).  
During cocaine withdrawal, increased CRF release in limbic and stress systems is 
associated with enhanced anxiety-like behaviors, which can be attenuated with CRF 
receptor antagonists (Basso et al., 1999; Sarnyai et al., 2001).  CRF R2 activity can be 
both anxiogenic and anxiolytic, and a CRF R2 antagonist decreases cocaine withdrawal-
induced enhancement of LTP in hippocampal slices (Bale and Vale, 2004; Guan et al., 
2009).  We found increased expression of CRF R2 mRNA and protein in the 
hippocampus of cocaine-sired male offspring, with no change of CRF R1 mRNA.  
Collectively, these data suggest that CRF R2-mediated hippocampal activity in cocaine-
sired males is increased, potentially resulting in dysregulation of the HPA axis, and thus 
heightening anxiety in these animals.  Interestingly, offspring serum corticosterone 
response 15 minutes after an acute stressor was unaffected by sire cocaine experience 
in our experiments.  However, it is possible that a more full assessment of HPA axis 
activation across multiple time points would expose sire-dependent differences.     
Hippocampal brain-derived neurotrophic factor (BDNF) expression regulates 
neurogenesis, LTP, and anxiety-like phenotypes, and is modulated by cocaine exposure.  
Mature (m) BDNF is produced when tissue plasminogen activator (tPA) cleaves the 
precursor protein, proBDNF, processing which is necessary for the expression of 
hippocampal neurogenesis and LTP via signaling through TrkB receptors (Pang et al., 
2004; Lu et al., 2005; Greenberg et al., 2009).  tPA is secreted from axon terminals into 
the extracellular space during neuronal activation (Pang and Lu, 2004).  Systemic 
injection of mBDNF increases hippocampal BDNF expression and neurogenesis while 
decreasing anxiety- and depressive-like behaviors (Schmidt and Duman, 2010).  
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Withdrawal following repeat experimenter-administered cocaine increases the 
expression of total BDNF mRNA in the hippocampus and depressive-like behaviors (Filip 
et al., 2006).  Conversely, prenatal exposure to cocaine reduces baseline expression 
and depolarization-evoked release of BDNF in offspring hippocampi (Yan et al., 2004).  
Collectively, these findings illustrate that the processing and signaling of BDNF in the 
hippocampus modulates the expression of anxiety and is sensitive to cocaine exposure.  
In naïve cocaine-sired male offspring, we found increased expression of 
proBDNF protein in the hippocampus and no change in expression of mBDNF protein or 
total BDNF mRNA.  Hippocampal proBDNF binding to p75 neurotrophin receptor (NTR), 
a member of the cell death pathway, increases LTD and spine atrophy, resulting in an 
attenuation of hippocampal-HPA control during acute stress exposure (Martinowich et 
al., 2007).  Though it did not reach significance, the increase in TrkB receptor protein 
expression in cocaine-sired males may represent a compensatory adaptation to 
dysregulated BDNF signaling.  Further, we illustrated trends towards increased 
expression of tPA mRNA and protein in the hippocampus of cocaine-sired males at 
baseline.  However, this effect is not associated with increased mBDNF protein 
expression in cocaine-sired males, suggesting that the conversion of pro-BDNF to 
mBDNF by tPA is disrupted.  Given that acute cocaine did not enhance the anxiety 
phenotype of cocaine-sired offspring, it is possible that hippocampal activation by acute 
cocaine challenge promotes the secretion of greater levels of tPA than in saline-sired 
offspring.  This might result in higher expression of hippocampal mBDNF protein, the 
signaling through which creates a protective effect against the anxiogenic effects of 
cocaine.  Collectively, these results suggest dysregulated BDNF processing and 
signaling in the hippocampus of cocaine-sired males likely contributes to the expression 
of anxiety-like behaviors. 
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In conclusion, our findings indicated that paternal cocaine self-administration 
caused increased anxiety-like behaviors in male, but not in female offspring.  Cocaine-
sired males do not exhibit depressive-like behaviors, nor do they show altered 
corticosterone levels relative to saline-sired males in response to an acute stressor.  
Notably, acute exposure to cocaine followed by a 30-minute delay enhanced latency to 
feed in saline-sired, but not cocaine-sired males.  We observed increases in mRNA 
and/or protein expression of CRF R2, tPA, TrkB, and proBDNF, in the hippocampus of 
cocaine-sired males.  Altered signaling through CRF and BDNF pathways is correlated 
with anxiety-like phenotypes and dysfunction of hippocampal-HPA axis control.  Thus, 
sire cocaine experience promotes a sex-specific, anxiety-like phenotype in offspring, 
potentially via modifications to proteins in the hippocampus known to influence mood 
regulation. 
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TABLE 4.1 
Primer Sequences Gene 
Forward Reverse 
Fold 
change 
(± SEM) 
P value 
Bdnf CCATAAGGACGCGGACTTGTAC AGACATGTTTGCGGCATCCA
GG 
1.05 
(± 0.07) 
0.6423 
Crhr1 CTGAACCCTGTGTCCACCTC CACTCCCGGTAGCCATTGTT 1.05 
(± 0.15) 
0.8434 
Crhr2 CAAGTACAACACGACCCGGA TGATGATGAGGGCGATTCGG 2.40 
(± 0.68) 
0.0268* 
Plat GCGGCCTGAGGCAATACAAA GAACTGATCAGCACCCCTCC 1.35 
(± 0.17) 
0.0862# 
5htr1a CTGTTTATCGCCCTGGATG ATGAGCCAAGTGAGCGAGAT 1.03 
(± 0.13) 
0.8742 
Ntrk2 GCTCTGACAGTGTTGACAGGAC AGAAAGAGACAATGCCAGAA
GC 
1.09 
(± 0.11) 
0.5704 
 
Hprt GTCAAGCAGTACAGCCCCAA TGGCCACATCAACAGGACTC housekeeper 
Tuba4a AGGCTCGAGAGGATATGGCT AACACAGTGAACAGGGCTCC housekeeper 
Gapdh AAGATTGTCAGCAATGCATCC ACTGTGGTCATGAGCCCTTC housekeeper 
 
Male offspring mRNA expression levels in hippocampus. Sequence summary 
and statistics of measured mRNA transcripts from the hippocampus of saline-sired 
(n=4-5) and cocaine-sired (n=8) male offspring.  Fold change of mRNA expression 
levels (mean ± SEM) were analyzed using a two-tailed t-Test. * indicates significant 
difference due to sire (p<0.05). # indicates significant trend due to sire (p<0.10).  
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FIGURE 4.1 
 
Cocaine-sired male offspring increased anxiety-like behavior. Data are 
expressed as latency (s, mean ± SEM) to ingest peanut butter chips in a familiar 
(home cage) or novel environment during a 15-minute test session. A) Cocaine-sired 
male offspring (n=10) have significantly increased latencies to feed compared to 
saline-sired male offspring (n=9).  Bonferroni post hoc p<0.001 for cocaine-sired vs. 
saline-sired latency in the novel environment. B) There is no difference between 
cocaine-sired (n=10) and saline-sired (n=9) female offspring latency to feed in the 
novel environment. All animals displayed increased latency to feed in the novel 
environment (significant main effect of environment for males and females, 
p<0.0001). 
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FIGURE 4.2 
 
Acute cocaine increases latency to feed in a novel environment. Data are 
expressed as latency (s, mean ± SEM) to ingest peanut butter chips in a familiar 
(home cage) or novel environment during a 15-minute test session.  Animals received 
0 (n=4), 2.5 (n=4), or 5 mg/kg (n=4) cocaine (i.p.) 30 minutes prior to all test sessions.  
Cocaine dose-dependently increased latency to feed in the novel environment, but 
not the homecage. Bonferroni post hoc p<0.01 for 2.5 mg/kg and p<0.001 for 5 mg/kg 
relative to 0 mg/kg cocaine (i.p.) in the novel environment. 
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FIGURE 4.3 
 
Acute cocaine increases latency to feed equally regardless of sire. Data are 
expressed as latency (s, mean ± SEM) to ingest peanut butter chips in a familiar 
(home cage) or novel environment during a 15-minute test session.  Animals received 
the 2.5 mg/kg dose of cocaine (i.p.) 30 minutes prior to all testing sessions to avoid 
potential ceiling effects at the 5 mg/kg dose.  A) Pre-exposure to 2.5 mg/kg cocaine 
(i.p.) significantly increases latency to feed in saline-sired male offspring.  Bonferroni 
post hoc p<0.01 for 2.5 mg/kg (n=6) relative to drug-naïve (n=9) animals in the novel 
environment.  B) Pre-exposure to 2.5 mg/kg cocaine (i.p.) did not enhance latency to 
feed in cocaine-sired male offspring. The novel environment increased latencies in 
drug-free (n=10) and pre-exposed (n=6) animals (main effect of environment 
p<0.001). 
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FIGURE 4.4 
 
Sire cocaine experience does not influence offspring depressive-like behaviors. 
Data are represented as counts (mean ± SEM) of immobility, swimming, or climbing 
behaviors recorded every 5 seconds during a 5 minute forced swim. Cocaine-sired 
(n=4) and saline-sired (n=4) male offspring had no significant difference in immobility, 
swimming, or climbing following Bonferroni post hoc analysis. 
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FIGURE 4.5 
 
Sired cocaine experience does not affect response to an acute stressor. Serum 
corticosterone concentration (pg/mL, mean ± SEM) was measured 15 minutes 
following a single 5-minute forced swim.  Cocaine-sired (n=7) and saline-sired (n=7) 
female offspring had significantly increased corticosterone levels (p<0.0001) 
compared to cocaine-sired (n=5) and saline-sired (n=5) male offspring.  There was no 
effect of sire cocaine experience on serum corticosterone levels.  
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FIGURE 4.6 
 
Cocaine-sired male offspring have increased hippocampal expression of 
cellular and molecular correlates of anxiety. Select mRNA data from Table 1 are 
graphically represented as fold change (mean ± SEM) of select hippocampal 
transcripts. A) Cocaine-sired male offspring (n=8) showed a trend towards increased 
expression of Plat transcript (p<0.0863) and significantly increased expression of 
Crhr2 transcript (p<0.0269) compared to saline-sired male offspring (n=4-5). There 
was no effect of sire on Bdnf, Crhr1, 5htr1a, or Ntrk2 expression levels. 
Total homogenate hippocampal protein expression levels (mean ± SEM) were 
quantified using western blot. B) Cocaine-sired male offspring (n=6-8) showed 
significantly increased expression levels of proBDNF (p<0.0293) and CRFR2 
(p<0.0065), with a trend towards increased tPA (p<0.0605) and TrkB (p<0.0597) 
compared to saline-sired male offspring (n=4-6).  There was no effect of sire on 
mBDNF expression levels. 
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CHAPTER FIVE 
 
GENERAL DISCUSSION AND FUTURE DIRECTIONS 
Samantha L. White 
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Cocaine abuse in the United States represents a costly public health concern 
lacking efficient, lasting treatment methods.  Five years after successfully completing 
long-term behavioral treatment for cocaine addiction, 25% of subjects report relapsing to 
weekly cocaine use and almost 50% of those unable to participate in long-term 
treatment programs succumb to relapse (Simpson et al., 2002).  Preclinical work using 
rodent cocaine self-administration and reinstatement paradigms can help delineate the 
mechanisms underlying human cocaine addiction and relapse.  Findings from studies 
using this animal model may lead to novel pharmacotherapeutic interventions that, when 
applied with current behavioral treatment methods, can reduce the burden of this 
addiction on our society.  The research presented in this dissertation examined the 
effects of cocaine experience on brain reward circuitry during initial exposure and during 
cocaine priming-induced reinstatement.  Additionally, these findings were expanded to 
include the consequences of paternal cocaine self-administration on the neurobiology 
and behavior of drug-naïve offspring.  Together, these results have expanded our 
understanding of how cocaine exposure negatively influences neurological functions in 
both the addict and progeny, simultaneously identifying novel biochemical targets for 
potential treatment interventions and highlighting the pressing need to stop this disease. 
Immediate Compensatory Response Following Cocaine Exposure 
The data presented in chapter two described transient, compensatory biochemical 
adaptations in the DL striatum during the early stages of drug use.  Increased 
phosphorylation of CaMKII (thr286) and GluA1 subunits (ser831) was illustrated in the 
DL, but not DM, striatum of rats following an acute, systemic injection of cocaine 
(10mg/kg, i.p.).  Animals with cocaine self-administration experience and those exposed 
to cocaine priming-induced reinstatement exhibited unaltered protein expression levels 
relative to saline-exposed control rats.  These results indicated that a tolerance to 
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cocaine-mediated biochemical adaptations in the DL striatum developed with extended 
cocaine exposure. 
  Altered protein expression in the DL striatum during early cocaine exposure 
represents previously unidentified involvement of this brain region during the initiation of 
cocaine seeking.  Historically, reward signaling in the DL striatum occurs subsequent to 
transmission in the ventral striatum, a transition that requires extended cocaine exposure 
and the development of habit-based drug responding (Pierce and Vandeschuren, 2010; 
Willuhn et al., 2012).  In fact, very little literature defines a role for the DL striatum 
following limited cocaine experience, while a large body of evidence indicates a 
multitude of biochemical and electrophysiological cocaine-mediated adaptations, 
particularly to the glutamatergic system, in the nucleus accumbens (Ferrario et al., 2010; 
McKee et al., 2005; Anderson et al., 2008; Edwards et al., 2007; Ortinski et al., 2012).  
Interestingly, transgenic mice expressing constitutively active striatal CaMKII exhibit 
deficits in goal-directed behavior, suggesting the relationship between drug exposure 
and biochemical modifications in the striatum is sensitive to time and experience 
(Wiltgen et al., 2007).  It remains to be seen, however, how the post-translational 
modifications illustrated in the DL striatum might affect the development of cocaine self-
administration and reinstatement.  Future experiments that manipulate DL striatal 
CaMKII and/or GluA1 phosphorylation at initial cocaine exposure and examine the 
consequences the expression of cocaine priming-induced reinstatement behaviors are 
warranted.  
 The results outlined in chapter two agree with a body of work suggesting DL 
striatum function is not necessary during priming-induced reinstatement.  Indeed, the 
lack of DL striatal protein expression and phosphorylation changes following cocaine 
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self-administration training and cocaine reinstatement suggests signaling in this region is 
not enlisted for these stages of cocaine experience.  Processing of the rewarding effects 
of cocaine first occurs through projections from the VTA to the accumbens shell and 
core in the ventral striatum before extending into the dorsal striatum (Porrino et al., 
2004).  Manipulations that disrupt activity in the ventral striatum to modulate cocaine 
self-administration or priming-induced reinstatement have no effect on this behavior 
when applied to the dorsal striatum (Bari and Pierce, 2005; Vassoler et al., 2008).  
Additionally, I found that selective blockade of CP AMPARs in the DL striatum during 
cocaine priming-induced reinstatement had no effect on drug-seeking behavior despite 
being very effective in the nucleus accumbens (see Chapter three, Figure 3.1C).  While 
there is some evidence of gene and protein expression changes in the DL striatum in 
animals with moderate cocaine self-administration experience, it is likely that the bulk of 
the biochemical adaptations necessary for priming-induced reinstatement do not occur in 
this region (Brown et al., 2011; Edwards et al., 2007; Pierce and Wolf, 2012).  In fact, it 
is possible that processing in the ventral striatum and other areas of the reward system 
necessary for cocaine reinstatement underlie the reversal of modifications measured in 
the DL striatum after acute exposure.  Reward processing in these regions can occur 
exclusive to the DL striatum through early stages of addiction, leaving insufficient 
positive feedback to maintain any modifications in the DL striatum (Bear, 2007).  
Unlike reinstatement with a cocaine prime, cued reinforcement typically involves 
extensive training and cocaine experience, is more resistant to devaluation, and 
correlates with the shift from ventral to dorsal striatum signaling (Di Ciano and Everitt, 
2005; Everitt et al., 2008; Pierce and Vanderschuren, 2010).  Following extensive 
training, strengthening of excitatory synapses in DL striatal neurons is observed, 
indicating reliance upon this region for the signaling of habit-based behaviors (Yin et al., 
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2009).  Inactivation of the DL striatum after cocaine seeking has become insensitive to 
devaluation (i.e. habitual) produces responding sensitive to outcome devaluation, 
suggesting a reversal to goal-directed, ventral striatum control (Zapata et al., 2010).  The 
short-access, 2-hour daily self-administration sessions employed in chapter two were 
likely insufficient to progress from goal-directed to habit-based drug seeking.  It is 
anticipated, therefore, that additional changes to DL striatum protein expression would 
have been observed had animals been trained to associate drug delivery with a cue or if 
cocaine experience had been sufficiently extended.   
The findings of chapter two point to temporary involvement of the DL striatum 
upon initial exposure to cocaine in spite of its established role in habit-based drug-
seeking behaviors.  The connection between cocaine-mediated compensatory 
adaptations in the DL striatum after acute exposure, adaptations identified in the reward 
system following additional drug experience, and the association with behavioral 
correlates of addiction and relapse require closer investigation.  Conceivably, 
adaptability in the biochemical environment of the DL striatum upon initial exposure to 
cocaine could play a pivotal role in vulnerability to habit-based drug seeking.  
Consideration of how cocaine modulates the reward system prior to the point at which 
an individual might be considered addicted is thus required when attempting to identify 
therapeutic interventions. 
Calcium-Permeable Glutamate Receptors During Priming-induced Reinstatement 
Chapter three presented evidence that CP-AMPAR transmission in the nucleus 
accumbens requires interactions with GluA1-containing AMPAR accessory protein 
SAP97 and is necessary for cocaine priming-induced reinstatement.  The CP-AMPAR 
antagonist Naspm or HSV vectors expressing “pore dead,” ion-impermeable GluA1 
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subunits (GluA1-Q582E) administered into either the core or shell of the nucleus 
accumbens attenuated reinstatement of cocaine-seeking behavior.  However, disruption 
of CP-AMPAR transmission in the shell led to a specific effect on cocaine seeking, while 
intra-core Naspm attenuated both cocaine and food-seeking behaviors.  Additionally, 
over-expression of functional GluA1 subunits (GluA1-WT) in the shell, but not the core, 
prior to a low-dose priming injection of cocaine promoted reinstatement behavior, and 
miRNA-mediated knock down of GluA1 accessory protein SAP97 in the shell attenuated 
the reinstatement of cocaine seeking.  Together, this data demonstrates a role for 
accumbens CP-AMPARs during cocaine priming-induced reinstatement, but also 
implicates a protein that does not directly influence ionic or neurotransmitter 
concentrations as a novel target for pharmacotherapeutic manipulations. 
 Cocaine-mediated dopaminergic signaling differentially modulates glutamatergic 
transmission in the accumbens core and shell to convey information regarding reward.  
VTA dopaminergic projections first reach the shell, which then provides GABAergic 
feedback to the VTA before signaling reaches the core (Day and Carelli, 2007).  During 
cocaine priming-induced reinstatement, activation of dopamine receptors in the shell 
alters AMPA receptor expression through a sequence of intracellular signaling cascades 
that enhances expression of GluA1-containing AMPARs to mediate behavior (Anderson 
et al., 2008; Famous et al., 2008; Ping et al., 2008).  The primary alteration in accumbal 
AMPARs following cocaine experience is a shift from CI- to CP-AMPARs (for a review, 
see: Pierce and Wolf, 2012 and Wolf and Tseng, 2012).  In chapter three, manipulations 
of CP-AMPAR transmission in the core and shell subregions differentially affected 
natural and drug reward-seeking behaviors.  This provides further evidence that 
modulation of glutamatergic transmission in the accumbens subregions by rewarding 
stimuli leads to divergent neurobiological and behavioral outcomes. 
	   124	   	  
Signaling in the accumbens shell is likely to mediate drug-specific reward 
efficacy, while the core may have a more general effect on reinforced behaviors.  
Previous research shows dopamine receptor antagonists infused into the shell 
selectively reduced cocaine self-administration, while the same antagonists attenuated 
both cocaine and food self-administration when microinjected into the core (Bari and 
Pierce, 2005).  Given that dopaminergic transmission modulates glutamatergic 
transmission, one might predict a similar effect on behavior following application of 
glutamate receptor antagonists.  However, injection of the broad AMPA/Kainate receptor 
antagonist CNQX into the core or shell selectively attenuates cocaine priming-induced 
reinstatement and has mixed consequences for the reinstatement of food seeking 
behavior (Park et al., 2002; Famous et al., 2008; Xie et al., 2012).  I showed that intra-
shell injection of Naspm selectively attenuated cocaine priming-induced reinstatement 
while intra-core microinjection also attenuated food reinstatement.  These findings 
indicate that CP-AMPAR blockade within the shell does not lead to generalized motor 
deficits nor deficits in operant learning.  However, transmission through accumbens core 
CP-AMPARs plays a more general role in the reinforcing efficacy of stimuli.  This 
suggests that potential pharmacotherapies for addiction targeting CP-AMPARs within 
the entire nucleus accumbens, or the core specifically, is likely to produce side effects. 
The inability of intra-core HSV GluA1-Q582E to modulate reinstatement of food-
seeking behavior challenges the hypothesis that CP-AMPAR transmission in this region 
plays a general role in reward.  One explanation is that while HSV exhibit a high infection 
rate in neuronal populations, fluorescent imaging provided qualitative evidence that a 
significant percentage of MSNs were not infected following in vivo injections (see Figure 
3.3B; Neve et al., 2005).  This might suggest that while intra-core over-expression of 
GluA1-Q582E attenuated cocaine reinforcement, a sufficient number of unaffected 
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neurons remained to allow for CP-AMPAR signaling of food reward.  An alternative 
option is that the dominant-negative GluA1 subunits incorporate into the vast majority of 
AMPARs, producing a general attenuation of AMPAR transmission similar to that of the 
less selective antagonist, CNQX.  This is supported by electrophysiological data 
illustrating a general reduction in AMPAR-mediated excitatory post-synaptic potentials 
(Figure 3.2B).  As non-selective AMPAR antagonists do not alter food-seeking behavior 
when microinjected into the core (Kelley and Swanson, 1997; Park et al., 2002), the 
effects of the virus on CI-AMPARs in the core may counter the role of CP-AMPARs.  
Given these findings, it is likely that HSV GluA1-Q582E injection into the accumbens 
core did not specifically reduce transmission through CP-AMPARs to the same degree 
as intra-core injection of Naspm.  Further, this suggests that cocaine priming-induced 
reinstatement is more sensitive to CP-AMPAR modulation than the reinstatement of 
more evolutionarily advantageous natural rewards. 
  Regardless of the method with which CP-AMPARs were manipulated, the 
involvement and necessity of functional CP-AMPAR transmission in the accumbens 
shell during the reinstatement of cocaine seeking was clearly illustrated in chapter three.  
AMPAR activation in the accumbens shell is known to elicit cocaine-seeking behavior to 
a greater degree than activation in the core (Ping et al., 2008).  Disrupting the 
incorporation of GluA1-containing AMPARs into the cell surface of the accumbens shell, 
potentially requiring simultaneous removal of GluA2-containing AMPARs, attenuates 
cocaine priming-induced reinstatement (Anderson et al., 2008; Famous et al., 2008; Ping 
et al., 2008; Bredt and Nicoll, 2003).  Similarly, my data showed attenuation of cocaine 
reinstatement following disrupted transmission through CP- and GluA1-containing 
AMPARs in the shell, in association with reduced CP-AMPAR-mediated currents.  
Further, over-expression of functional GluA1 subunits in the shell, but not the core, 
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promoted cocaine-seeking behaviors in response to a sub-threshold cocaine priming 
injection.  This suggests that glutamate, presumably released from vmPFC efferents, 
binds specifically to GluA1-containing AMPARs in the shell to signal perception of 
reward following re-exposure to cocaine.  In support of these findings, another group 
illustrated attenuation of D1-like dopamine receptor-mediated reinstatement of cocaine 
seeking following over-expression of GluA1-Q582E in the core (Hobson et al., 2013).   
There is some disagreement between my findings and those of other groups who 
have used viral manipulations of AMPAR transmission in the accumbens subregions.  
One study indicates that intra-core GluA1-Q582E promotes, while GluA1-WT attenuates, 
cocaine priming-induced reinstatement (Bachtell et al., 2008).  Methodological 
differences, including different self-administration and withdrawal procedures, are most 
likely responsible for these discrepancies.  Another study finds intra-core AMPA-induced 
reinstatement is enhanced by GluA1-WT expression in the core, whereas intra-core 
expression of GluA1-WT had no effect in my experiments (Hobson et al., 2013).  Hobson 
et al. (2013) target a more medial portion of the accumbens core where viral 
microinfusions are likely to overlap onto projections of the accumbens shell (Meredith et 
al., 2008).  Thus, it is possible that unintentional GluA1-WT expression in the 
accumbens shell mediated the enhancement of reinstatement behavior.  Alternatively, 
assuming viral spread is isolated to the core, it is possible that GluA1-WT over-
expression increases the population of core CI-AMPARs.  It is possible that synthetic 
AMPA-mediated activation of a large population of calcium-impermeable AMPARs 
sufficiently enhances MSN depolarization to alter behavioral output.  This implies that 
cocaine-mediated glutamate release does activate the same proportion of AMPARs, 
which could explain the need for CP-AMPARs in order to observe changes to behavior.  
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On a broader note, these discrepancies underscore limitations and pitfalls of using 
varied reinstatement procedures to model the same human behavior.            
GluA1-containing AMPAR Accessory Proteins: Novel Targets During Cocaine 
Reinstatement 
CP-AMPARs lack the GluA2 subunit and contain GluA1 subunits, making the trafficking, 
stabilization, and function of GluA1-containing AMPARs in the accumbens shell an 
integral part of cocaine priming-induced reinstatement (Lee, 2012).  Previous work 
indicates expression of GluA1 subunits, particularly at the cell surface of the shell, is vital 
to the reinstatement of cocaine-seeking behaviors (Anderson et al., 2008; Ping et al., 
2008).  In fact, intra-shell expression of an interfering peptide containing the GluA1 C-tail 
binding domains of most known accessory proteins for GluA1 prevents the trafficking of 
endogenous GluA1-containing AMPARs to the cell surface and attenuates cocaine 
priming-induced reinstatement (Anderson et al., 2008).  Two accessory proteins that 
support GluA1-containing AMPARs are SAP97 and 4.1N, the interactions with which are 
likely disrupted by the GluA1 C-tail peptide (Lisman et al., 2012).  In chapter three, I 
used alternative methods to selectively disrupt interaction of endogenous GluA1 with 
4.1N or SAP97.  I found that SAP97, but not 4.1N, interaction with GluA1-containing 
AMPARs in the acumbens shell is necessary for the cocaine priming-induced 
reinstatement of drug seeking.  This novel finding brings to light a specific mechanism by 
which transmission through GluA1-containing CP-AMPARs can increase in the 
accumbens shell to mediate cocaine-seeking behaviors. 
My initial hypothesis that protein-protein interactions between GluA1-containing 
AMPARs and protein 4.1N were required for cocaine reinstatement was not correct.  The 
C-terminal domain (CTD) of 4.1N binds the membrane proximal region of GluA1 
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subunits to stabilize GluA1-containing AMPARs at the actin-spectrin cytoskelton, and 
knockdown of 4.1N reduces the insertion of GluA1 subunits into the cell surface in vitro 
(Anggono and Huganir, 2012; Lin et al., 2009).  Theoretically, HSV-mediated over-
expression of a dominant-negative peptide of the CTD would bind endogenous GluA1 
subunits without interacting with the plasma membrane and cytoskeleton, disrupting the 
stabilization of GluA1-containing AMPARs, thus attenuating cocaine priming-induced 
reinstatement.  Following accumbal microinjection, viral expression was confirmed via a 
50% increase in 4.1N protein and fluorescence of GFP co-packaged with 4.1N-CTD (see 
Figure 3.5).  Thus, it is unlikely that an absence of behavioral effect was due to 
methodological issues with the virus.  However, due to redundancy in this system, it is 
possible that despite binding to 4.1N-CTD, GluA1-containing AMPARs interacted with 
other accessory proteins to successfully incorporate into the cell surface (Lisman et al., 
2012; Jackson and Nicoll, 2011).  For example, regardless of 4.1N-CTD binding, GluA1 
subunits might still directly interact with SAP97 and, through SAP97 association with 
endogenous 4.1N, indirectly interact with endogenous 4.1N.  Future experiments using 
co-immunoprecipitation to examine such interactions are warranted, as this would allow 
for unimpeded trafficking, stabilization, and function of GluA1-containing AMPARs.  
In support of the idea that SAP97 may play a more critical role in the function of 
GluA1 subunits, we found that disrupting the association between SAP97 and GluA1-
containing AMPARs attenuated cocaine priming-induced reinstatement of drug seeking.  
The second PDZ domain of SAP97 binds the PDZ binding motif at the extreme C-tail of 
GluA1 subunits while various other domains enable SAP97 to anchor at the plasma 
membrane (Cai et al., 2002; Zheng et al., 2011).  Although some suggest this interaction 
is connected to the trafficking of GluA1-containing AMPARs to the cell surface 
(Passafaro et al., 2001; Nikandrova et al., 2010) others indicate the interaction is not 
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required for GluA1 subunit trafficking, but instead enhances synaptic stabilization, the 
formation of dendrites, and AMPAR transmission (Kim et al., 2005; Zhou et al., 2008; 
Howard et al., 2010).  Regardless of the mechanism through which SAP97 modulates 
GluA1-containing AMPAR transmission, I demonstrated that knockdown of SAP97 using 
a micro (mi) RNA that reduces endogenous SAP97-GluA1 interactions attenuated the 
reinstatement of cocaine-seeking behaviors 96 hours after microinjection into the shell.  
This novel result identifies SAP97, not the AMPA receptor itself, as a target for potential 
pharmacotherapeutic interventions to prevent cocaine relapse.  Modulating one of many 
intracellular accessory proteins instead of receptors might allow for more finely tuned 
adjustment of excitatory transmission that is likely to reduce side effects (like the inability 
to signal natural rewards). 
Due to discrepancies in the literature, it was unclear how HSV miSAP97 
influenced CP-AMPARs to attenuate drug-seeking behavior.  Unpublished in vitro 
experiments indicate HSV miSAP97 significantly reduced SAP97 protein expression 
levels in numerous culture systems.  Although miSAP97 appeared to knockdown 
endogenous SAP97 by 30% in vivo, these results did not reach significance, likely due to 
background noise from uninfected neurons.  The question remained: what were the 
consequences for GluA1-containing AMPARs in miSAP97-infected MSNs?  Surface 
biotinylation of accumbens from drug-naïve animals that received microinjections of HSV 
miSAP97 or a scrambled miRNA revealed no change in cell surface expression of GluA1 
or GluA2/3 AMPAR subunits (data not shown).  Preliminary electrophysiological 
recordings from infected and uninfected MSNs of drug-naïve animals following miSAP97 
microinfusion hinted at attenuated synaptic strength and reduced inward rectification 
(data not shown), the hallmark of CP-AMPARs, in infected cells (Tanaka et al., 2000).  
Together, these findings indicate that GluA1-containing AMPARs are still able to traffic 
	   130	   	  
and insert into the cell surface despite SAP97 knockdown, but without SAP97 the 
receptors are possibly dysfunctional, resulting in attenuated CP-AMPAR transmission.  A 
caveat to this conclusion is that the biochemical and electrophysiological assays of HSV 
miSAP97 were performed in drug-naïve rodents.  Given evidence that surface 
expression of GluA1 subunits increases in the shell during cocaine priming-induced 
reinstatement, examination of the receptor trafficking and electrophysiological profiles of 
infected neurons during cocaine reinstatement is necessary.  Further, these experiments 
could be extended to include other scaffolding proteins known to traffic GluA1-containing 
AMPARs, such as stargazin, to confirm the necessity of CP-AMPAR cell surface 
expression to mediate the behavioral effects of cocaine (Tomita et al., 2005; Bedoukian 
et al., 2006; Ferrario et al., 2011b; Ferrario et al., 2011a; Jackson and Nicoll, 2011).  
Finally, in addition to the PDZ 2 domain that binds GluA1 subunits, SAP97 contains at 
least 6 additional domains and inserts known to interact with a variety of receptors and 
accessory proteins (Zheng et al., 2011).  It is conceivable that SAP97 knockdown 
attenuates signaling through CP-AMPARs due to disruption of intracellular complexes at 
the post-synaptic density.  Additional experiments involving proteomic analysis of the 
PSD in drug naïve and drug experience animals, as well as examination of protein 
expression and protein-protein interactions in the PSD following HSV miSAP97 
microinfusions would clarify the mechanism through which this virus attenuates cocaine 
priming-induced reinstatement. 
Collectively, the results of chapter three highlight manipulations of CP-AMPA 
receptors, which are known to mediate cocaine-seeking behavior, that could generate 
new pharmacotherapies to prevent relapse in a clinical setting.  The circuitry involved in 
drug addiction, and biochemical modifications therein, shares amazing similarity with 
that used for learning and memory for adaptive behaviors in general (Kelley, 2004).  
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Accordingly, there is a need for sensitive and selective targeting of the mechanisms 
underlying addictive behaviors in an effort to avoid disrupting the function of natural 
reward systems (Hyman et al., 2006).  Recent clinical trials on cocaine vaccines that 
produce antibodies to prevent the drug from entering the brain are promising, but face 
issues in maintenance of therapeutic antibody titers as well as ethical dilemmas that 
preclude their use in the near future (Shen et al., 2012).  Short of directed brain surgery 
(see: Vassoler et al., 2008), most biological treatments will have an effect on the entire 
brain, potentially leading to undesired results.  Thus, though preventing ion conductance 
through CP-AMPARs in the accumbens attenuated the reinstatement of cocaine 
seeking, the same treatment in the hippocampus might dramatically disrupt learning and 
memory (Lisman et al., 2012).  Due to redundancy in receptor trafficking and 
stabilization, targeting accessory proteins, however, might allow for selective intervention 
in one system (the accumbens reward pathway) with fewer side effects in others 
(hippocampal-dependent memory) (Anggono and Huganir, 2012).   
Intergenerational Consequences of Cocaine Use 
Research into the treatment of cocaine addiction and relapse is largely focused on the 
direct effects of cocaine on the user, but a growing body of evidence suggests that there 
are biological and behavioral consequences for subsequent generations as well. 
Environmental challenges, including drug exposure, experienced by ancestors modulate 
the physiology and behavior of subsequent generations (Champagne, 2010; Feil and 
Fraga, 2012; Nestler, 2013).  In humans, parental drug use greatly increases the 
likelihood of developmental and behavioral deficits, including drug abuse, in future 
generations (Merikangas et al., 1998; Kendler et al., 2007).  However, it is difficult to 
separate the genetic and environmental factors that alter the phenotypes of the children 
of parents who abuse drugs like cocaine (Goldman et al., 2005).  Rodent models, such 
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as the cocaine self-administration and reinstatement paradigm employed in this 
dissertation, provide controlled environmental conditions that allow for more selective 
investigations into the ability of cocaine to induce epigenetic changes.  Delineating the 
inheritance of traits due to parental cocaine exposure will help to create more 
appropriate resources, addiction-related or otherwise, for the children of addicts. 
 The paradigm described in chapter four of this dissertation focuses on the 
potential epigenetic inheritance of neurobiological and behavioral phenotypes through a 
paternal lineage. The vast majority of preclinical addiction research, including that 
described in chapters two and three, utilized male rodents to ascertain the effects of 
cocaine on the brain.  Females (across species) show differences in initiation and 
escalation of drug-seeking behavior and have differences in dopaminergic signaling in 
brain reward regions – all of which are modulated by ovarian hormones (Becker and Hu, 
2008).  Accordingly, using a paternal lineage model ensures consistency from studies of 
direct cocaine exposure to those examining intergenerational consequences.   
From an epigenetic perspective, paternal exposure ensures the transmittance of 
sire cocaine experience occurs via genetic and epigenetic material contained in sperm 
alone (Curley et al., 2011).  We have previously established that paternal cocaine self-
administration prior to mating had no effect on the breeding or nurturing abilities of the 
drug-naïve dams (Vassoler et al., 2013).  Thus, the development and maturation of first 
generation offspring occurred in a completely drug-free context.  Although half of the 
genetic material of the first generation was subject to cocaine exposure, precluding any 
conclusions on inherited epigenetic modifications to the germline, future studies that 
track phenotypic differences into the second generation will provide evidence of the 
long-lasting, transgenerational effects of cocaine.  Regardless of their context-dependent 
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nature, the findings of Vassoler et al. (2013) and those outlined in this dissertation 
provide vital evidence of the effects of cocaine outside of glutamatergic transmission in 
the reward system. 
Paternal Cocaine Exposure Confers An Anxiety Phenotype 
Expanding upon previous work illustrating a cocaine-resistance phenotype in male, but 
not female, offspring of cocaine-experienced sires, I identified an anxiety-like phenotype 
in cocaine-sired male offspring (Vassoler et al., 2013).  My experiments uncovered 
increased anxiety-like behavior in drug-naïve cocaine-sired male offspring, suggesting 
intergenerational transmittance of the anxiogenic effects of cocaine.  The anxiogenic 
properties of cocaine use are well documented across clinical and preclinical research 
(for review: Ettenberg, 2009; Erb, 2010).  However, exposure to low-dose cocaine 
enhanced anxiety-like behavior of saline-sired males without exacerbating the 
expression of anxiety in cocaine-sired males, as measured by latency to feed in a novel 
environment.  Our findings are in contrast to others who have described depressive-, but 
not anxiety-like, behaviors in the offspring of male mice exposed to non-contingent 
cocaine (Killinger et al., 2012).  It is likely that differences in species, paradigm, and 
behavioral test underlie the discrepancies of particular results from our study.  However, 
Killinger et al., came to a similar conclusion that sire cocaine experience alters the brain 
circuitry of mood stabilization in offspring.  Together, these findings indicate impaired 
emotional regulation in cocaine-sired male offspring.     
 Although the cellular and molecular correlates to the expression of anxiety are 
numerous, we identified select changes to mRNA and protein expression in the 
hippocampus of cocaine-sired male offspring.  The hippocampus is generally considered 
to have a role in negative feedback on stress and anxiety following HPA activation 
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(Herman et al., 2005; Jankord and Herman, 2008).  Cocaine exposure modulates 
hippocampal expression and signaling of CRF and BDNF (Sarnyai et al., 1993; Yan et 
al., 2004; Filip et al., 2006; Guan et al., 2009).  We found increased CRF R2 and tPA 
mRNA and protein expression and increased protein expression of proBDNF and TRkB 
receptor in the hippocampus of male cocaine-sired offspring.  While the mechanism 
through which these cellular and molecular changes mediate the anxiety phenotype 
requires further investigation, dysregulation of these signaling pathways in the 
hippocampus is clear.  Tying this dysregulation to epigenetic modifications of CRF and 
BDNF genes in the hippocampus was beyond the scope of this dissertation, but given 
evidence for cocaine-mediated epigenetic modifications in the sperm of sires as well as 
the mPFC of these offspring, future experiments using chromatin immunoprecipitation 
could uncover altered methylation and acetylation patterns in the hippocampus as well 
(Vassoler et al., 2013).  
Despite evidence for connections between the serotonergic system and anxiety 
(Bechtholt et al., 2007; Donaldson et al., 2013), particularly with regard to cocaine 
exposure (Filip et al., 2010; Ettenberg et al., 2011; Pentkowski et al., 2012), initial 
investigations revealed no changes in cocaine-sired offspring.  Given that male cocaine-
sired offspring exhibit cocaine-resistant and anxiety behavioral phenotypes, it is likely 
that some aspects of hippocampal serotonergic signaling are altered.  Future 
investigations into serotonergic release and the receptor populations in the hippocampus 
of these offspring are necessary. 
There is a wealth of data connecting hippocampal BDNF and the expression of 
anxiety.  A polymorphism in the pro-domain of BDNF (Val66Met) reduces the availability 
of mBDNF, potentially due to impaired processing of pro- to mBDNF by tPA, has been 
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correlated with increased anxiety in humans and anxiety-like behaviors, such as novelty 
induced hypophagia, in mice (Chen et al., 2006; Chen et al., 2008b).  Similarly, 
increased expression of proBDNF, decreased tPA activity, and increased LTD in the 
hippocampus due to prenatal stress exposure increases the expression of anxiety 
behaviors in offspring (Rice et al., 2007; Neeley et al., 2011; Yeh et al., 2012).  
Conversely, tPA cleavage of proBDNF to mBDNF mediates hippocampal LTP (Pang et 
al., 2004) and increased expression of mBDNF in the hippocampus using viral vectors or 
by systemic or intra-hippocampal injection decreases novelty induced hypophagia in 
addition to depressive-like behaviors in rodents, likely via signaling through Trk receptors 
(Shirayama et al., 2002; Schmidt and Duman, 2010; Quesseveur et al., 2013).  Further, 
viral-mediated knockdown of tPA in the dorsal hippocampus increases anxiety- and 
depressive-like behaviors, including latency to feed in NIH (Bahi and Dreyer, 2012).  
Bahi and Dreyer (2012) also show that over-expression of tPA in the hippocampus both 
reduces anxiety behaviors and increases expression of mBDNF protein.  Thus, 
dysregulation of the processing and signaling of BDNF in the hippocampus disrupts 
mood regulation, which may provide one mechanism for the anxiety phenotype observed 
in the cocaine-sired male offspring. 
 The mechanisms through which CRF acts in the hippocampus to mediate 
anxiety-like behaviors are more complex.  Both CRF receptors (R1 and R2) are 
expressed in the hippocampus, but their binding by CRF released following activation of 
the HPA axis does not produce the same effects (Primus et al., 1997; Bear, 2007).  In 
some instances, stress exposure promotes anxiety by increasing hippocampal 
expression of CRF R1 mRNA and protein, and a CRF R1 antagonist reduces the 
expression of anxiety (Wang et al., 2011).  Others have shown decreased expression of 
CRF R1 but increased expression of CRF R2 mRNA and protein in the hippocampus 
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following an acute restraint stress (Greetfeld et al., 2009).  A selective CRF R2 
antagonist administered into the ventricles reduces the expression of anxiety across a 
variety of behavioral tasks (Takahashi et al., 2001), but CRF R2 knockout mice typically 
display an impaired stress response and increased anxiety-like behaviors (Bale and 
Vale, 2004; Goel and Bale, 2007).  Cocaine withdrawal enhances both the expression of 
anxiety and hippocampal LTP, but application of a selective CRF R2 antagonist 
decrease withdrawal-mediated enhancement of LTP (Guan et al., 2009).  Interestingly, 
there is evidence of decreased CRF and CRF R1 expression in the hippocampus 
following cocaine exposure (Sarnyai et al., 2001).  With regard to anxiety, the exact role 
of CRF receptors in the hippocampus requires further investigation, though it appears 
possible that at least some of the anxiogenic effects of cocaine may arise from CRF R2 
signaling in the hippocampus. 
Concluding Remarks 
This dissertation provided evidence that cocaine exposure influences both the 
glutamatergic system in brain reward regions of the user and the circuitry that mediates 
emotional regulation in drug-naïve offspring of cocaine-experienced sires.  Though much 
evidence indicates cocaine exerts its rewarding effects through immediate modulation of 
the dopaminergic and glutamatergic systems, particularly in the nucleus accumbens, the 
findings presented here establish novel, compensatory adaptations to AMPARs and 
associated proteins in the DL striatum (Wolf et al., 2003; Schmidt et al., 2005; Schmidt 
and Pierce, 2010; Pierce and Wolf, 2013).  Given the established involvement of the DL 
striatum during habit-based drug seeking after extensive cocaine experience, the effects 
following acute exposure may indicate a more broad engagement of the 
mesocorticolimbic reward circuitry by cocaine that later becomes region-specific with the 
development of addiction (Pierce and Vanderschuren, 2010; Milton and Everitt, 2012).  It 
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remains to be seen, however, whether disrupting the changes observed in the DL 
striatum would enhance or attenuate the development of addiction.   
Continued cocaine experience promotes modifications of glutamatergic receptor 
proteins and altered excitatory transmission in the nucleus accumbens, which is 
particularly evident during cocaine priming-induced reinstatement (Anderson et al., 2008; 
Pierce and Wolf, 2013).  The results of this dissertation expanded upon this knowledge, 
identifying a necessity for CP-AMPAR transmission that requires interaction with 
accessory protein SAP97 in the accumbens shell to mediate the reinstatement of 
cocaine seeking.  Thus, therapies that manipulate accessory proteins to indirectly 
modulate receptor functioning may prove more fruitful in selectively combating addictive 
behaviors.  Further, research into pharmacotherapeutic interventions for addiction 
should consider not only the circuitry of the relapsing addict, but also those with very 
limited exposure to cocaine, as glutamatergic transmission in regions that process 
reward is susceptible to modification at all stages of use.  
Finally, although interventions focused on preventing deviant glutamatergic 
transmission in reward pathways are likely to address issues of addiction and relapse in 
the user, attention must be paid to the offspring of individuals with a history of cocaine 
use.  Cocaine use in one generation clearly influences the behavior and physiology of 
the following generation, potentially via epigenetic modifications to genetic material 
(Nestler, 2013).  The male offspring of cocaine-experienced rats exhibit altered reward 
processing (Vassoler et al., 2013) and, as illustrated in this dissertation, impaired 
emotional control.  That said, the consequences of parental cocaine use are likely to 
extend to other types of processing, such as that for executive function and learning and 
memory (He et al., 2006a; Ivanov et al., 2012; Buckingham-Howes et al., 2013).  
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Understanding the manners and mechanisms in which parental cocaine experience 
affects offspring, particularly given our understanding of cocaine-mediated adaptations in 
the brains of addicted individuals, will improve investigations into treatment therapies for 
all impacted by this drug of abuse.     
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